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Abstract
The current study evaluated interactions between the mycotoxins aflatoxin
Bi (AFBi) and fumonisin Bi (FBi) in pure systems as well as in com. During
storage at 25°C with high moisture (ca. 50%), com contaminated with Aspergillus
flavus (L I3) and/or Fusarium moniliforme (A00102) presented different aflatoxin
and fumonisin levels. Toxin production/degradation varied over storage time (0-45
days). Evaluation of the mutagenicity of unifungal or bifungal com extracts with
the Salmonella/microsomal assay (tester strains TA-100 and TA-98) with metabolic
activation (S9) showed positive mutagenic responses.
Different ratios o f pure AFB|/FBi produced divergent mutagenic responses
(tester strains TA-100 and TA-98) with S9. The mutagenicity of 103 ng AFBi/pIate
was reduced by addition o f 1 to 102 ng FBi/plate. Higher FBi concentrations (103 to
103 ng/plate) caused an opposite effect. The mutagenic potential of 2aminofluorene (2-AF) was also affected by FB|. This suggested that FBi affects the
enzyme systems responsible for activating AFBi and 2-AF.
Analysis by liquid chromatography of AFBi/AFBi-metabolites after
reaction with FBi and S9 showed decreased recovery when 103 ng AFBi were
exposed to 1 to 102 ng FBi, but at higher FBi levels (103 to 103 ng), recovery was
increased. Thin layer chromatography analysis of these samples suggested that
unidentified AFBi-metabolites derivatized with trifluoroacetic acid were indirectly
detected as AFBi.

xvii
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FBi (1 to 103 ng/plate) inhibited gap-junction intercellular communication
of Clone-9 rat liver cells. This could be a possible mechanism by which FBi acts as
a non-genotoxic carcinogen. Addition of 1 to 103 ng AFBi to 103 ng FBi did not
change the effect of FBi. An increase in the uptake of neutral red by Clone-9 rat
liver cells exposed to AFBj/FBi implied that peroxisome proliferation and
oxidative metabolism may be involved in AFBi/FBi interactions.
H2 O2 (3%) and NaHCC>3 (2%) were effective in decontaminating/
detoxifying aflatoxin-fumonisin naturally co-contaminated com without generating
mutagenic by-products.
This study showed preliminary evidence that simultaneous exposure to
AFB 1/FB 1 can give different toxicologicai responses than single exposure to either
of these compounds. More research is needed to better assess the toxicologicai
impact of AFB 1/FB 1 co-contamination and to develop possible control strategies.

xviii
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I.

Introduction
Aflatoxins and fiimonisins are mold secondary metabolites produced by

Aspergillus flavus and Fusarium moniliforme. respectively. The potential risks
associated with these metabolites have long been recognized. However, recent
reports have shown that aflatoxins and fiimonisins can co-contaminate com. This
poses new research and regulatory questions because information about the
potential hazards associated with simultaneous exposure to both toxins is not
available.
This is not uncommon since availability data on exposure and toxicity of
most chemical mixtures is limited, and roughly 95% of the research resources in
toxicology is still devoted to the study of single chemicals (Krishnan and Brodeur,
1991; Yang, 1994). Concurrent or sequential exposure to a multitude of chemicals,
e., food additives, mycotoxins, pesticides, environmental and occupational
pollutants, etc., is a real issue and has pointed to the necessity of exposure
assessment, hazard identification, and risk assessment of chemical mixtures.
Furthermore, there has been increased public and regulatory concern regarding
exposure to complex systems that has triggered the interest of scientists and
toxicologists in this challenging vanguard of toxicology (Cassee, 1998).
The study of chemical mixtures is controversial and has exacerbated debates
on concepts such as similar joint action and independent joint action versus
interaction of chemicals, design of experimental studies and analysis o f results.

1
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This project has focused on an initial in vitro approach in the study of a
mycotoxin mixture that frequently occurs in nature. This is a simplistic view
because these toxins co-exist in com, a more complex matrix that consists of tens,
hundreds or even thousands o f compounds. However, adequate testing of such
mixtures is virtually impossible; therefore, choosing a combination of two o f the
compounds that have been recognized as toxic and that have been reported to exist
in the same commodity could give better information on the activity of the mixture.
Furthermore, if all possible combinations of all possible compounds present in the
mixture were to be evaluated, a complete experimental design would grow in
exponential proportions, making adequate testing virtually impossible.
One of the main interests in the field of combination toxicology is to find
out whether the toxicity of a mixture is different from the sum of responses to the
single compounds. The genotoxic nature of aflatoxin Bj (AFBi) coupled with the
non-genotoxic status o f fumonisin Bi (FBi) and their ubiquitous, unpredictable and
unavoidable occurrence, triggered the interest in this area of research. The overall
objective of this project focused on studying the interactive effects of AFBi and
FBt in concentration ranges that can occur naturally as well as mechanisms of
toxicity and decontamination procedures.
The diverse components of this project concentrated on the study of
AFB i/FB i co-contamination from different perspectives. The first section focused
on the mycological aspects o f toxin production. The objective was to do a
preliminary evaluation of the production/degradation of both, aflatoxins and

2
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fumonisins in the same environment under optimal mold growth conditions. The
second objective centered on the evaluation of potential toxin interaction by testing
whether FB| had an effect on the mutagenic potential of AFBi. From this study,
two approaches were taken and explored. If FB| interacted with AFBi, was it
directly by chemical reaction of the toxin and/or toxin by-products or were there
mechanistic implications?
Changes in gap-junction intercellular communication have been proposed
as a non-genotoxic carcinogenesis mechanism. Since the role of fumonisin in
carcinogenesis is still unclear, the third objective was to determine whether FBi
affected gap-junction intercellular communication, and the subsequent role of
aflatoxin interaction in this toxic response.
Finally, since information on the potential risks associated with AFBi and
FBi is still limited, decontamination treatments were explored as options in
mycotoxin risk management. Therefore, the fourth objective of this study was to
evaluate the effectiveness of H2 O2 and/or NaHCC>3 in decontaminating/detoxifying
naturally contaminated com.
The toxicology of complex mixtures is still a new research area that poses
many new research and regulatory concerns. It is important to use an
interdisciplinary approach to better assess these issues and understand the risks
posed by simultaneous exposure to two or more mycotoxins.

3
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II.

Literature review

A.

Historical background
Mycotoxins have played an important role in the history of humankind.

Although the consumption of moldy food has not always been recognized as a
health hazard, mycotoxins have been intricately involved in the social, political,
and economical environment of cultures around the world. The earliest known
mold-associated disease is ergotism or “holy fire” that resulted from the
consumption of grains infected by the mold Claviceps purpurea. A gangrenous
form of ergotism was very common in Europe from the ninth to the fourteenth
centuries. The victims of this poisoning complained o f numbness in the limbs,
intense sensations of heat and cold, followed by gangrene; and eventually the loss
of the extremity. At this point in history, such afflictions were associated with
religious events rather than dietary practices. Thus, this mycotoxicosis was known
as St. Anthony’s fire and was associated with sinful behavior (Smith and Moss,
1985). Later, between the sixteenth and the nineteenth centuries, a form of
convulsive ergotism was described. This type of intoxication was also noted in the
United States where it was implicated in the Salem witchcraft trials of 1692
(Matossian, 1982). During the seventeenth century, a form of cardiac beriberi
associated with yellow rice toxins was described in Japan (Ueno, 1983). Also, other
diseases such as “red mold” or “scabby disease” have also been associated with rice
and rice products (Beuchat, 1978).

4
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Wars have shaped world history. As they bring about violent change, they
also make obvious alterations in the behavioral pattern of the population. Since
dietary practices are strongly related to this kind o f event, some wars have shaped
our understanding o f the impact of mycotoxins on human health. A particularly
severe mycotoxicosis, alimentary toxic aleukia (ATA), was first recognized in
Russia in 1913 where food shortages near Siberia forced the consumption of over
wintered grains (wheat, millet, and barely). The melting snow raised the moisture
content of the grains and favored mold growth and toxin production (Smith and
Moss, 1985). ATA has had a constant place in Russian history. In the twentieth
century, it reached epidemic proportions during and after World War II. In this
outbreak, mortality was as high as 60%. Highly toxic T-2 toxin and other
trichothecenes toxins were later confirmed to be the cause of the epidemic
(Bullerman, 1979; Ueno, 1987). Although mycotoxins have played an important
role in history, awareness of mold-related diseases was practically non-existent
until the 1960s. During this time, scientific attention focused in England where a
hepatotoxic disease in turkeys was reported. Thousands of poults died of an
unknown hepatic disease (Asplin and Camaghan, 1961; Blount, 1961; Lancaster et
al., 1961). This syndrome was dubbed as turkey "X” disease, and marked the
initiation o f formal research in mycotoxicology. Shortly after the first report of the
“X” disease, there were other reports of poisoned chickens and ducklings. All of
these syndromes were characterized by hepatic necrosis, marked bile duct
hyperplasia, acute loss of appetite, wing weakness, and lethargy (Blount, 1961).
5
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Later. Asplin and Camaghan (1961) identified the responsible toxins as metabolites
o f Aspergillus flavus. These toxins were chemically characterized by Asao et al.
(1963) and designated with the term aflatoxins. After this incident, the field of
mycotoxicology gained the interest of the scientific community, and research on
this area proliferated. Thus, in the last three decades, many other mycotoxins have
been identified and related to human and animal health problems.
Fusarium moniliforme is one of the most prevalent fungi associated with
com (Zea mays) throughout the world (Marasas et al., 1984). Although it has been
barely a decade since the fumonisins have been characterized as food-bome
mycotoxins, the toxicities associated with them have long been recognized. In
1881, Saccardo implicated Oospora verticilloides contaminated com with pellagra
in Italy. Years later, in 1902, Butler successfully reproduced equine Ieukoencephalomalacia (ELEM) in horses by feeding them with naturally contaminated
moldy com. Sheldon (1904) identified F. moniliforme as the causative agent of
com toxicoses in farm animals in the United States. Much later, in South Africa,
Kellerman et al. (1972) induced a hepatotoxic syndrome by feeding horses with F.
moniliforme culture material.

In 1976, Marasas and collaborators reproduced

ELEM in horses by feeding pure F. moniliforme culture material. Marasas (1981)
also reported that F. moniliforme is significantly more prevalent in com from
geographical areas with a high incidence of human esophageal cancer than in those
with low incidence. Subsequently, Marasas et al. (1984) were able to induce liver
cancer in rats by feeding a pure culture of F. moniliforme from South African com.

6

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Four years later, in 1988, Gelderblom demonstrated the cancer promotion activity
of F. moniliforme cultures in a rat short-term cancer initiation/promotion assay.
That same year, Gelderblom et al. isolated fumonisins Bi (FBi) and B2 (FB2 ) from
cultures of F. moniliforme MRC 826. The chemical structures of these toxins were
elucidated by Benzuidenhout et al. (1988). In 1988, intravenous injection of FBi
resulted in a syndrome resembling ELEM (Marasas et al., 1988). Thus, there was
evidence that FBi was the etiological agent o f ELEM. In 1989, confirmation was
provided when Laurent et al. isolated and characterized two new mycotoxins from
F. moniliforme: macrofusin and micromonilin. The structure of one these toxins,
macrofusin, proved to be identical

to FBi. In 1989, com screenings caused

widespread ELEM and porcine pulmonary edema (PPE) outbreaks in the United
States (Harrison et al., 1990; Ross et al., 1990; Wilson et al., 1990). After these
outbreaks, the scientific community gained interest in the recently characterized
mycotoxins.
Molds and mycotoxins have a considerable impact worldwide in terms of
public health, agriculture and economics. Naturally occurring toxicants are
unavoidable, unpredictable and pose a unique challenge to food safety. The Food
and Agriculture Organization of the United Nations has reported that the
production o f agricultural commodities is barely sustaining the world's increasing
population; and every year, at least 25% of the world’s food crops are contaminated
with mycotoxins. Mycotoxigenic fungi and their control pose a serious economic
impact around the world. They assert discernible costs to farmers, livestock and
7
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poultry producers, grain handlers, and food and feed processors. However, it is
difficult to estimate the actual economical losses due to the large variability of
incidence of mycotoxins among commodities, years and seasons. Roughly, the
Council for Agricultural Sciences and Technology (CAST) has estimated that in the
United States alone, twenty million dollars is lost annually on peanuts
contaminated with aflatoxin (CAST, 1989). The ubiquity of toxigenic molds (i.e.,
A. flavus and F. moniliforme), the importance of com as human food and animal
feed, reports of possible co-contamination with aflatoxins and fumonisins and the
implication of these toxins with diverse toxicological syndromes, has provoked an
increased scientific and regulatory interest. To date, there are still many questions
without answers. Thus, research in this area is abundant.
B.

Aflatoxins

1.

Mycology and occurrence
The ubiquity of A. flavus, as well as, its ability to colonize multiple

commodities has prompted a vast amount of work on the causes, course and
prevention of contamination. Earlier studies assumed that invasion was a function
of inadequate storage conditions (i.e., drying, temperature, and moisture).
However, newer studies have shown that, invasion before harvest is equally or
more important (McDonald and Harkness, 1967; Petit et al., 1971; Cole et al.,
1982; Klich et al, 1984). In com, pre-harvest invasion is primarily dependent on
insect damage of the developing cobs. The fungus can also invade by growing
down the silks of the developing ears (Jones et al., 1980; Lillehoj et al., 1980). The

8
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ability to grow as a non-destructive pathogen in the tissues of a variety of plants
over the normal range of food storage temperatures as well as the capacity to grow
at low water activities give A. flavus the potential to grow in the vast majority of
commodities if pre-harvest, harvest and storage conditions are less than ideal.
Weather conditions also play an important role in aflatoxin formation. Since
A. flavus is considered an opportunistic pathogen, any factor that affects the normal
development of the plant, will favor fungal invasion; and subsequently, toxin
production. Payne et al. (1986) showed that irrigation helped reduce aflatoxin
formation; and reported that drought stress led to an increased number of infected
kernels in silk-inoculated ears. Other environmental factors that affect toxin
production and accumulation include lack or excess of nitrogen, excessive plant
populations, and poor irrigation practices (Payne et al., 1989; Fortnum and
Manwiller, 1985; Anderson et al., 1975).
The aflatoxigenic species of the Aspergillus group include A. flavus, A.
parasiticus, and A. nomius. A. flavus and A. parasiticus may colonize the food/feed
and produce mycotoxins. The role of A. nomius in aflatoxin contamination of crops
is still unknown. Specific strains of A. flavus and A. parasitucus are capable of
producing aflatoxins Bi, B2 , G|, G2 , and Mi, and other related compounds (Wilson
and Payne, 1994). At the present time, the taxonomy of the A. flavus group is
uncertain. The differences between these fungi are often inconclusive, so it is
difficult to identify distinct species. According to Wicklow (1983) and Klich and
Pitt (1988), A. flavus and A. parasiticus are taxonomically distinct species.
9
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However, previous reports by Hesseltine et al. (1970) have described several
isolates with intermediate taxonomic characteristics between A. flavus and A.
parasiticus. In 1986 Kurtzman et al., complicated matters by proposing that both,
A. flavus and A. parasiticus were so closely related; so they should be considered
varieties of the A. flavus group. Therefore, they should be classified as A. flavus
var. flavus and A. flavus var. parasiticus. However, these classifications are only of
concern to the pure taxonomist. Most o f the literature refers to the toxigenic species
as the A. flavus group without further specifications.
Aspergillus flavus and Aspergillus parasitucus grow in Czapek yeast extract
agar (CYA) showing colonies o f 60-70 mm in diameter, plane, sparse to
moderately dense. The colonies are characteristically greyish green to olive yellow,
sometimes only yellow and become green with age. They are distinguished by their
rapid growth both at 25 and 37°C. The difference between these two species is that
A. flavus produces conidia which are variable in shape and size and have thin walls
that vary from smooth to moderately rough. In contrast, A. parasiticus conidia are
spherical with relatively thick, rough walls (Pitt and Hocking, 1997).
Growth temperatures for A. flavus vary from a minimum near 10-12°C, a
maximum near 43-48°C, and an optimum near 33°C (Domsch et al., 1980; ICMSF,
1996). The water activity needed for growth also varies in a range of 0.78 at 33°C
(Ayerst, 1969) to 0.84 at 30°C and 0.80 at 37°C (Pitt and Hocking, 1977). These
molds can grow in a very wide range of pH. It has been observed that growth can

10
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occur from pH 2.1 to 11.2 at 25, 30 and 37°C. Optimal growth was recorded from
pH 3.4 to 10 and a peak near 7.5 (Wheeler et al., 1991; Olutiola, 1976).
A. flavus is adapted to use a broad assortment of organic resources as a
source of nutrients. It is considered a saprobe, as well as, an opportunistic pathogen
o f plants, insects, domestic animals and humans. In the field, A. flavus populations
increase during hot and dry conditions. They grow especially well on crop debris,
on dormant tissues, and or damaged or weakened crops (Asworth et al., 1969;
Stephenson and Russel, 1974).
2.

Toxin production
Aflatoxins B and G are produced by all toxigenic strains of A. parasiticus.

On the other hand, most, but not all A. flavus isolates produce only the B aflatoxins
(Pitt, 1989). In general, commodities contaminated with only the B aflatoxins may
be contaminated with A. flavus. However, there is no real evidence that suggests
that A. parasiticus is the only source of the G aflatoxins (Wilson and Payne, 1994).
Some strains of A. flavus produce cyclopiazonic acid (CPA). This toxin has
been reported to be toxic in rats, dogs, pigs, and chickens (Domer et al., 1983;
Lomax et al., 1984; Nuehring et al., 1985; Purchase, 1971). CPA has metal
chelating properties, and it has been reported that it can bind physiologically
important cations such as calcium, magnesium and iron (Gallagher et al., 1978).
CPA occurs naturally in com, peanuts, cheese and millet and it can be found with
aflatoxins (Richard et al., 1989; Gallagher et al., 1978; Trucksess et al., 1987). Due
to this co-contamination, the toxicity of commodities contaminated with A. flavus

11
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can be greater than expected from the levels of aflatoxins. The role of CPA and
aflatoxin co-contamination should be explored to

further understand the

toxicological implications of consumption of foods/feeds contaminated with A.
flavus.
3.

Chemical characteristics
Aflatoxins (Figure 2.1) are a group of bisfuran coumarin compounds

produced by mold secondary metabolism and have no obvious physiological role in
the primary growth and function o f

the mold (Bhatnagar, 1991). However,

byproducts of primary metabolism are generally precursors of secondary
metabolites. Thus, primary and secondary metabolisms are intricately related
(Drew and Demain, 1977). Aflatoxin biosynthesis is related to mold lipid
biosynthesis (Townsend et al., 1984). Its basic structure is derived from acetate
units from the polyketide pathway. Bhatnagar et al. (1991) have suggested that
AFB1 biosynthesis is based on a C2 0 polyketide (decaketide) precursor (Bhatnagar,
1991). Polyketides are a large group o f structurally diverse compounds that arise
from the head-tail condensation of acetate units (Applebaum, 1981). These
molecules then undergo several transformation reactions where the chain is folded,
condensed, oxidized, reduced, cleaved and rearranged to produce a wide variety of
molecules, including the aflatoxins (Bhatnagar, 1991). Hamid and Smith (1987)
have reported the degradation of aflatoxins in old or aging mycelium. There
evidence that suggests the involvement of fungal cytochrome P-450
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Figure 2.1 Chemical structiares of most common naturally-occurring aflatoxins
(Pavao et al., 1995)
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monooxygenease enzyme systems in the degradation of aflatoxin Bi and Gi by
intact mycelium and cell-free extracts of A. flavus.
Each o f the known aflatoxins has a different structure with variable activity
(Figure 2.1) (Pavao et al., 1995). The names of the most common aflatoxins, B and
G for blue and green, respectively, refer to their fluorescent colors under ultraviolet
light. In the case of aflatoxin M. an important aflatoxin metabolite, the letter refers
to its presence in milk (Bhatnagar et al., 1994).
Aflatoxin Bi is one of the most potent naturally occurring carcinogens.
Chemically, it has a carbonyl group in a five-membered ring and cross-conjugated
with an alpha, beta-unsaturated function. Its formula is C 17 H 12 O 6 with a molecular
weight of 312 (Pavao et al., 1995). Aflatoxins are soluble in a number of non-polar
solvents and insoluble in water.
4.

Metabolism

a.

Absorption and distribution
Human exposure to aflatoxins occurs mainly via ingestion of contaminated

foodstuffs. Thus, most of the pharmacokinetic considerations are associated with
the chronic administration of relatively low doses of AFBi through the oral route
(Hsieh and Wong, 1994). AFBi is a relatively low molecular weight (312 g/mole)
lipophilic compound. This suggests that its absorption after ingestion is efficient.
Wogan et al. (1967) reported that absorption after oral administration of 0.07
14
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•

mg/kg [ C] labeled AFBi in male Fisher rats was complete when compared to
intraperitoneal administration. They observed that up to 20 and 60% of the original
14
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dose was eliminated via urinary and fecal routes, respectively. Slow passage
through the intestinal tract was noted since little radioactivity was excreted in the
first 8 hours. After 24 hours, the residual radioactivity in the carcass (7.6% o f the
original dose) was found in the liver, indicating that it is the primary site of
accumulation of AFBi, its metabolites and/or bound material.
Absorption studies by Kumagai (1989) have shown that AFBi is rapidly
absorbed from the small intestines into the mesenteric venous blood. The
duodenum was considered the site of

most efficient absorption.

This study

suggested that species differences in AFBi uptake may be due to differences in the
composition of the intestinal epithelium. The author also reported that the degree of
aflatoxin uptake is proportional to AFBi concentration indicating that it is absorbed
by passive diffusion. AFGi, a less lipophilic analog, was absorbed at a lower rate,
indicating the importance of Iipophilicity in aflatoxin absorption.
Excretion of AFBi occurs primarily through the biliary pathway, followed
by the urinary pathway. From the intestine, AFBi apparently enters the liver
through the hepatic portal blood supply (Wilson et al., 1985). The liver readily
concentrates the toxin. Given the high efficiency of the liver to extract free AFBi
from the blood, the binding of AFBi to serum albumin at the site of intestinal
absorption has not been considered a major mechanism of detoxification. The
kidneys also concentrate aflatoxin, but to a lesser extent (Hsieh and Wong, 1994).
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b.

Phase I metabolism
Cytochrome P-450 (P450) enzymes are involved in the oxidation of

numerous steroids, eicosanoids, alkaloids, and other endogenous substrates. These
enzymes also have major involvement in the oxidation of potential toxicants and
carcinogens such as those encountered among environmental pollutants, solvents,
pesticides and many natural products like aflatoxins (Guenguerich et al., 1996).
AFBi is considered the most potent of the aflatoxins and related
benzofurans in most genotoxicity assays; it is also the most hepatocarcinogenic
(Busby and Wogan, 1984). However, all evidence available to date shows that
AFBi by itself is not particularly genotoxic, and that the metabolically produced
8,9-epoxide is the only genotoxic product as evidenced by either base-pair
mutations, ffameshift mutations or induction of bacterial SOS response (Busby and
Wogan, 1984; Gamer et al., 1972; Baertschi et al., 1989). The stereochemistry of
AFBi epoxidation is of considerable significance in determining the course of its
toxicity.

P450 enzymes produce two different stereomeric forms of the 8,9-

epoxide, the exo-epoxide in which the ring is positioned “below” the plane and the
endo- 8,9 epoxide in which the ring is positioned “above” the plane. O f these, the
exo isomer is at least 103 times more genotoxic than its endo counterpart
(Guenguerich et al., 1996). The bioactive form of aflatoxins is considered a strong
electrophile that can form covalent adducts with macromolecules such as proteins,
RNA and the N7 position o f guanidine residues in DNA (Figure 2.2) (Foster et al.,
1983; Miller, 1991).
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Figure 2.2 Formation o f the aflatoxin Bi- N7 guanidine adduct (Miller, 1991)
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Cytochrome P450 metabolic isozymes render a number of products that can
be considered activated metabolites (i.e., 8,9-epoxide) or detoxification products,
such as aflatoxins Mi, Pi and Qi (Figure 2.3) (Langouet et al., 1996). Although
peroxidases and lipoxygenases have been reported to oxidize AFBi (Battista and
Mamett, 1985), the P450s are more active in catalyzing the reaction. The relative
quantities of each metabolite depend largely on the relative activities of different
P450 isozymes. Among the P450s, CYP3A4, CYP1A2, CYPIA1 and CYP3A5
have been shown to transform AFBi. Cytochromes 1A2 and 3A4 have been
considered the most active. However, there is controversial information as to which
is the dominant enzyme. Ueng et al. (1995) have reported that CYP3A4 appears to
be the enzyme involved to the greatest extent in AFBi activation. Forrester et al.
(1990) and Aoyama et al. (1990) previously provided evidence that supports this
hypothesis. On the contrary, Gallagher et al. (1996) reported that CYP1A2
contributes to over 95% o f AFBi activation in human liver microsomes at 0.1 juM
AFB i. The discrepancies between these studies may be a result of different sources
of P450’s used among the different experiments. The reconstitution system of Ueng
et al. (1995) was rather complex and cannot be considered similar to the in vitro
system employed by Gallagher et al. (1996). Also, the source of the human
CYP1A2 cDNAs used in the experiments of Ueng et al. (1995) contained a
modified N-terminus (Sandhu et al., 1994) and therefore may have exhibited
somewhat

different catalytic

activities

from

the

CYP1A2 cDNA -

expressed microsomes used in the Gallagher et al. (1996) study. This study also
18
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Figure 2.3 Biotransformation pathways for aflatoxin Bi (Eaton et al., 1994)
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reported kinetic models that support CYPlA2’s dominant role in AFBi metabolism
in vivo.
c.

Phase II metabolism
Phase II metabolism leads to the conjugation of phase I metabolites to make

them less toxic and more available for excretion. Species differences in the
susceptibility to the toxicity and carcinogenicity of AFBi are determined largely by
the organism’s ability to biotransform the toxin. The major phase II metabolites are
the glutathione, glucoronide and sulfate conjugates (Hsieh and Wong, 1994). The
glutathione (GSH) conjugate o f the AFBi 8,9-epoxide has been identified as the
major phase II reaction. Thus, the sensitivity of a particular species has been related
to its ability to conjugate the epoxide with GSH. There is some evidence that
indicates that the various glutathione-S-transferases have differential activity
toward the endo and the exo forms of the 8,9-epoxide.
Glucoronide conjugation also plays a role in biotransformation and
excretion of AFBi and/or its metabolites. Loveland et al. (1984) reported that
glucoronides of aflatoxicol and aflatoxicol-Mi are the principal biliary metabolites
of AFBi in trout. Phase I metabolites such as aflatoxins Pi, Qi and Mi go through
glucoronide conjugation. The rate of conjugation of these three metabolites differs.
According to Metcalfe and Neal (1983), the phenolic hydroxyl group present in
AFPi is a much better site for glucoronide conjugation than the hydroxyl groups
present in AFMi and AFQi.
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d.

Competitive pathways: activation and detoxification
The fate o f AFBi in an organism depends on a delicate equilibrium between

several pathways. The quantity of aflatoxin available to exert toxic, mutagenic and
carcinogenic effects will depend on the amount converted to the various
metabolites and their relative biological activity. Thus, the hydroxylated
compounds (AFM|, AFPi and AFQO are considered detoxification products due to
their lower ability to react with DNA and proteins. The 8,9-epoxide is not always a
toxic product since detoxification of this reactive molecule may occur through
phase II conjugation with glutathione. Hydrolysis o f the electrophilic epoxide to
form a dihydrodiol also represents a decrease in toxic potential. The dihydrodiol
can exist in a resonance form as a phenolate ion that is capable of forming SchifF
base adducts with protein amino groups, particularly lysine (Lin et al., 1978). Even
if the binding to protein can represent a toxicological risk, the relative toxic,
mutagenic and carcinogenic effects of protein conjugation is much lower than that
of the active epoxide.
It is difficult to discuss AFBi activation and detoxification pathways
without considering the kinetics involved in each reaction. Unfortunately, most in
vitro studies use AFBi concentrations that surpass the actual dietary human
exposure. It has been noted that humans and animals are chronically exposed to
low doses rather than to one acute single dose. Thus, it is difficult to extrapolate
from in vitro studies. Another factor to consider is that the activity of the different
metabolizing enzymes varies from species to species. Ramsdell and Eaton (1990)
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demonstrated substantial variations in the patterns of liver microsomal AFBi
oxidation over a range of concentrations for four species: rat, mouse, monkey and
human. Affinity to detoxification reactions also plays an important role in AFBi’s
ultimate toxic effect. As with microsomal activation, the affinity of the enzyme
glutathione S-transferase to the AFBi-8,9-epoxide varies across species.
The information available to date suggests that the ultimate toxic response
to aflatoxin is not a univariate process. It is a multivariate equilibrium that depends
on external factors, such as, toxin concentration, presence of other xenobiotics,
environmental stress and nutritional status among others; and internal factors that
can include but are not limited to genetic predisposition, type and activity of
microsomal enzymes, and availability o f efficient detoxification mechanisms.
5.

Toxicity
The liver is considered the primary target organ for aflatoxin toxicity. Since

its characterization in the early 1960’s, acute structural and functional damage to
the liver has been reproduced in a wide variety o f species. Acute aflatoxicosis has
been characterized by vomiting, abdominal pain, pulmonary edema, and fatty
infiltration and necrosis of the liver (Shank, 1977; 1981). Although there is ample
evidence for substantial human exposure in certain populations, information on
clinical aflatoxicosis in humans is still limited (Busby and Wogan, 1984). Review
of the effects o f acute exposure to aflatoxin reveals that a wide variety of
vertebrates, invertebrates, plants, bacteria, and fungi are sensitive to these toxins,
but the range of sensitivity is wide. The basis for the species and strain variation in
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the acute toxicity of aflatoxin is not fully understood. As discussed in the previous
section, two important factors are (1) the proportion of AFBi that is metabolized to
the 8,9-epoxide relative to other metabolites that are considerably less toxic and (2)
the relative activity of phase II metabolism, which forms non-toxic conjugates and
inhibits cytotoxicity (Cullen and Newbeme, 1994).
The aflatoxins have been studied extensively in vitro (IARC, 1987). It has
been reported that all the members of the family (AFBi, AFB 2 , AFGi and AFG 2 )
produce genotoxic injury. AFBi is considered the most potent genotoxic agent in
vitro (as it is in vivo) and AFG2 the least potent, but all naturally occurring
aflatoxins, as well as, the metabolite AFM|, have been reported to produce some
injury to DNA. AFBj produces chromosomal aberrations, micronuclei, sister
chromatid exchange, unscheduled DNA synthesis, and chromosomal strand breaks,
and forms adducts in rodent and human cells (IARC. 1987). AFGi produces
chromosomal aberrations in Chinese hamster bone marrow cells in vivo. as well as
chromosomal aberrations and sister chromatid exchange in Chinese hamster cells in
vitro. AFB2 binds covalently to DNA of rat hepatocytes, produces sister chromatid
exchange in Chinese hamster ovary cells, and stimulates unscheduled DNA
synthesis in rat hepatocytes but not in human fibroblasts. AFG 2 produces sister
chromatid exchange in Chinese hamster cells but does not induce unscheduled
DNA synthesis in human fibroblasts in vitro. Unscheduled DNA synthesis in rat
and in hamster hepatocytes results following exposure to AFG 2 and AFMi in vitro.
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The aflatoxins have been examined for potency in a range of primary
cultures, as well as, in established cell lines. Liver cell cultures from chick embryos
demonstrate cytotoxicity of AFBi to both mesenchymal and parenchymal cells
(Terao, 1967). Zuckerman et al. (1967) reported that 1 pg/ml exhibited cytotoxic
effects to 50% of human embryo liver cells following 24 hours exposure. Electron
microscopy revealed nucleolar capping of the chromatin, rounding of the cell, and
granulation of the endoplasmic reticulum (Zuckerman et al., 1967).
Experimental study of aflatoxin-induced carcinogenesis supports the
paradigm of cancer as a multistage process. Aflatoxin is considered a potent
tumorigenic agent, but it has also been shown to have promoting ability (Newbeme
and Butler, 1969; Busby and Wogan, 1984). Virtually all the toxic effects o f AFBi
are now recognized to be attributable to the action of its electrophilic metabolites
on macromolecules (DNA and proteins). Aflatoxin carcinogenesis can be promoted
by a variety of factors, including an enhanced proliferative rate and alterations in
dietary intake (Rogers, 1994). Since Wogan (1966) reported that continuous
lifetime exposure to aflatoxin was unnecessary for the development of tumors,
shorter-term exposure to aflatoxin has been used to assess the risks associated with
this toxin. The early studies of aflatoxin-induced liver carcinogenesis in rats
indicated the presence and sequential development of precursor lesions (Lancaster
et al., 1961). Chronic and subchronic exposure to AFBi is an efficient method to
produce hepatic cancer. For example, 2 cycles each of 5 days duration with 25 mg
AFBi per day to young (approximately 100 g) Fischer 344 rats yielded putative
24
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preneoplastic foci at 2-3 months postdosing (Appleton and Campbell. 1983;
Roebuck et al., 1991; Kensler et al., 1992). Hepatic cancers arise by approximately
1 year postdosing (Roebuck et al.. 1991).
C.

Fumonisins

1.

Mycology and occurrence
Fusarium is the main pathogenic fungal genus found in com. The most

commonly occurring species are F. graminearum, F. moniliforme and F.
subglutinans (Burgess et al., 1981; Marasas et al., 1984). Fusarium moniliforme
and its related species, F. proliferatum, are endemic in com with a worldwide
distribution occurring not only in the humid and sub-humid temperate zones, but
also extending into the subtropical and tropical areas o f the world. It has been
isolated from Australia, Brazil, Canada. Central America, China, Egypt, Germany,
India, Indonesia, Israel, Italy, Jamaica, Japan, Hong Kong, Libya, Nepal, New
Zealand, Nigeria, Pern, Philippines, South Africa, Switzerland, Taiwan, Turkey, the
United States of America, Zambia and Zimbabwe (Cole et al., 1973; Marasas et al.,
1978; Marasas et al. 1979; Sydenham et al., 1991; Thiel et al., 1991; Pittet et al.,
1992; Bacon and Nelson, 1994; Burgess et al., 1994; Visconti and Doko, 1994;
Yoshiazwa et al., 1996). It is found rarely in the cold temperate zones of the world,
but has been reported from Russia and Iceland (Bacon and Nelson, 1994).
F. moniliforme is an important pathogen of com and sorghum. In addition,
it is commonly isolated from several other grains including wheat, rice and oats.
Although there is no evidence that F. moniliforme is a pathogen o f wheat, barley or
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oats in nature (Cook, 1981), it can be found as an occasional contaminant of wheat
and barely stored seed (Bottalico et al., 1989). It also occurs, although infrequently,
on other food and non-food commodities, such as beans, cotton, green peppers,
flax, soybeans and sugar cane. F. moniliforme is also found on forage grasses such
as Panicum coloratum as well as alfalfa, red clover, and pearl millet (Bacon and
Nelson, 1994). This fungus can also decompose wool, cotton, filter paper and can
oxidize hydrocarbons and the herbicide, simanzine (Bacon and Nelson, 1994).
F. moniliforme and F. proliferatum in the section Liseola are characterized
by conidiophores bearing abundant straight, fusiform to obovoid microconidia in
long chains. The conidia are produced from branched and non-branched
polyphialides and monophialides in F. moniliforme and in F. proliferatum. These
fungi also produce falcate microconidia, but do not produce chlamydospores. There
are four taxa within this section of which F. moniliforme is the most common.
Another cosmopolitan species of this section is F. proliferatum. Both fungi are
similar morphologically, but may be readily distinguished by the presence of
polyphialides in F. proliferatum and their absence in F. moniliforme (Bacon and
Nelson, 1994).
F. moniliforme grows at a maximum temperature of 32-37°C and a
minimum temperature o f 2.5-5°C with an optimum o f 22.5-27.5°C (Armolik and
Dickson, 1956). The minimum water activity for F. moniliforme growth is 0.87;
and Marin et al. (1995) have reported that there is production of fumonisins at 0.92
aw. Moisture and aeration are important factors for fumonisin production. It has
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been observed that fiimonisin production is minimal at low oxygen tension. Thus,
storage of grains under modified atmosphere conditions, and low kernel moisture
<22% should reduce or prevent toxin formation (Pitt and Hocking, 1997).
Although F. moniliforme is one of the earliest known examples of a
mycotoxic and phytotoxic species, its relationship to com is not fully understood
(Bacon et al., 1992). F. moniliforme is seed and soil bome (Riley, et al., 1993); and
the association o f this fungus in the com plant is considered endophytic, while on
com kernels it is both external and systemic. The systemic kernel infection does not
affect the seed germination, but rather seedling vigor and growth can be reduced.
Within the com kernel, the fungus is associated with the tip cap end. the point of
attachment to the cob. The fungus is located within this area just below the vascular
tissue of each kernel. Only small amounts of hyphae are found in sound kernels.
However, from this location and under improper storage conditions, the small
amount o f inoculum can become highly invasive to the kernel (Bacon and Nelson,
1994).

In addition to kernels, the fungus is also found in com plant residues,

especially stems and cobs where it can survive in the soil at least a year or more
(Liddell and Burgess, 1985; Nyvall and Kommedahl, 1970). The systemic location
of this fungus within the seed provides favorable conditions to maintain virulence
and viability for years. Bacon and Nelson (1994) reported that in laboratory studies,
com seeds can still harbor viable F. moniliforme after 8 years. The visual results of
ear infection vary, some kernels are symptomless while others are obviously
damaged and infected. F. moniliforme is also believed to infect com by growing
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along the silks, through tip ends of ears, over the kernel surface and into the
pedicels, into the vascular cylinder of the cob, and finally into the kernels
(Koehler, 1942; Salama and Mishricky, 1973). In the case of ear infection via an
external route, insect damage may play an important role by causing wounds on the
kernel pericarp thus allowing fungal penetration (Koehler, 1942). In kernels
associated with animal toxicity, the fungus is usually found as an extensive mass of
sporulating hyphae which colonizes most of the internal section of the kernel,
including the embryo (Bacon and Nelson,1994).
Both F. moniliforme and F. proliferatum produce two kinds of spores, and
both of these spores function in the survival and infection aspect of their life cycle.
These fungi do not produce chlamydospores as survival structures, but they can
survive in the soil as thickened hyphae within a soil moisture range o f 5 to 35% at 5
to 10°C for 12 months (Bacon and Nelson, 1994). Macroconidia can survive the
longest. Thus, they might function to carry these fungi over the seasons while
microconidia, which are windblown, function as secondary infective propagules,
infecting plants during the growing season. Dormant microconidia can survive for
900 days although survivability is inversely related to both high temperatures and
relative humidity (Liddell and Burgess, 1985).
2.

Toxin production
F. moniliforme consists of a

complex of biological species or mating

populations. Currently, it is defined as having six different mating populations
among which exist bisexual, self-sterile groups (Riley et al., 1993). Only mating
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populations "A" and "F" of this fungus have been found to be toxigenic, producing
the mycotoxins fumonisins, fusaric acid and fusarin C. These mating populations
are distributed worldwide and are found primarily on cereal grasses in the warmer
regions o f the world. Although members o f all six mating populations can be
recovered from both com and sorghum, the distribution appears to be host species
specific. It has been observed that fungi of mating population "A" , "D" and “E”
are found in com and of mating population “F” are primarily found on sorghum
(Jardine and Leslie, 1992; Leslie et al., 1992a; Leslie et al., 1992b). Although it has
not been established whether these two species vary in their pathogenicity or
specificity for each host, it has been found that the "A" mating population is a
better producer o f fumonisin Bi than the "F" population (Riley et al., 1993). Also,
the mating population "D" of Giberella fujikori has been reported as being a good
producer o f fumonisin Bi (FBi) (Riley et al., 1993). Recently, it has been reported
that Alternaria alternata produces FBi (Chen et al.. 1992); and this suggests that F.
moniliforme might produce the AAL toxins as well. In addition to F. moniliforme
and F. proliferatum, several other newly described species, not yet placed in any
Fusarium section, also produce these toxins and include: Fusarium nygamai,
Fusarium napiforme, Fusarium anthophilum and Fusarium dlamini (Nelson et
al., 1992). However, since these species are not usually associated with food and
feed products, they are not considered important as far as the natural production of
fumonisins on agricultural commodities.
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Little is known about the biology of F. moniliforme and F. proliferatum in
terms o f food contaminants and physiology of toxin production. These fungi
produce several mycotoxins including: fusarins, fusaric acid and fumonisins
(Chamberlain et al., 1993). Nelson and collaborators (1983) have discounted
reports o f production of zearalenone and deoxynivalenol by F. moniliforme. More
recent reports require confirmation Fusarium proliferatum has been found to
invade com and to produce fumonisins and moniliformin (Bullerman and
Draughon, 1994). However, due to the increasing concern about fumonisin in foods
and feeds, more research is being conducted to understand these factors. Since both
fungi are plant pathogens, they also produce phytotoxins and several of the
mycotoxins are also phytotoxins. Thus, these fungi produce a series of substances
toxic to plants and animals. Some of the important mycotoxins/phytotoxins
produced by F. moniliforme and F. proliferatum include: fusaric acid: A
phytotoxic, mycotoxic, hypertensive agent as well as a synergist for other
mycotoxins; fusarin C: A mutagen and macrophage inhibitor; moniliformin: A
phytotoxic and mycotoxic agent; and fumonisins: A class of compounds that have
shown to be hepatotoxic, nephrotoxic and hepatocarcinogenic in rats, neurotoxic in
equines and pulmonary edema inducers in porcine species, and

suspected

carcinogens in man. The fumonisins are also herbicidal to several plant species and
can induce adventitious root on non-sensitive detached tomato shoots (Bacon and
Nelson, 1994).

30

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

The fumonisins have been detected in com cobs, bee wings (glumes of old
com florets) and com screenings. The highest concentrations have been found in
the bee wings, although com screenings have higher concentrations than whole
com and have produced the most toxicological concern, particularly to swine and
horses (Bacon and Nelson, 1994; Ross, 1994). Desjardins et al. (1997), have shown
that Giberella fiijikori isolated from rice from various geographic areas is capable
of producing significant levels of FBi (>5 pg/g) and moniliformin (>100 pg/g)
when grown in autoclaved maize substrate. To date, the occurrence of these
mycotoxins in rice and rice-based foods has received little attention (Pestka, 1994).
Other reports indicate that the highest fumonisin concentrations are found in com
screenings (also called fines) which are generated as com moves through various
distribution channels (Ross, 1994). Once a plant is infected, the precise timing and
accumulation pattern of the fumonisins in planta are unknown. Bacon and Nelson
(1994) have indicated that although a range of 9 to 91% infection is usually
reported for some seed lots of com, in some years com kernels may be

100

%

infected by F. moniliforme indicating that abiotic factors, primarily rainfall might
be responsible. Biotic factors, such as com cultivar and fungal isolate, might also
be responsible.
Because Fusaria are generally considered to develop as a result of weather
and crop stress, local weather conditions were studied by several laboratories. The
researchers concluded that no single set of weather circumstances were responsible,
but general drought stress, followed by wet and warm weather was the pattern most
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likely to be involved in fumonisin production (Ross, 1994). There are some
important factors that have to be considered for post-harvest fumonisin control such
as:
1. Aeration: There is low production o f fumonisins under a low oxygen tension
and a modified nitrogen, carbon dioxide atmosphere.
2. Moisture: A kernel moisture content of less than 22% will prevent toxin
production (Riley et al., 1993)
3. Temperature: Le Bars et al. (1994) reported that FBi production rate was
maximal at 20°C and decreased sharply according to temperature following the
order: 25, 15, 30 and 10°C
Control o f soil-borne and kernel infection may be achieved with the use of
microorganisms (soil and endophytic bacteria).

Control of F. moniliforme on

foodstuff should focus on its complex infection cycle and/or potential mechanisms
for developing com resistance (Riley et al., 1993). The successful utilization of
biocontrol measures must be based on detailed knowledge of the basic biology of
F. moniliforme and F. proliferatum and their associations with com and other
agricultural commodities, information, which is not yet available.
3.

Chemical characteristics
Chemically, the

fumonisins consist of several

structurally

related

homologues of which fumonisin Bi (FBi), 2-amino-12,16-dimethy 1-3,5,10trihydroxy- 14,15-propane-1,2,3-tricarboxy eicosane, is of primary concern since it
is considered the most active cancer promoting component within the fumonisins
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(Figure 2.4) (Bacon and Nelson, 1994). The other fumonisins are FB 2 , FB3 . FB4 ,
FCi, FAi and FA2 and each differ by lacking one of the hydroxyl groups at either
the C-5 or C-10 position of the 10 carbon aminopentol backbone. The latter three
fumonisins may be artifacts of isolation. The A series differs from B series by
possession of a N terminal acetyl group (Tanaka et al., 1993). Hydrolytic removal
of one of the propanetricarboxylic acid moeities from fumonisins Bi and B2 yields
partially hydrolyzed fumonisins (PHj and PH2 , respectively). The removal of both
moeities yields the aminopentol fraction (AP[ and AP2 , respectively) (Sydenham,
1994).
Gelderblom et al. (1993) studied the relationship between molecular
structure and biological activity. Their results suggest that the fumonisin molecule
must be both, intact and have a free amino group to exert its effects. Independent
studies with synthesized analogues of FBi also indicate that these same structural
properties are necessary for biological activity of the toxins (Kraus et al., 1992).
Fumonisins Bi, B2 and B3 exist as colorless compounds that are soluble in
polar solvents such as water, methanol, or acetonitrile and insoluble in non-polar
solvents (i.e., hexane). FBi has a molecular formula of C34H59NO14 and a molecular
mass of 721 g/mole, while both, FB2 and FB3 contain one oxygen atom less, having
similar molecular formulae of C34H59NO14 and molecular mass o f 705 g/mole
(Sydenham, 1994). None o f the fumonisin mycotoxins possess chromophores, and
therefore they do not absorb either ultra-violet (UV) or visible light, nor do they
fluoresce (Sydenham, 1994).
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Figure 2.4 Structures of the fumonisin A and B analogues (Sydenham, 1994)

34

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

4.

Metabolism

a.

Absorption and distribution
To date, there is limited information on FBi absorption, distribution and

excretion. However, all studies available (Shephard et al., 1992; Prelusky et al.,
1994; Vudathala et al., 1994; Norred et al., 1996) have indicated that it is poorly
absorbed and rapidly cleared from the blood. It undergoes both, biliary and urinary
excretion and it tends to persist in relatively small quantities in the liver and
kidneys for prolonged periods (>96 hours). It is still unclear if these low persisting
quantities are responsible for the cascade of biochemical events prompted by FB|,
or if the short residence time of the higher doses is responsible for eliciting the
toxic responses. Furthermore, if humans are exposed to FBi through daily
consumption of contaminated com, there would always be a persisting low dose
with longer hepatic and renal residence times. This idea is supported by an in vivo
study in male Sprague-Dawley rats where it was shown that only prolonged
exposure to an hepatotoxic dietary level (250 mg FBi/kg) that induced
hepatotoxicity over a period of 14 to 21 days resulted in cancer initiation
(Gelderblom etal., 1992).
Studies regarding the metabolism of fumonisins by various enzyme
preparations have shown that they are not substrates for the microsomal
cytochrome P450, estereases, or hepatic triglyceride lipase systems (Cawood et al.,
1994). Fractionation, purification and analysis

of the hepatocyte incubation

medium treated with fumonisins failed to indicate the presence of any metabolites.
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This information shows that unlike aflatoxin. the intact fumonisin molecule is
needed for its biological activity (Gelderblom et al., 1993).
b.

Mode of action
Chemically, fumonisins have been found to be similar to sphinganine. an

intermediate in the biosynthesis of complex sphingolipids (Figure 2.5) (Sweeley.
1991; Bell et al., 1993). Sphingolipids have been reported to play an important role
in cellular membrane function, regulation of cell growth, differentiation, cellular
signaling and apoptosis (Mato, 1990; Merrill et al., 1997). This similarity has led to
the hypothesis that fumonisins interact with sphingolipid metabolism enzymes
(Merrill et al., 1996). To date, numerous studies have reported that fumonisins are.
indeed, potent inhibitors of the biosynthesis and turnover of complex sphingolipids
(Norred et al., 1992; Wang et al., 1992; Merrill and Shroeder, 1993; Merrill et al.,
1993; Abbas et al., 1994; Merrill et al., 1995a; Merrill et al., 1995b; Schroeder et
al., 1994; Schwartz et al., 1995; Smith and Merrill, 1995; Wu et al., 1995; Yoo et
al., 1996; Merrill et al., 1997). It has been reported that FBi interferes with
sphingolipid metabolism by competitively inhibiting the enzyme sphinganine
(sphingosine) N-acyltransferase (ceramide synthase) with respect to both of its
substrates, sphinganine and fatty acyl-CoA (Merrill et al. 1995b). In vitro studies
with diverse cells such as hepatocytes (Wang et al., 1991), neurons (Merrill et al.,
1993a), kidney cells (Riley et al., 1994) and plant cells (Abbas et al., 1994) have
shown that this enzyme plays a key role not only in sphingolipid biosynthesis, but
also in their turnover. The inhibition of the turnover pathway results in sphinganine
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Figure 2.5 Structures of fumonisin Bi, sphinganine and sphingosine (Merrill et al..
1998)
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accumulation. In the presence of FBi, a portion of the accumulated sphinganine is
phosphorylated to sphinganine-1-phosphate and then degraded to hexadecanal and
ethanolamine phosphate, which is incorporated into phosphatidylethanolamine
(Merrill et al., 1993b) (Figure 2.6). This raises the possibility that fumonisin also
affects the metabolism of phosphoglycerolipids via this indirect route.
Some of the accumulated cellular sphinganine is released from cells and
appears in the bloodstream and urine. Therefore, it has been hypothesized that the
increase of sphinganine in blood and/or urine could be used as a biomarker for
exposure to fumonisin. The accumulated bioactive compounds, as well as, the
depletion of complex sphingolipids, may account for the toxicity, and perhaps the
carcinogenicity, of fumonisins (Merrill et al., 1996). The determination of the
change in the sphinganine/sphingosine ratio may indicate the amount of liver
damage and regeneration caused by FBi. The inhibition of sphingolipid
biosynthesis and turnover has also been proposed as an important factor in FBi
tumorigenic potential,
c.

Carcinogenicity
Gelderblom et al. (1989) observed that fumonisin B( (FBi) is a cancer

promoter

in

a

short-term

cancer

initiation-promotion

assay

using

diethylnitrosamine (DEN)-initiated rats. FBi is also a cancer initiator as evidenced
by the induction of resistant hepatocytes in rat liver (Gelderblom et al., 1992; 1994).
Although FBi has been shown to be a complete carcinogen in rat liver, it is
considered a poor cancer initiator. In a study reported by Gelderblom et al. (1994),
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The first steps occur in the endoplasmic reticulum (ER), where serine is condensed with palmitoyl-CoA (PalCoA) to yield 3-ketosphinganine (Ksa), which is reduced to sphinganine (Sa). Sphinganine is acylated to
hihydroceramides by ceramide synthase using various long-chain fatty acyl Co-A’s. Glycosidic groups and the
4,5-trans-double bond (of sphingosine - So) are subsequently added to the 1-hydroxyl group in the Golgi and
plasma membranes. Sphingolipid turnover is thought to involve the internalization of the sphingolipids, followed
by their hydrolysis in acidic compartments (lysosomes and endosomes) to ceramides (N-Acyl-So), then to
sphingosine (So). Sphingosine is cither reacylated or phosphorylated to sphingosine-phosphate (So-P) and
cleaved to fatty aldehyde and ethanolamine phosphate, which is incorporated into phosphtidylethanolamine (PE).
In the presence of fumonisin B|, (FBi) sphinganine accumulates and there is also an increase in sphinganine 1phosphate (Sa-P).
Figure 2.6 Sphingolipid biosynthesis and turnover (Merrill et al., 1996)

prolonged exposure (21 days) to a relatively high dietary level (250 mg/kg) resulted
in tumorigenesis. Thus, it was concluded that a time and dose dependent threshold
level exists for cancer initiation by FBi. At a dietary level of 1000 mg/kg for 21
days, only the B fumonisins (FBi, FB?, and FB3) initiated cancer in rat liver,
whereas, the N-acetylated analogues, FAj and FA2 , and the hydrolysis products
(aminopentol), AP| and AP 2 , and tricarballilic acid (TCA) did not (Gelderblom et
al., 1993). Thus, it has been considered that the free amino group and the intact
molecule are required for cancer initiation. However, the mechanism by which
fumonisin acts as a tumorigenic agent is still unknown.
The role of fumonisin in carcinogenesis is still unclear. Although FBi has
been reported as a complete carcinogen in rats (Gelderblom et al.. 1988), it is not
positive results in any o f the traditional mutagenicity assays. Several authors
(Gelderblom et al., 1991, 1992; Park et al., 1992), have reported negative results in
the Salmonella/microsomal mutagenicity assay with and without metabolic
activation. FBi does not induce unscheduled DNA synthesis in isolated rat
hepatocytes (Norred et al., 1991a), and is not genotoxic in the in vivo and in vitro
DNA repair assays in primary rat hepatocytes (Gelderblom et al., 1992a; Norred et
al., 1992a,b). The fumonisins also failed to induce any genotoxic effects in the
DNA-repair assay using Escherichia coli (strains 3431753. uvrB/vecA and
3431765.uvr+/vec+) and the umu-microtest (with Salmonella TA 1535/pKS 1002)
with and without rat liver S9 mix (Gelderblom et al., 1996). No micronuclei
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induction by FB| has been observed, and its mitogenic activity is still under debate
(Gelderblom et al., 1996).
Although the fumonisins were negative in various in vitro genotoxicity and
mutagenicity assays, short term in vivo studies have shown that FB| mimics
genotoxic carcinogens with respect to the induction of resistant hepatocytes in rat
liver (Gelderblom et al., 1992; 1994). Furthermore, it has been observed that FBi
induces two important enzymes, gamma glutamyltranspeptidase (GGT) and the
placental form of glutathione S-transferase (GST), which are accepted histological
markers for preneoplastic lesions initiated by genotoxic carcinogens. Feeding
experiments with fumonisins in rats indicated that an increase in cell proliferation
is also likely to play a critical role in the induction o f resistant hepatocytes, and the
resultant regenerative cell proliferation is a prerequisite for initiation (Gelderblom
et al., 1994). In this regard, regenerative cell proliferation is also a critical event
during FBi carcinogenesis (Columbano et al, 1991). However, single and/or
multiple dosages of fumonisins in the presence of a stimulus for regenerative cell
proliferation fail to cause initiation (Gelderblom et al., 1992).
It has been widely accepted that carcinogenesis is a multiphase process
where many factors are involved. It would be unreasonable to consider a single
event on the ultimate carcinogenic outcome. In a real human diet, exposure to FBi
would not be considered the only event leading to cancer of the gastrointestinal
tract. An example is the epidemiological and molecular evidence from studies on
cancer patients, where a close association between aflatoxin B\ (AFBi) and
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hepatitis B virus (HBV) infection with hepatocellular carcinoma was shown. It has
been reported that a mutation at codon 249 in the p53 gene is commonly detected in
this type of cancer (Bressac, 1991). FBj has been shown to co-contaminate grains
with aflatoxin Bi under natural conditions (Chamberlain et al., 1993; Chu and Li,
1994), so potential interaction and/or synergistic activities could also be related.
Therefore, the aflatoxin/hepatitis environment could be further complicated by the
presence of other toxins, such as, the fumonisins. Potential interactive effects need
to be determined. Studies currently in progress, are investigating the role of p53
associated mutations in early hepatocyte lesions and the ultimate cancer induced by
FBi in rats chronically fed

50 mg FBj/kg for two years. DNA from rat liver

nodules was amplified by polymerase chain reaction (PCR) with gene specific
primers, corresponding to codon 249 of the human gene. Results from this study
show that the positive control, AFBi, induced mutations at a very low frequency at
rat codon 243, the equivalent to codon 249 in humans. No mutations were detected
after cancer initiation with FBi. Only one rat fed 50 mg/kg for 12 months, showed
a mutation at codon 243 while none of the rats with hepatic carcinomas after 18 to
26 months showed any mutations in p53 (Sheffield et al., 1993). More information
is needed on the mechanism by which fumonisin acts as a tumorigenic agent; the
factors that affect this process and its relationship with other hepatic carcinogens.
Furthermore, it has been reported that many of the natural composition diets fed to
laboratory animals potentially contain fumonisins (Merrill et al., 1997). Merrill et
al. (1997) performed a pilot feeding study in which female Sprague-Dawley adult
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rats were fed with several standard laboratory diets for 2-3 weeks. Urine was
collected and analyzed for sphinganine and sphingosine as biomarkers for exposure
to fumonisin. This study revealed a statistically significant correlation (p=0.042)
between sphinganinersphingosine ratio and the fumonisin content of the diets; even
when the fumonisin levels in the diets were fairly low (<4 pg/g). These results
suggested that the presence of fumonisin in natural composition diets should be
considered when feeding studies that might be affected by the presence o f this
mycotoxin are designed and interpreted. Furthermore. Martinova and Merrill
(1995) have reported that fumonisins alter immune function. Thus, the content of
fumonisin in laboratory diets might be of particular concern in studies that use
transgenic

and/or

immunocompromised

animals

(Merrill

et

a l,

1997).

Sphingolipids are not considered “essential” nutrients and provide few calories.
However, recent findings have shed new light on the nutritional significance of
these highly bioactive components of food (Merrill et al., 1997). As new
information is revealed, it is important to consider that dietary agents that alter
sphingolipid metabolism, such as the fumonisins, could be implicated in diseases
other than the epidemiologically related esophageal cancer.
5.

Fumonisin Bi related toxicoses

a.

Hepatotoxicity
Hepatic injury is a common manifestation of fumonisin toxicoses in many

species, and seems compatible with the interference of normal biochemical
processes such as sphingolipid metabolism (Ledoux et al., 1992). This condition
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has been primarily reported in animals with the experimentally produced disease
(Ledoux et al., 1992). The fumonisin induced liver lesion differs from that of most
hepatotoxicants including

aflatoxins

(Ledoux et al., 1992).

In this case,

fumonisins are diffusely distributed throughout the liver. A study conducted in rats
by Norred and Plattner (1993) found that radioactively tagged fumonisin was
accumulated in the liver and kidneys. The concentration of radioactivity was low
but remained constant for at least 96 hours. The sub-acute pathological changes in
the livers of rats caused by FBi were also similar to those caused by
material of F. moniliforme MRC 826 (Voss, 1994).

culture

In a 90-day feeding study

involving the purified toxin, mouse liver lesions were observed (Gelderblom et al.,
1991). Increased incidence (10 o f 15 rats) of hepatocellular carcinoma was shown
on rats fed FB1 (>90% pure) at 50 pg/g in a semi-purified diet for 18-26 months
(Jaskiewicz et al., 1987).

Hepatotoxicity was evident after 6 months and

progressed in severity with time. Rats fed com either contaminated with F.
moniliforme or F. moniliforme culture materials developed liver tumors (Hascheck

and Haliburton, 1984). The sub-acute pathological changes in the livers o f rats
caused by FBi were also similar to those caused by culture material o f F.
moniliforme (Voss, 1994)

In equines, hepatotoxicity is manifested by icterus,

hemorrhages and edema (Harrison et al., 1990).

Hepatic damage has not been

reported in field cases of fumonisin toxicoses in swine. This may be due to the
rather subtle nature of the liver lesions compared to the grossly evident pulmonary
edema (Harrison et al., 1990). Liver lesions were seen only in the swine
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experimentally fed com screenings (Colvin and Harrison, 1992). In a feeding study
reported by Colvin et al. (1992), liver changes were observed in all pigs. The mild
lesions were characterized by centrolobular and random hepatocellular cytoplasmic
vacuolar change, hepatocellular cytomegalia, disorganized hepatic cords and early
perilobular fibrosis. At lower doses of fumonisin in swine and equines, the most
prominent feature is slowly progressive hepatic disease.

Additional research is

needed before FBi can be considered a hepatotoxin for swine (Colvin and Harrison,
1992). Liver is a target organ in most of the affected animals and is involved in all
fumonisin associated diseases, so analysis of liver enzymes may serve as a
nonspecific indicator of fumonisin toxicoses,
b.

Equine leukoencephalomalacia (ELEM)
ELEM is a syndrome clinically characterized by an acute neurological

disorder preceded by lethargy and inappetence and presence of Iiquefactive necrotic
lesions in the white matter of the cerebrum. Necrosis o f the gray matter may also
be involved (Harrison et al., 1990; Shier et al., 1991). It appears that this disease
occurs only in equines.
ELEM has been recognized since the nineteenth century as a sporadic,
seasonal, "epidemic-like" condition (Ross et al., 1992). Since its first report in the
United States in 1891, ELEM has been recognized in South America, China,
Greece, Egypt, South Africa and Germany (Ross et al., 1992).
Historically, the diagnosis of ELEM has been based on tissue lesions in
conjunction with clinical signs and the isolation of F. moniliforme from suspected
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feeds (Marasas et al., 1988).

Since the recognition

of F. moniliforme as the

causative fungus, ELEM has been reproduced several times under diverse
experimental conditions.

Marasas et al. (1988) produced ELEM in a horse by

intravenous administration trying to avoid hepatotoxicity as much as possible.
Research shows that ELEM has been produced in horses given pure FBi by
stomach tube and by feeding naturally contaminated screenings (monitoring for
liver toxicity) (Shier et al., 1991). Because of the uncertain reports, it is not
possible to speculate on what levels of fumonisin contamination may be a problem.
When FBi levels of feed associated with ELEM were compared to those that were
not related, a pattern emerged suggesting that concentrations above 10 pg/g in
horse feed could be involved with ELEM (Marasas et al., 1992). This pattern has
remained constant in cases where the feed is representative. Marasas et al. (1988)
succeeded in reproducing ELEM in a horse by intravenous injection of 7 daily
doses o f 0.125 mg FBj/g live mass spread over 10 days. Kellerman et al. (1990)
induced ELEM in two horses with oral daily dose of 1.25-4 mg FBi/g body weight;
both animals developed typical symptoms of ELEM in 25 days.

Wilson et al.

(1992) reported that for levels above the 10-20 pg/g range, there should be concern
for toxicity in horses. However, ponies fed 8 pg/g (Osweiler et al., 1992) did show
minor non-specific lesions in liver, kidney and brain stem.

Current evidence

suggests that horses that consume feed containing levels as low as 8 pg/g of FB1
may be at risk for developing ELEM (Wilson et al., 1991), but further evaluation of
diets at 8 pg/g FBi is needed. Up to this point, researchers have found that in
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equines, high dosage levels cause fatal hepatotoxicity and mild brain lesions while
low dosage levels produce mild hepatotoxicity and severe brain lesions (Shier et
al., 1991).
c.

Porcine pulmonary edema (PPE)
PPE is a syndrome in which swine experience acute, interstitial pulmonary

edema, hydrothorax and death. Thoracic cavities are filled with a golden-yellow
liquid that clots when exposed to atmosphere; trachea and bronchi contain a clear
foamy liquid (Haliburton and Buck, 1986). Microscopical examination o f sections
of lung tissue reveal edema so severe that individual lobules and pleura are
separated from the parenchyma.

The alveolar septa are congested but without

hyperplasia or fibroplasia (Haliburton and Buck, 1986). When the dead swine were
analyzed, the absence o f epithelial hyperplasia or fibroplasia suggested that these
conditions were perhaps due to an unusual toxin (Colvin and Harrison, 1992). The
lesions induced by FBi are remarkably distinctive and should not generally be
confused with other conditions that induce pulmonary and/or thoracic effusion.
A possible mechanism of the development o f PPE is that

altered

sphingolipid metabolism causes hepatocellular damage resulting in release of
membranous material into circulation. This material is phagocytosed by the
pulmonary intravascular macrophages (PIM's) thus, triggering the release of
mediators which ultimately results in pulmonary edema. This is emphasized by the
fact that studies in swine indicate that at lower doses of FBi, the most prominent
feature is slowly progressive hepatic disease, while at higher doses, acute
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pulmonary edema is superimposed on hepatic injury and may cause death (Ledoux
et al., 1992).
The pancreas appears to be similar to the lung in its sensitivity to FBi.
Pancreatic lesions were present in three cases o f experimentally induced acutely
fatal FBi toxicoses (Colvin and Harrison, 1992).

In cases o f suspected FBi

toxicoses in swine, examination o f the pancreas should provide valuable diagnostic
information. In 1989-1990 outbreaks of pulmonary porcine edema (PPE) were
reported in different parts o f USA (Shier et al., 1991; Bane et al., 1992; Rheeder
et al., 1992). Two workers from Georgia (Marasas et al., 1988) published the
initial report on PPE and its association with FBI. In these two field cases, pigs
consumed com screenings containing 162 and 99 pg/g FBi. Com from the 1989
crop was associated with deaths of 34 mature swine in Southwest Georgia. To
confirm that FBi was the causative agent, the syndrome was reproduced using the
screenings and then intravenous injections of pure FB|. The results of these studies
showed a strong association between F. moniliforme and PPE (Rheeder et al.,
1992). Chemical and mycological investigations have revealed the presence o f FBi
at concentrations of 20 to 360 pg/g in suspect swine feeds (Marasas et al., 1988).
Animals fed with com screenings naturally contaminated with

175 pg/g

fumonisins developed PPE, but presented hepatotoxicity when fed doses higher
than 23 pg/g for 14 days (Ledoux et al., 1992; Colvin and Harrison, 1992; Ross et
al., 1991). Purified FBj administered intravenously has been shown to produce
PPE (Ledoux et al.,

1992; Colvin and Harrison, 1992; Ross et al., 1991).
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Harrison et al. (1990) induced pulmonary edema in a pig by injection o f 0.4 mg
FBi of body weight daily for 4 days. As with ELEM. a strong correlation exists
between the fumonisin content of feed obtained from different farms and outbreaks
of PPE. More studies are required in order to obtain the necessary information to
treat and to prevent the disease (Haschek et al. , 1992).
d.

Human esophageal cancer
Fusarium moniliforme infection of com has been correlated with human

esophageal cancer (EC) risk in Transkei, South Africa where com is a dietary staple
and in China (Haschek et al., 1992). Esophageal cancer also occurs in higher than
normal concentrations in portions of Iran (Kmet and Mahboubi, 1972) and the
Charleston, South Carolina area of the United States (Fraumeni and Blot, 1977).
Transkei has been the most studied region due to the fact that its rate of EC is 50100 per 100,000 population while normal occurrence for esophageal cancer
elsewhere is less than 5 cases per 100,000 population (Shier et al., 1992). In this
region, the com is grown locally, harvested and stored in open cribs; and
frequently, it is visibly moldy. A retrospective study of com samples collected over
the period 1976-1989 from Transkenian areas of high esophageal cancer showed
higher levels of fumonisins in com than samples from areas with low incidence
(Rheeder et al., 1992). Contamination of com with Fusarium moniliforme and
fumonisins in the areas of high EC is statistically higher than that found in areas of
the Transkei with lower cancer incidence (Hascheck et a l , 1992; Sydenham et al.,
1990; Bane et a l , 1992).

Thiel et al. (1992) reported that based on a daily
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consumption of 460 g com/day by a 70 kg person, the estimated intake of FBi was
0.44 mg/kg/day.

This daily dose is alarmingly high when compared to daily

intakes of 0.6-4.0 mg/kg/day that give rise to ELEM in horses or 3.75 mg/kg/day
that produce hepatocarcinogenesis in rats (Hascheck, et al., 1992). It is important
to point out that com samples from high and low cancer rate areas in the Transkei
are not commercial com but rather home-grown, produced, harvested, stored and
consumed by the people living in rural areas. Laboratory studies have shown a
high correlation between the cancer promoting activity and toxicity of different
strains of F. moniliforme. There is evidence that fumonisins are neither genotoxic
nor mutagenic and do not appear to be metabolized to a significant extent in vivo,
so the mechanism of carcinogenicity is difficult to ascertain (Shier et al., 1992).
Nonetheless, the carcinogenic potential has been shown in laboratory rats (Voss,
1994; Jaskiewicz et al.,

1987).

Gelderblom et al. (1992) demonstrated

hepatocarcinogenicity in rats by incorporating 50,000 ng/g to the diet in a 26 month
period. In other cancer experiments in rats, approximately 66% of the animals
developed hepatocellular carcinoma while a cancer rate as low as 0.02% can be
considered a significant risk to a human population (Haschek et al., 1992). Results
of experiments with rats imply that FBi is a complete carcinogen and, together with
other related compounds, might be responsible for the hepatocarcinogenicity of F.
moniliforme (Voss, 1994). FBi and FB2 pose a potential risk to humans as they
occur in food and have been shown to be statistically correlated with the prevalence
of human esophageal cancer in Transkei. However, it is important to establish that
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cancer manifestation may take a lifetime and the presence o f fumonisin has only
been analyzed recently.

It is necessary to follow the

EC rate and fumonisin

contamination in time to assess if the population develops this condition. On the
other hand, there are social economic, cultural, genetic and a diverse scope of
factors that can contribute to a high cancer rate. Whether the high rate of EC in
regions of the Transkei is caused by fumonisins cannot be determined conclusively,
but the available evidence suggests that their presence may be at least partly
responsible.
e.

Developmental toxicity
The developmental toxicology of FBi has been evaluated in different

species. In vivo studies with culture material extracts have reported embryotoxic
effects in hamsters (Floss et al., 1994a,b), mice (Gross et al., 1994), and rats
(Lebepe-Mazur et al., 1995. Studies using purified FBi rather than culture material
reported embryotoxicity to hamsters in vivo (Floss et al., 1994b) and to chick
(Zacharias et al., 1996) and rat embryos in vitro (Johnson et al., 1993; Flynn et al.,
1996). However, FBi embryotoxicity has been questioned by other studies that
have shown negative results. LaBorde et al. (1997) reported lack o f embryotoxicity
in New Zealand white (NZW) rabbits at 0.5-1.0 mg/kg/day doses. However, they
reported that FBi was quite toxic to NZW rabbits at doses as low as 0.5 mg/kg/day.
In this study, adverse developmental effects (decreased fetal weight) were observed
only at doses producing maternal toxicity. Another study by Ferguson et al. (1997)
reported minimal maternal or offspring toxicity in rats. This study suggested that
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doses <9.6 mg purified FB|/kg body weight and/or <1.6 mg FBi/kg body weight
obtained from culture material caused minimal maternal toxicity and produce few
developmental functional alterations. In addition, potential FBi related functional
alterations were prevalent only in males suggesting that there is a mild sex-specific
effect of fumonisin. In developing rats, Kwon et al. (1997) observed that FBi alters
brain sphinganine levels and myelination. These diverse reports emphasize the need
to do more research to understand FB| mechanism of action and its potential risk to
human fetuses.
In addition to high rates o f esophageal cancer, it has been reported that the
incidence of neural tube defects (NTDs) in the Transkei is significantly higher than
in other areas of South Africa (Ncyiyana, 1986; Viljoen et al., 1995). The incidence
of NTDs has also been reported to be higher in the Hebei province of the People’s
Republic of China than the average for the rest o f the country. This province
contains the Cixian county that is also one o f the areas of China having a high
incidence of esophageal cancer (Chinese Birth Defects Monitoring Program, 1990).
In the United States, high rates o f NTDs have been observed in Cameron County,
Texas from 1990 to 1991 (Texas Department of Health, 1992) and in Harris
County, TX from 1989 to 1991 (Canfield et al., 1996). The prevalence of these
defects was high among Hispanics (Canfield et al., 1996) for whom com and com
products represent a dietary staple. In 1989-1990 there were reports of clusters of
horse fatalities due to ELEM in this same area in Texas. This event established that
the com crop in that area was contaminated with fumonisins during this period.
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Moreover, recent findings have reported that fumonisin Bi induces depletion of
cellular sphingolipids and interferes with folate uptake (Stevens and Tang, 1997).
Folate and its derivatives are vitamins that function as coenzymes in several
metabolic reactions. They are considered essential for the biosynthesis of molecules
such as thymidine and purines, as well as, the conversion of homocysteine to
methionine (Wolf, 1998). It has been reported that dietary folate is taken up by
cells by two mechanisms. The first one uses a high capacity, low affinity protein
transmembrane transporter known as the “reduced folate carrier”. The second one
is a membrane-anchored receptor protein with high affinity for both, folic acid and
reduced folates denominated as “membrane folate receptor” (MFR). The MFR is
important in tissues, such as, the kidneys, the placenta and breast where high folate
levels are required. This receptor is attached to the plasma membrane through a
covalent link to a glycosylphosphatidylinositol anchor (GPI) in a membrane
domain that is rich in cholesterol and sphingolipids. Folate uptake by MFRs
appears to take place by the classical endocytosis process. The MFR on the plasma
membrane is bound and the folate is internalized by invagination that forms
vesicles that are pinched off and enter the cell. After the folate has been unloaded,
the MFR is recycled back to the membrane. It has been suggested that
sphingolipids, particularly glycosphingolipids interact through hydrogen bonding
with the GPI anchor of the membrane protein to localize it in a particular
membrane domain (VanMeer, 1992).

53

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

The involvement of sphingolipids in the folate uptake mechanism led to the
hypothesis that factors affecting sphingolipid metabolism could be involved in
defective cellular folate uptake. Stevens and Tang (1996) reported that intestinal
cells (Caco-2 cells) are depleted of sphingosine after treatment with FBi. Uptake
into the cells of the folate derivative 5-methyltetrahydrofolate was virtually
eliminated by FBi. When ceramide was added to these cells, the folate uptake was
renewed. In this study, the authors concluded that the inhibition of the folate uptake
was caused by the loss of the receptor rather than by its redistribution within the
membrane. The authors showed that the MFR is critically dependent on the
sphingosine and cholesterol levels on the membrane. There is evidence that the GPI
anchor requires a sphingolipid/cholesterol-enriched domain, possibly to target the
receptor to a particular site on the membrane. These results are important since the
risk of fetal NTDs is known to be associated with dietary folate deficiency (Creizel
and Dudas. 1992). Stevens and Tang (1996) considered that inhibition of folate
uptake through dietary exposure to FBi could be related to the high incidence of
NTDs among Texas’ Hispanic population. Furthermore, D’Angelo and Selhub
(1997) have reported a correlation between increased risk of heart disease and
elevated blood levels of homocysteine associated with folate depletion. These
findings have focused attention on fumonisins’ potential role in other human health
problems.
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f.

Other diseases
There are several non-specific syndromes that affect other species exposed

to fumonisin. Many reports implicate F. moniliforme with poultry diseases and wild
bird mortality (Voss et al., 1989; Shier et al.. 1992). A 21-day feeding study in
broiler chicks reported that dietary fumonisin resulted in depressed weight gains,
increased organ weights, diarrhea, thymic cortical atrophy, multifocal hepatic
necrosis, biliary hyperplasia, and rickets (Voss et al., 1989). Other researchers
report that com cultures fed to chicken and birds produce immunosuppression.
According to the actual evidence, the level necessary to promote toxicosis in
poultry is below 100 mg/kg (Voss et al., 1989). During 1988 and 1989, a distinct
swine disease syndrome (Mystery Swine Disease - MSD), characterized by
epidemics of prenatal and neonatal mortality and respiratory diseases and immune
system dysfunction in older swine was reported in North America (Gelderblom et
al., 1992). The etiology of this disease is unknown at this time, but Bane et al.
(1991) reported that the distribution of MSD in Illinois was the same as for PPE.
The results of one study (Gelderblom et al., 1992) do not indicate a direct cause
and effect relationship, but show a strong relationship between MSD and feeding
com contaminated with fumonisin at concentrations o f 20 pg/g or greater.
Fumonisin may be the initiating "trigger" factor leading either directly or indirectly
to MSD.
Studies in rats show that the kidney is also a sensitive target organ for FB|
fed either as contaminated com or pure FBi (Fincham et al., 1992; Shier, et al.,
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1991). Other studies suggest that the kidney is not an important target organ for
this toxin (Jaskiewicz et al., 1987). The reason for this difference has not yet been
explained. Recently, it has been reported that intravenous injection of FBi at doses
of 1 mg/kg for five days can cause severe and acute kidney damage in rabbits
(Gumprecht et al., 1994). Vervet monkeys, that were fed low levels (0.25-1%) of
F. moniliforme culture material in a diet based on com, low in fat and high in
carbohydrates for up to two years, showed atherosclerosis (Riley et al., 1993).
Research showed that atherogenic potential is secondary to chronic hepatotoxicity
(liver fibrosis) (Riley et al., 1993).
Fumonisins seem to affect an important
animals.

metabolic pathway in several

This is evidenced by the generalized presence o f several degrees of

hepatotoxicity in all the fumonisin-associated diseases that have been studied.
Each species will

react in different ways to these alterations, so most of the

toxicoses are species-specific and present a wide variety o f syndromes in different
target organs.
D.

Inhibition of gap-junction intercellular communication as a nongenotoxic mechanism in carcinogenesis
The general concept of traditional chemical carcinogenesis mechanisms has

relied on the genotoxicity of xenobiotics. The idea that non-genotoxic pathways
can induce cancers has not even been considered until recently. Recently, a
considerable amount of data has been presented on the carcinogenic potential of
compounds with no apparent genotoxic potential. Thus, the scientific community
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has been faced with the challenge to understand the process of carcinogenesis from
a non-genotoxic point of view, since these compounds pose significant regulatory
dilemmas relating to the risk assessment of human exposure (Ricci and Melton,
1985).
In a simplistic approach, cancer can be regarded as a rebellion in an orderly
cellular society. Cancer cells disregard their neighbors and grow autonomously
over surrounding normal cells. Intercellular communication is considered to play an
important role in maintaining an orderly society through control of cell growth, cell
differentiation and homeostasis (Yamasaki, 1987). Thus, it has been proposed that
disruption of cell-cell communication could be involved in carcinogenesis
(Loewenstein, 1979; Murray and Fitzgerald, 1979; Yotti et al., 1979).
Most cells have two different ways to communicate with other cells. One is
communication mediated by growth factors or hormones where direct cell contact
is not needed. Since this type of communication depends on extracellular factors
that are easily identified, the involvement of these factors in carcinogenesis has
been recognized. There have been several reports showing that many oncogenes
encode growth factors or growth factor receptors (Bradshaw and Prentis, 1987).
The second type of communication is cell contact-mediated intercellular
communication or gap junction intercellular communication (GJIC). During this
type of contact, cells exchange signals directly from the inside of one cell to the
inside of a second cell (Yamasaki, 1996, 1990; Bennett et al., 1991).
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In tissues, cells communicate directly by exchanging low molecular weight
molecules (<1000 daltons) through gap junctions (Simpson et al., 1977). Some of
these exchanged molecules may include sugars, nucleotides, amino-acids and ions
that are important in normal cell function. Second messengers, i.e. calcium, cAMP
and inositol triphosphate can also be exchanged through gap junctions and
participate in tissue control (Saez et al., 1989).
GJIC is mediated by gap junction channels that are composed o f protein
channels comprised o f connexin molecules. Six connexin molecules form a
connexon in a cell. A gap junction channel is formed when a connexon from a
neighboring cell is aligned and linked (Yamasaki, 1996). These six monomers form
a channel that closes by twisting of the six units (Zampighi and Unwin, 1979). Gap
junctions in different tissues are not always identical. So far, 12 cDNAs coding for
different connexin molecules have been cloned (Beyer, 1993). Connexins are
composed of four transmembrane domains with their C- and N- terminals in the
cytoplasm. The amino acid sequences on the terminal cytoplasm portions vary
significantly

between

different

connexins

extracellular portions are more conserved

while

the

transmembrane

and

(Zhang and Nicholson, 1989;

Goodenough et al., 1988; Milks et al., 1988). Protein kinase regions are present at
the C-terminal end of some of the connexins, and phosphorylation has been
considered to play an important role in regulating gap junction function (Moreno et
al., 1992). Since connexins are proteins, they are regulated by the usual regulatory
mechanisms that apply for most proteins. These include transcription, mRNA
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stabilization and translational control, and post-translational phosphorylation. Other
control levels that affect connexin function include, change in cell adhesion
molecules, change in membrane structure and conformation, and growth factors
(Musil and Goodenough, 1995; Meyer et al., 1992; Jongen et al., 1991; Spray et
al., 1987; Zampighi and Unwin, 1979).
The discovery that many tumor promoting agents can block GJIC is the
most supportive evidence of its involvement in carcinogenesis (Trosko and Chang,
1983; Enomoto et al, 1981; Bradshaw and Prentis, Murray and Fitzgerald, 1979;
Yottie et al., 1979). In addition, it has also been shown that inhibition of GJIC by
phorbol esters can be antagonized by various mouse skin anti-promoting agents
such as retinoic acid, glucocorticoids and cAMP (Yamasaki and Enomoto, 1985).
To further support this concept, there are also other lines of evidence that tumor
promoter mediated inhibition of GJIC is associated with enhancement of cell
transformation (Yamasaki and Katoh, 1988). Although there have been studies that
contradict the involvement of GJIC in carcinogenesis, it can be considered as a
plausible mechanism for certain tumor promoters. It is conceivable that multiple
mechanisms are involved and that different chemicals will affect cells through
diverse pathways that will ultimately result in cancer.
While the relevant mechanism that causes the opening and closing of gap
junction channels remains obscure, the involvement of protein kinase C action in the
regulation of intercellular communication has been implicated. It has been
hypothesized that the intercellular protein kinase C is related to the inhibition of gap
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junction function. Moreover, complex sphingolipids have many important functions in
cell membranes. The regulated breakdown and turnover of complex sphingolipids,
such as, sphingomyelin, are known to result in the formation of lipid "second
messengers". These second messengers act as intracellular signals for turning on and
off cellular processes including the expression of genes and activation or inactivation
o f specific proteins, such as, protein kinase C (Riley et al., 1994). The fumonisinrelated inhibition of de novo sphingolipid biosynthesis and transformation may play
an important role in disrupting the production of protein kinase C. Which in turn,
results in disrupted gap-junction cell communication and, ultimately,

in cancer

promotion. The simultaneous exposure to a genotoxic carcinogen (aflatoxin) and a
non-genotoxic carcinogen (fumonisin) may have a synergistic effect on the complex
carcinogenesis process.
E.

Effects of processing on mycotoxin-contaminated foods*
Mycotoxins comprise a structurally diverse and chemically complex group

that can contaminate a wide variety of food products. Table 2.1 presents a summary
o f some of the most commonly affected commodities, the potential toxic mold
genera/species, and the mycotoxins that contaminate them.
Most of the research on the effects of processing has been related to the
aflatoxins, but some processing and stability experiments have been done on other

*This section has been reprinted from Ref. (98-160), p. (407) by courtesy of Marcel
Dekker, Inc. (See Appendix C)
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Table 2.1 Summary of selected reports o f potentially toxic molds from various food
or agricultural commodities (CAST, 1989)

C o m m o d ity

P o t e n tia lly to x ic g e n e r a /s p e c ie s
fo u n d

W heat, flour, bread, c o m m e a l,
popcorn, tortillas, ch ip s

Peanut, in -sh ell p ecan s, nuts

Aspergillus
F law s
Ochraceus
Versicolor
Fusarium
Moniliforme

Penicillium
citrinum
citreo-viride
cyclopium
martensii
patulum
pubertum

Aspergillus
Flavus
Ochraceus
Versicolor

Penicillium
cyclopium
expansum
citrinum

Fusarium
sp.
M eat p ie s, co o k ed m eats, c o c o a
pow der, h ops. C h eese

Aspergillus
Flaw s

A ged m eat products, cured ham
m o ld y m eats, ch eese

Aspergillus
F laws
Ochraceus
Versicolor

B lack and red pepper, pasta
n ood les

Aspergillus
Flavus
Ochraceus

Penicillium
viridicatum
roqueforti
patulum
commune
Penicillium
viridicatum
cyclopium

Penicillium
sp.

P o te n tia l
m y c o to x in s
a flatoxin s
ochratoxin A
sterigm atocystin
patuiin
p e n ic illic a cid
d e o x y n iv a le n o l
zearalen on e
fu m on isin
a flatoxin s
ochratoxin A
patuiin
sterigm atocystin
trich oth ecen es
c y to c h a la sin s
oosp orein
afla to x in s
ochratoxin A
patuiin
p e n ic illic acid
afla to x in s
ochratoxin A
patuiin
p e n ic illic acid
sterigm atocystin
penitrem
A fla to x in s
och ratoxin A

(continued)
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C o m m o d ity

P o te n tia lly to x ic g e n e r a /s p e c ie s
fo u n d

P o te n tia l
m y c o to x in s

D ry beans, so y b ea n s, c o m ,
sorghum , barley

Aspergillus
Flavus
Ochraceus
Versicolor
Alternaria sp.
Fusarium
moniliforme

Penicillium
cyclopium
viridicatum
citrinum
expansum
islandicum
urticae

afatoxin s
och ratoxin A
sterigm atocystin
p en ic illic acid
patuiin
citrm tn
g riseofu lvin
altem ariol
alten u en e

R efrigerated and frozen pastries

Aspergillus
flavus
versicolor

a flatoxin s
sterigm atocystin
ochratoxin A
patuiin
p e n ic illic acid
citrinin
penitrem

M o ld y superm arket fo o d s

Penicillium
cyclopium
Fusarium
oxysporum
solani

Penicillium
cyclopium
citrinum
martensii
citreo-viride
palitans
puberulum
roqueforti
urticae
viridicatum
Aspergillus
sp.

p e n ic illic acid
trichothecenes
afla to x in s
p o ssib ly other
Aspergillus and

Penicillium
toxin s
F ood s stored in h o m e s, both
refrigerated and nonrefrigerated

Penicillium

A p p les and apple products

Penicillium
expansum

sp.

Aspergillus
sp .

a flatoxin s
kojic acid
ochratoxin A
penitrem
patuiin
p e n ic illic acid
patuiin
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Aspergillus and Penicillium metabolites, such as, ochratoxin A, citrinin, penicillic
acid and patuiin. More recently, research has been conducted on the effect of
processing on the Fusarium toxins, i.e.. trichothecenes, fumonisins, deoxynivalenol
(DON), T-2 toxin and zearalenone (Scott, 1984). Research in this area is extensive
and beyond the scope of this publication. This section will only discuss a few
examples pertinent to the effectiveness of normal processing operations in reducing
the risks associated with mycotoxin contamination and the industrial applicability
of selected decontamination procedures.
1.

Physical methods of mycotoxin removal

a.

Cleaning and segregation
Once a contaminated product has reached a processing facility, cleaning and

separating are the first alternatives o f control. These procedures are usually noninvasive; and, except for milling, will not significantly alter the product. In some
cases, these are the best methods to reduce mycotoxin presence in the finished
products, i.e., a significant amount o f aflatoxins in shelled peanuts can be removed
by electronic sorting and hand-picking (Dickens and Whitaker, 1975). However,
complete removal of all contaminated particles or aflatoxin cannot be expected
with physical methods of separation. Since the toxin can diffuse into the interior of
the kernel, residual contamination may be present at very low levels in the final
product. If there is a high level o f residual contamination, other procedures must be
used to manage the contamination in the final product.
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Floatation and density segregation of aflatoxin-contaminated com and
peanuts have been reported to significantly reduce aflatoxin concentrations (Cole,
1989). Kirskey et al. (1989) reported that 95% of the aflatoxin in 21 of 29 samples
o f peanuts was contained in kernels that floated in tap water. Furthermore, Phillips
et al. (1994) reported that the mean aflatoxin level was decreased from 301 ng/g to
20 ng/g using floatation as a separation mechanism. Although there is still an
aflatoxin residue, separation has been shown to significantly reduce aflatoxin
contamination and can be considered as an effective first line of defense for certain
products.
Separation of fumonisin-contaminated com, particularly screenings, based
on size has been reported as a possible candidate for decontamination. Com
screenings are broken com kernels that usually contain about 10 times the
fumonisin content of intact com (Murphy et al., 1993). However, screenings
represent a significant proportion of the com used for feed, so it is not possible to
segregate fumonisin contents by screening size without compromising the feed
supply. Further decontamination procedures need to be used to treat com
screenings used for feed.
Although significant quantities (ca. 25%) of deoxynivalenol (DON) can be
removed by cleaning and polishing, the toxin remains in wheat flour at levels
ranging from 60-80% of original toxin levels from the starting wheat (Seitz et al.,
1986; Trenholm et al., 1991). Another study on wheat samples from several states
showed a reduction in deoxynivalenol content in flour from spring wheat that had
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been cleaned by aspiration prior to milling into flour (Bennett et al., 1992).
However, the toxin residues found in the flour indicate that physical separation
should only be considered a step in a more elaborate risk management plan.
If apples rotted with Penicillium expansum are used for commercial juice
production, the final product may contain patuiin. It has been reported that
trimming of apples to remove the rot reduces the patuiin content by 93 - 99%
(Lovett et al., 1975). In general, physical separation or trimming of apples before
processing is the best method to reduce patuiin contamination. In this case, physical
separation should be considered the focal point of the risk management plan. The
correct use of trimming and separation will render safe high quality commercial
juice.
Cleaning and segregation represent a primary source of the removal of
hazard in mycotoxin contaminated food. In some cases, these procedures will
eliminate the problem. However, in most cases, further processing is needed to
reduce the risks associated with mycotoxin contamination.

Although some

contamination may persist, physical separation is a good alternative for industry.
These processes require an initial investment to purchase adequate equipment, but
their maintenance is rather inexpensive. Furthermore, physical removal will not
affect the product's characteristics; so after the initial separation stage, there is no
other significant alteration o f the product. With well-calibrated separating
equipment and appropriate planning, this method is a good choice for products such
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as peanuts, and other tree nuts (aflatoxin), com (aflatoxin and fumonisin), and
apples (patuiin).
b.

Wet milling
Wet milling is a process widely used for com. Thus, there have been several

studies that evaluate the effects of this process on mycotoxins associated with this
grain. In this case, an established processing method can be used to manage
contaminated grains. It is important to identify the fraction(s) that remain toxic.
These fractions may then be diverted to less risk uses or subjected to
decontamination procedures. Laboratory studies have reported that during wet
milling of inoculated com, aflatoxin Bi was distributed in the milling fractions. It
went primarily into the steep water (39 to 42%) and fiber (30 to 38%), with the
remainder found in gluten (13-17%), germ (6 - 10%) and starch (only 1%) (Bennet
et al., 1978; Wood et al., 1982). The distribution of mycotoxins in the different
fractions poses new concerns. In a good risk management plan, an individual
contaminated fraction needs to be considered as a new product because it will have
its own unique characteristics. Some of the factors to be considered for a particular
milling product include: the end use, the chemical properties, and the level and type
of contamination. Each product or by-product should be approached differently,
and risk management decisions should be made on an individual basis.
Other mycotoxins are also distributed during wet milling o f com.
Zearalenone concentrates in the gluten (49 to 56%) and milling solubles (17 to
26%), but is absent in the starch (Bennett et al., 1978; Bennett and Anderson,
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1978). Recent wet milling laboratory-scale studies on naturally-contaminated com
have shown that zearalenone remains mostly in the gluten and the germ remains
relatively free of the toxin. The starch fractions, which account for 65-71% of
milled products, were free of detectable zearalenone. Milling solubles contained
one to four times the levels o f zearalenone in the starting com and gluten fractions.
The most contaminated fraction contained two to seven times the levels in starting
com. Although these fractions account for only 14-19% of the com, they account
for 72-75% of the zearalenone. Fiber and germ fractions contained up to three times
the levels of zearalenone in the starting com and these fractions account for 1516% of the milled product. These results show that if a mycotoxin-contaminated lot
of com is processed by wet milling, toxin free starch is produced; however, other
products generally used in animal feed have much higher levels o f toxin than the
starting com (Bennett and Anderson, 1989). The concentration of toxin in a
particular fraction simplifies the process o f risk management. The other milling
fractions can be considered safe, and decisions need to be taken on a single product.
The management o f only one toxic fraction can be simpler than the handling of
several contaminated milling products.
An advantage o f wet milling is that additional chemicals can be added to the
steeping solution. So, a modified process could be used to ensure the safety o f the
final products. Bennet and Richard (1996) have conducted traditional wet milling
(using lactic acid-sulfurous acid steeping) of two samples of fumonisin B1
naturally-contaminated com.

In com containing 13.9 pg/g of fumonisin B|, a
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portion (22%) o f recoverable toxin was found in the steep and process waters.
Other fractions contained fumonisins with gluten having the highest concentration
followed by fiber and finally germ with the lowest concentration. The gluten and
fiber from com contaminated at 13.9 gg/g could pose a risk because they contain
toxins at levels considered to be harmful to certain animals (Ross et al., 1991).
In wet milling of deoxynivalenol-contaminated com, much of the DON
went into the steep liquor, although measurable amounts remained in the starch
(Scott, 1984). Experimental wet-milling of com contaminated with T-2 toxin
showed that 67% of the toxin was removed by the steep and process water (T-2
toxin is more water soluble than aflatoxin or zearalenone). Wet-milling o f com
containing ochratoxins A and B showed that 43% of ochratoxin A remaining in the
steeped com went into the process water and solubles on subsequent processing,
with 4% remaining in the germ and 51% in the grits (Wood, 1982).
Mycotoxins have diverse chemical characteristics, so the distribution during
wet milling will vary according to the commodity and the type and level of
contamination. Each case should be considered separately when developing a risk
management plan for wet milling operations,
c.

Dry milling
Dry milling will also fractionate the toxin(s). Thus, the identification of the

toxic fractions is needed to adequately use milling as a decontamination procedure.
In dry milling o f naturally contaminated com, aflatoxin B| concentrated in the
germ and hull fractions; but distribution varied with the contamination levels. The
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grits, low-fat meal and low-fat flour (the prime products) contained only 6 to 10%
o f the aflatoxin Bi. In artificially contaminated rice aflatoxin was greatly reduced
by milling, with more than 95% in the bran and polish fraction (Achroder, 1968). In
durum wheat, aflatoxin Bj was determined to be in peripheral parts of the kernel.
Upon milling, the aflatoxin concentration in the flour varied according to the
quality of the final product and was maximal in the bran. Prior conditioning
reduced the aflatoxin content by 47% (Scott, 1984).
For zearalenone-contaminated com, all dried milled com fractions
contained zearalenone and only 3 to 10% was removed (Scott, 1984). Dry cleaning
(screening) of the zearalenone-naturally contaminated com does not significantly
reduce toxin levels in com lots. Bennet et al. (1976) reported that all mill fractions
from laboratory scale and commercial processes were contaminated with
zearalenone. The highest levels of toxin were found in the hull and high fat
fractions. Prime product mix (grits, low-fat meal, and flour, which account for 5763% of product yield) contained about 20% o f the zearalenone from the starting
com samples (Bennett et al. 1976).
No specific dry milling studies have been conducted on fumonisincontaminated grains. However, assays on com based foods have shown that the
toxin is present in human foodstuffs, i.e., com grits and com meal (Bennett and
Richard, 1996; Sydenham et al., 1991; Stack and Eppley, 1992). On the industrial
perspective, milling can be used as an effective method o f separation. If the
distribution of the toxin is determined, and alternate management of the toxic
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fraction is developed, milling can be considered a good cost/benefit method. A
combination of cleaning, sorting and milling can significantly reduce the risks
associated with mycotoxins.
2.

Physical methods of detoxification

a.

Thermal inactivation
Thermal inactivation is a good alternative for products that are usually heat

processed. However, some of the mycotoxins are chemically stable at processing
temperatures. Thermal inactivation should be evaluated for the conditions of a
particular process. Additional processing steps, i.e., use o f compounds that would
promote the chemical degradation of a toxin, could be employed to ensure the
safety o f the procedure. In some cases, a change in conditions such as pH or
moisture content will contribute to the chemical modification of a particular toxin.
Aflatoxins are resistant to thermal inactivation, and are not destroyed
completely by boiling water, autoclaving or a variety o f food and feed processing
procedures (Christensen et al., 1977). Aflatoxins may be destroyed partially by oiland dry roasting of peanuts. However, Stoloff (1982) reported that aflatoxins are
generally stable in peanut materials at room temperature. Baur (1975) found no
significant changes in levels of aflatoxins Bi, B2 , G| and G 2 in peanut meals, and
raw and roasted peanut butter stored at 23° C for two years. Lutter et al. (1982)
reported that alternative peanut roasting methods, i.e., microwave roasting, destroy
aflatoxins almost completely. Unfortunately,

this process would involve an
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increase in processing cost, making it commercially impractical. Thus, microwave
roasting is not a good industrial solution, even if it yields a safe product.
Roasting has been a good method for certain commodities, i.e., peanuts. As
mentioned before,

if an operation that is regularly used in processing is an

effective decontamination procedure, then that operation would be the first choice
to manage that particular product. This would provide a safe, inexpensive risk
management method. An example of roasting as an effective means of control is its
use in coffee processing. It has been reported that roasting green coffee beans
containing added aflatoxin Bi at 200° C produced a 79% toxin loss after 12 min.
and more than 94% loss after 15 min. (Levi, 1980). Furthermore, roasting of green
coffee beans at 200° C for 20 min. destroyed
laboratory conditions (Levi et al., 1975).

6 8

% of added sterigmatocystin under

It is important to mention that these

studies were performed with spiked coffee beans. The use o f spiked material for
experimental processes gives useful information. However, the effects of roasting
should be confirmed with naturally-contaminated green coffee beans because
naturally occurring toxins may have different interactions with the food matrix. It is
important to confirm the effectiveness o f a processing operation under industrial
conditions before using it as part of a risk management plan.
Several studies have reported that aflatoxin Bi is moderately stable in
heated peanut oil, com oil and coconut oil. Therefore, flying in unrefined oils
could add aflatoxin during processing (Dawarkanath et al., 1969; Peers and Linsell,
1975). Fortunately, oils are not of concern because only a small percentage of
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aflatoxin Bi present in oilseeds passes into extracted or pressed oil; and refining
and bleaching operations essentially eliminate it (Parker and Melnick, 1966).
Gracian (1980) reported that the average loss of total aflatoxin concentration in
pressed olive oil was 76% .
Conway et al. (1978) reported that roasting com (145-165° C) yielded a
reduction of 40-80% of the original aflatoxin Bj. Studies on cooking of aflatoxincontaminated rice found that normal cooking of rice destroyed about 49% of
aflatoxin B§; pressure cooking and cooking with excess water destroyed more of
the aflatoxin Bi in the rice (73 and 82%, respectively). These results provide
evidence of the influence of water on stability of aflatoxin during heat processing.
Furthermore, when pasta products contaminated with aflatoxins were cooked for 10
min. in boiling water, 29% of the aflatoxin was found in the drained water and

6 6

%

in the cooked pasta (Stoloff et al., 1978).
Surveys have shown that thermally processed com products, i.e., canned
com, tortillas, and ready to eat cereals generally have lower concentrations of FB|
than do unprocessed products, i.e., com meal and grits (Parker and Melnic, 1966;
Pittet et al., 1992; Doko and Visconti, 1994). Since most corn-based foods receive
some sort of thermal processing, it has been suggested that this kind of procedure
could have an effect on the fumonisin content in food. However, results reported
by Jackson et al. (1995), Alberts et al. (1990), Dupuy et al. (1993), and Scott and
Lawrence (1994) indicate that the fumonisins are fairly heat stable compounds. In
general, it has been reported that the loss of FBi and FB2 was more rapid and
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extensive in alkaline or acidic environments than at neutral pH. Thermal processing
operations, such as, boiling or retorting, which occur at temperatures <125°C, have
little effect on the fumonisin content of food; however, foods that reach
temperatures >150°C during processing may have significant losses o f fiimonisins.
Although some o f these studies show decomposition o f fiimonisins, the toxic
potential is not necessarily eliminated (R. Lopez-Garcia and D. L. Park,
unpublished data); therefore, detoxification of these compounds cannot be
assumed. Further work is needed to determine the toxicity of thermally processed
fumonisin-contaminated foods (Jackson et al., 1996). In this case, thermal
processing is not a good choice for industry. Alternative methods for fumonisin
decontamination need to be applied.
Studies on the effect of heat processing of ochratoxin A-contaminated flour
have reported that considerable reduction of ochratoxin A (76%) occurred in
samples of white flour heated to 250°C for 40 minutes. Ochratoxin A appears to
be more readily destroyed in dry cereal than in the presence o f water (unlike
aflatoxin Bi and patuiin) (Scott, 1984). This was also evident in a study reported by
Osbome where ochratoxin A was not degraded during breadmaking, but 62% was
lost after baking o f biscuits, which have a lower water content (Osbome, 1979).
Processing o f other commodities naturally contaminated with ochratoxin A
have shown that after blanching, salting and heat processing beans, about 53% of
ochratoxin A remained (Harwig, 1974). In this case, it is important to determine if
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the

heat

processing

will

yield

products

with

unchanged

technological

characteristics.
Several authors have studied the effect of making bread on aflatoxin present
in w'heat flour or in maize flour (El-Banna et al., 1983; Reiss, 1978). Variable
destruction levels have been observed, but there are still conflicting results. Bennett
and Richard (1996) reported that baking does not destroy or significantly reduce
levels of deoxynivalenol. DON has proven to be more heat stable during food
processing than any other mycotoxin tested. No DON was destroyed during the
baking of different ethnical products such as Egyptian bread. Western style bread
or cookies baked from hard wheat flour (Scott, 1984).
b.

Irradiation
The effects of irradiation on most mycotoxins is relatively unknown.

However, with the state of today's processing facilities, irradiation does not seem to
be a good commercial method. The cost involved in setting up an irradiation
facility and the reluctance of the consumer to accept irradiated products makes this
method inaccessible to most industries.
Feuell (1966) reported that gamma irradiation (2.5 Mrad) did not degrade
aflatoxin in contaminated peanut meal, and UV light produced no observable
change in fluorescence or toxicity of the treated sample. However, exposure to
contaminated peanut oil to short-wave and long-wave UV light resulted in
reduction of aflatoxin levels (Feuell, 1966; Shantha and Sreenivasamurthy, 1977).
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a

c.

Adsorption from solution and covalent binding
Adsorption from solution or covalent binding of aflatoxins to non-biological

materials are good methods for aflatoxin decontamination. In industries such as the
oil refineries, the use o f adsorbent materials is readily available and is part of
normal processing operations. A variety o f adsorbent materials; i.e., activated
carbon and clays, has been shown to bind aflatoxins in aqueous solutions, and
certain aluminosilicates have been reported to bind aflatoxins in peanut oil and
animal feeds. The long-term effects and safety of the aluminosilicates has not been
determined (Mansimanco et al., 1973; Decker, 1980; Machen et al., 1988).
However, a phyllosilicate clay (HSCAS or NovaSil™) that is currently used as an
anti-caking agent in the feed industry has been studied for its ability to bind
aflatoxin and reduce the toxicity/mutagenicity of the final product. Phillips et al.
(1994) have reported that this clay [1] tightly binds aflatoxins in aqueous
suspensions; [2 ] markedly diminishes aflatoxin uptake by the blood and
distribution to target organs; [3] prevents acute aflatoxicosis in farm animals; and
[4] decreases the levels o f aflatoxin Mi residues in milk. In this case, phyllosilicate
clay is an effective decontamination agent that is readily used in the feed industry.
However, its only approved use is as an anti-caking agent and its use for removal of
aflatoxin from feed is not permitted in certain countries including the United States
of America. Thus, its beneficial effects are limited to a particular industrial process.
The bentonite clays used in oil purification (to remove pigments) seem to adsorb
aflatoxins present in the unrefined oil. Activated charcoal has also proven to be
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effective in reducing the patuiin in naturally contaminated fruit juices (Sands et al.,
1976; Chu et al., 1975). More research is needed for the application o f this method
with other mycotoxins and commodities.
3.

Biological decontamination
Biological methods are a good option for the fermenting industry, i.e.,

breweries. In this case, however, it is important to determine the yeast's viability in
the presence of mycotoxins. It is also important to determine the effect of
mycotoxins on the yield and development of secondary characteristics associated
with the final product. It is relevant to note that biological methods demonstrating
effective decontaminating properties are usually the result of specific compounds
produced by selected microorganisms. When this occurs, it is usually more efficient
and economical to add the active agent directly.
Chu et al. (1975) reported that aflatoxin Bj is not completely removed
during the beer brewing process, i.e.,

18 and 27% remained from two

contamination levels of starting material, 1 and 10 ng/g, respectively. It was
relatively stable in the cooker mash treatment, but significantly lost in the wort
boiling and final fermentation steps. Dam et al. (1977) found that aflatoxin B[ is
reduced by 47% after cooking and fermentation of com, wheat or com:milo.
Following distillation, a concentration effect was observed more aflatoxin B| was
present in the wet solids (dry weight basis) than in the starting com (Lindroth,
1980). Aflatoxin from contaminated com does not go into the alcoholic distillate,
but accumulation of aflatoxin in spent grains is a potential problem when using this
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material as animal feed. Further decontamination procedures must be used if these
by-products are to be used as animal feed (Dam et al.,\911\ Lindroth, 1980).
Bennet and Richard (1996) reported that although pure fumonisins exhibit
considerable water solubility, residues of toxin remain in the distillers’ dried grains.
This fermentation product accounts for 31-35% of the total fumonisin B|, in the
starting com. Facilitated by solubility in water, 51-54 %

of fumonisin Bi, in

starting com was extracted into whole stillage. No toxin could be detected in
distilled ethanol. The fermentation process did not destroy fumonisin and 85% of
the toxin could be recovered in the products. Products from ethanol fermentation of
fumonisin-contaminated com generally used as animal feeds could be detrimental if
consumed by pigs or horses, animals sensitive to relatively low levels of this toxin.
The use of zearalenone contaminated com for ethanol production was
investigated by Bennet et al. (1981). The presence o f toxin had no apparent effect
on ethanol yields and there was no carry-over from zearalenone to distilled ethanol.
However, the fermentation process did not destroy the toxin and recovered solids
contained 2 to 2.5 times the level of zearalenone in the starting com. Traditional
fermentation for brewing o f com beer has shown 51% carry-over o f zearalenone
into the finished product (Okoye, 1987). Fermentation by Saccharomyces
cerevisiae of wort containing zearalenone resulted in conversion of 69% of the
toxin to beta-zearalenone, a metabolite with less activity than the parent compound
(Scott et al., 1992). Chu et al. (1975) reported that 91 to 96% of ochratoxin A

77

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

remained after the cooker mash treatment of the beer brewing process and none
was destroyed during pasteurization and boiling of beer itself (Chu et al., 1975).
Almost

complete

destruction

of

patuiin

occurs

during

alcoholic

fermentation of apple juice (Burroughs, 1977). Fermentation of juice containing
patuiin at a level of 40 pg/mL using S. cerevisae effectively eliminated patuiin in 2
weeks (Harwig et al., 1973). Winemaking has also been reported to destroy patuiin
(Scott, 1977).
In a survey performed by Scott et al. (1993), deoxynivalenol was found in
29 of 50 samples of Canadian and imported beers. Nine samples contained greater
than 5 ng/mL deoxynivalenol. There are conflicting results on DON stability during
the beer making process. Data is dependent upon the extraction and the analytical
method.
4.

Chemical inactivation
Ammoniation of com, peanuts, cottonseed, and meals to alter the toxic and

carcinogenic effects of aflatoxin contamination has been subject

to intense

research efforts. Results of these studies have been summarized by Park et al.
(1988). Reports on the extensive evaluation of this procedure demonstrate support
for the efficacy and safety of ammoniation as a practical solution to aflatoxin
decontamination in animal feeds. This process has been successfully used for many
years in the U.S., France, Senegal, Sudan, Brazil, Mexico and South Africa. The
practical applications along with research results strongly support the use o f the
ammonia treatment to reduce risks posed by aflatoxin contamination. Particularly
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in the high temperature/high pressure where process parameters are clearly defined
and followed. With the ambient temperature/atmospheric pressure method, caution
must be exercised to assure even distribution of ammonia gas/water or aqueous
ammonia solution in the product. This process is limited to whole kernel seed/nut
products and has not been successful for ground or meal products due to the
inability of the ammonia to penetrate the commodity. Norred et al. (1991) found
that atmospheric pressure/ambient temperature ammoniation reduced fumonisin
content o f F. moniliforme culture material but did not reduce the toxicity of
material when fed to rats. Park et al. (1992) reported 79% reduction of fumonisin
levels in com after high pressure/ambient temperature ammoniation followed by a
low-pressure/high temperature treatment.
Nixtamalization, the traditional alkaline heat treatment of com used in the
manufacture of tortillas, reduces significantly the levels of aflatoxin (Ulloa and
Herrera, 1970; Ulloa Sosa and Schroeder, 1969). However, subsequent studies have
shown that much o f the original aflatoxin is reformed on acidification of the
products (Price and Jorgensen, 1985). This treatment has also been proposed as a
method to detoxify fumonisin-contaminated com (Sydenham et al., 1991). A
feeding study reported by Hendrich et al. (1993) showed that nixtamalization
greatly reduces FB i content. However, when nixtamalized com was fed to weaning
rats, the toxicity o f the inoculated com was not reduced. The major toxic product of
fumonisin hydrolysis during nixtamalization appears to be hydrolyzed fumonisin
Bi (HFBO, but it is possible that other breakdown products, such as calcium-FBi
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complexes and other products may also play a role in the toxicity of nixtamalized
com. The hydrolysis of FB| by treatment with Ca(OH) 2 and heat does not render a
detoxified product. It produces a more toxic final product. Feeding weaning rats
with culture material containing
symptoms

8-11 pg/g of HFBi

as severe as did 45-48 pg/g FBi.

produced some toxicity

These data indicate that the

production of hydrolyzed fumonisins in the processing o f goods for human
consumption may be of significant concern. Park et al. (1996) have reported a
"modified nixtamalization" procedure that involves the addition of hydrogen
peroxide and sodium bicarbonate to the traditional process. Results from this study
show 40% reduction of brine shrimp mortality when comparing the products of
traditional

nixtamalization

and

modified

nixtamalization.

Traditional

nixtamalization is probably not a useful strategy for fumonisin detoxification
(Murphy et al., 1995). However, the modified procedures where other agents, such
as, hydrogen peroxide and/or sodium bicarbonate are used, pose a good alternative
for Latin American countries where nixtamalized com is a major component of
the diet.
It has been shown that sodium chloride has marked influence on loss of
aflatoxins in artificially contaminated unshelled peanuts. Cooking in water in a
pressure cooker for 0.5 h caused a loss in concentration of 80-100% with sodium
chloride, but only 35% without the salt (Scott, 1984). Sodium bisulfite has been
shown to react with aflatoxins (Bi, Gi, Mi, and aflatoxicol) under various
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conditions of temperature, concentration, and time to form water-soluble products
(Hagler et al., 1982).
Non-enzymatic browning has been proposed as a decontamination
procedure for fumonisin Bi. When FBi was incubated with glucose or fructose to
mimic non-enzymatic browning conditions, a first order rate reaction was observed.
This showed that the amine group of FBi was derivatized by the sugar. Preliminary
cell tissue culture tests, with these adducts suggest they are less toxic than FBi
(Murphy et al., 1995).
Both, patulin and penicillic acid are moderately stable in apple juice, with a
half-life of several weeks (Pohland and Allen, 1970). The rate of disappearance of
these toxins increased markedly with the addition of ascorbate or a mixture of
ascorbate and ascorbic acid to the juice (Brackett and Marth, 1979).
Processed foods are very complex systems. Processing not only alters the
food but also adds new ingredients and conditions. These new factors change the
environment, so many new interactions can occur. Exploring the application of
known food additives to mycotoxins as an integral part o f the process can open a
lot of opportunities for risk management.
5.

Other industrial processes
Since molds and their secondary metabolic products are ubiquitous in foods

and feeds, there have been several reports on the effects o f processing and storage
on mycotoxins present in commodities other than grains and oilseeds, i.e., cured
meats, dairy products, and fruit products. It has been reported that recovery of
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aflatoxins added to meats is only 16% from raw ham, and 19% from salami after
storage for

6

to

8

weeks at 5 to 37° C (Stott and Bullerman, 1976). Storage at 5° C

for shorter periods of time (up to

1

week) did not destroy aflatoxins Bi and Gi in

bologna or cheese (Lieu and Bullerman, 1977), nor did curing and cooking bacons
and hams greatly reduce aflatoxin levels (Furtado et al., 1981). Van Egmond
(1983) reported that sterigmatocystin was stable in cheese for at least 3 months at
temperatures of -18° to 16°C. Aflatoxins B| and Gi were completely unstable in
berry jams stored for 6 months at 22°C, although 26 to 38% of aflatoxins B2 and G 2
were recovered (Pensala et al., 19?).
Aflatoxin Mi is stable during pasteurization (Wiseman et al., 1983).
Aflatoxin Mi has been reported to be more stable in naturally contaminated milk
than in freeze-dried spiked milk. Evidence has been obtained that aflatoxin Mj
binds to milk protein casein (Scott, 1984)
In most cases, there is no single method that will insure the complete
removal of the contaminant. Integrated management with a combination of
different methods can significantly reduce the risks associated with mycotoxin
contamination and yield products that are safe and acceptable to the consumer.
The ubiquity of Aspergillus, Fusarium and Penicillium in food and feed
commodities, as well as, their ability to produce a wide variety of toxic compounds,
makes mycotoxicology a complex field. There is great need for more research in
areas, such as, toxin production, identification, toxicological properties, potential
interactions and control alternatives.
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More information is needed on the ecological relationships between
different mold species and their effect on mycotoxin production. This information
could lead to a better understanding of the role o f mycotoxins in fungal physiology
as well as in plant pathology. Since there have been reports on the co
contamination o f different mold species in a wide range of commodities, their
interactions need to be understood to more clearly define the factors that affect
toxin production in the field, during harvest and in storage. This information would
be useful in the development of preventive measures and possible biological
control mechanisms. Furthermore, the understanding of fungal interactions could
also lead to a better assessment on types and quantities of toxins produced under
certain conditions. Therefore, facilitating the evaluation of potential human and
animal exposure to different toxic agents.
Toxicological perception of the effect o f exposure to a single compound
gives valuable information on its mode of action and potential effects. However, in
reality, humans and animals get exposed to a wide variety of xenobiotics that can
have potential interactions. These effects can have positive or negative influences
on the ultimate toxic outcome. Although the study o f the toxicological effect of
complex chemical mixtures is a difficult area, research on the potential interactions
between agents that are known to co-exist in nature (i.e., aflatoxins and fumonisins)
could give valuable information on the toxicological significance of more complex
mixtures.
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It would be unreasonable to believe that all toxic outcomes are the result of
single events rather than a combination o f factors. If

a "healthy'’ status is

considered to be a physiological equilibrium or homeostasis, we need a better
understanding o f the factors that upset this state. Intrinsic individual factors, such
as, genetic predisposition, general health status, age and gender, as well as extrinsic
factors such as diet and environment among others play an important role on the
equilibrium. All of these are very complex areas that interrelate on several levels.
From the food toxicology point o f view, research in mycotoxicology could lead to a
better understanding of the role o f diet in health and disease.
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III.

Preliminary evaluation of the production of aflatoxins and fumonisins
by Aspergillus flavus and Fusarium moniliforme during storage at
optimal mold growth conditions

A.

Introduction
Although it is generally assumed that cereal grains are pristine in nature and

that agricultural commodities are a source of good nutrition and health, the
contamination of food and feeds with naturally-occurring toxins, i.e., mycotoxins,
has presented new concerns. These contaminants are persistent, unavoidable and
unpredictable. Thus, every year, large amounts of food and feed are contaminated
with a diverse range of mycotoxins. These toxins differ in chemical nature and
biological activity; and in some cases, {i.e., aflatoxins) can present a serious health
risk to humans and animals. Therefore, the understanding of the conditions that
affect their production and stability is an essential tool for the design of strategies
that could prevent their formation or control their proliferation.
Aspergillus flavus and Fusarium moniliforme are widely distributed
throughout the world. Although each mold has its unique mode of action, their co
existence in plants, such as, com indicates that there could be an interactive
relationship between both species. In the past it was widely believed that one mold
species persisted over the other; however, more recent reports have suggested that
they can co-exist in the same environment (Chamberlain et al., 1993). This concept
leads to new research questions. If these species co-exist, how does this affect the
biosynthesis and degradation of secondary metabolites like mycotoxins? If there is
an interaction, are mycotoxins produced as a defense mechanism? Does the
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presence of other mold species trigger the production of certain biologically active
compounds?
Chamberlain et al. (1993) reported that A. flavus and F. moniliforme infect
com by different routes. While A. flavus is considered a non-pathogenic fungus that
colonizes com through kernel damage into the outer seed covering; F. moniliforme
is recognized as a pathogen that enters the kernel through the pedicle and occupies
the internal space (Zummo and Scott, 1990). Thus, since in theory, these molds
occupy different microhabitats within the com plant, it could be assumed that they
do not interact. However, Zummo and Scott (1992) reported that inoculation of
kernels with both fungi resulted in inhibition o f A. flavus and decrease in aflatoxin
concentration. Conversely, Chamberlain et al. (1993) observed that in com
contaminated with both, aflatoxigenic and fumonisin-producing fungi, the
concentrations of aflatoxin and fiimonisin were independent. These reports
suggested that when conditions within the kernels are favorable, both, aflatoxins
and fumonisins can be produced.
After harvesting, and during storage the plant structure is altered allowing
more opportunity for mold interaction. It has been observed (Lopez-Garcia and
Park, unpublished data; Price, personal communication) that during storage of
ground aflatoxin-fumonisin- co-contaminated com, changes in toxin concentrations
occur.

During storage

under refrigerated

conditions (ca. 4°C), aflatoxin

concentrations decreased while fumonisin concentrations increased. This suggested
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a dynamic system where fungi were interacting. Thus, new research concerns were
presented.
The objective of this study was to provide preliminary information on the
relationships between toxigenic strains of A. flavus and F. moniliforme in cracked
com during a short storage period under moisture and temperature conditions that
favor mold growth. Also, the toxin-producing potential of untreated com under the
same moisture and temperature conditions was determined. Since mold growth is a
complex process, one can expect the production of innumerable compounds other
than aflatoxins and fumonisins. Thus, the toxic/mutagenic potential of raw com
extracts from different sampling periods was also determined. This study will only
provide initial data on the toxin production by the A. flavus and F. moniliforme.
This information can be used to develop other more detailed studies.
B.

Materials and methods

1.

Corn and fungal and bacterial cultures
Non-contaminated whole kernel com samples were obtained from Cargill

(Port Allen, LA). Fusarium moniliforme (A00102, Leslie et al., 1992) was kindly
provided by Dr. Raymond Schneider (Louisiana State University, Department of
Plant Pathology, Baton Rouge, LA) and Aspergillus flavus (13L, Cotty, 1989; 1990)
isolated from Arizona agricultural soil was provided by Dr. Robert Brown (United
States Department of Agriculture, Southern Regional Research Center, New
Orleans, LA). Salmonella typhimurium tester strains TA-100 and TA-98 were
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kindly provided by Dr. Bruce N. Ames (University of California Berkley, Berkley,
CA).
2.

Chemicals
Acetic

acid,

ammonium

sulfate,

ampicillin, D-biotin,

disodium

hydrogen phosphate, glucose-6 -phosphate, L-histidine, magnesium sulfate, 2mercaptoethanol,

ortho-phtaldehide,

sodium

ammonium

sulfate,

tetraborate, sodium chloride, sodium dihydrogen phosphate,

6

disodium

-nicotinamide

adenine-dinucleotide phosphate (NADP) and trifluoroacetic acid were all purchased
from Sigma Chemical Co. (St. Louis, MO). Chloroform (HPLC grade), citric acid
monohydrate, dimethyl sulfoxide, ethyl ether anhydrous, hexane (HPLC grade),
methanol (HPLC grade), potassium chloride, potassium phosphate dibasic
anhydrous and water (HPLC grade) were acquired from Mallinckrodt Baker, Inc.
(Paris, KT). Bacto agar, potato dextrose agar and crystal violet were ordered from
Difco Laboratories (Detroit, MI); glucose was from Fisher Scientific (Fair Lawn,
NJ). Acetonitrile (HPLC grade) was from Baxter Co. (Muskegon, MI). Ethanol was
obtained from Aaper Alcohol and Chemical Co. (Shelbyville, KT). Oxoid nutrient
broth No. 2 was purchased from Unipath LTD (Basingstoke, Hampshire, England).
Post-mitochondrial

supernatant (S9 mix)

was

purchased

from Molecular

Toxicology, Inc. (Boone, NC).
Pure fumonisins Bi and B2 were kindly provided by Dr. Robert M. Eppley
(Center for Food Safety and Applied Nutrition - CFSAN, U. S. Food and Drug
Administration-FDA, Washington, D.C.). Pure aflatoxin Bj was generously

88

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

provided by Dr. Mary Trucksess (CFSAN-FDA, Washington, D. C.). Aflatoxin Bi,
Bi, Gi, and G2 HPLC standard 50 pg/g mixture was purchased from Romer
Laboratories, Inc. (Union, MO).
3.

Corn inoculation
Inoculation and com culture was performed according to the method

reported by Leslie et al. (1992). Briefly, yellow aflatoxin/fumonisin free whole
com kernels were coarsely cracked in a Willey mill, then homogenized in a tumble
blender. Samples (300 g.) were placed in sterile Fembach flasks, and 33 ml of
sterile distilled water were added to each flask. The flasks were covered with a
cheesecloth plug and aluminum foil; then autoclaved at 121°C for 30 minutes.
After autoclaving, another 33 ml of sterile distilled water were aseptically added to
each flask.
Fungi {A. flavus and F. moniliforme) were cultured on potato dextrose agar.
After colonies had covered the entire petri dish, culture material was aseptically
scraped off and rinsed with sterile distilled water (ca. 10 ml/plate). The mold/water
suspensions from each plate were collected to make a stock inoculating suspension.
In the case of the combined sample, equal amounts of Aspergillus and Fusarium
suspensions were mixed thoroughly. This procedure ensured that com samples
would have equal mold inoculi. Seventy five ml of the conidia suspension were
added to their respective flasks (ca. 107 conidia/flask) (Table 3.1).
Flasks were incubated in the dark for 45 days at 25°C. The cultures were
thoroughly mixed with a sterile metal spatula every other day to evenly distribute
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the inoculum. Different spatulas were used for each sample and the hood was
thoroughly disinfected with 70% ethanol between samples to avoid cross
contamination. For the naturally contaminated samples, the same amount o f total
sterile distilled water was added (141 ml), but the samples were not autoclaved.
Therefore, the naturally occurring fungi and other micro flora, i.e., yeast and
bacteria were allowed to grow. The control samples had the same amount o f water
added, but they were not inoculated. Samples (approximately 100 g.) were removed
from of each flask at 15, 30 and 45 days of incubation. The samples were placed in
sealed plastic bags and stored at -20°C until analysis.
Table 3.1 Com inoculation design
Sample

N

Heat treatment

Water added

Inoculum

A

3

121°C; 30 min

141 ml

A. flavus

F

-»

121°C; 30 min

141 ml

F. moniliforme

A+F

3

121°C; 30 min

141 ml

A. flavus and F. moniliforme

NC

J

No treatment

141 ml

No inoculum

Control

3

121°C; 30 min

141 ml

No inoculum

All samples were analyzed in triplicate
4.

Safety precautions
Since highly toxigenic strains of Aspergillus and Fusarium were used in this

study, several safety measures were taken to avoid exposure to toxic material and
mold spores. A half-face negative pressure respirator equipped with HEPA filters
was used every time the com samples were handled. Also, protective eye wear and
nitrile gloves were worn at all times. All samples were handled in a biological
laminar flow hood. During the first portion of the storage spore high production
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was high; so special care was taken to prevent airborne spore contamination by
thoroughly cleaning the hood after each flask was handled.
5.

Toxin extraction
Com samples (100 g.) were placed in a blender with 300 ml MeOH:HzO

(77:23) and blended at high speed for 5 minutes. The extracted slurry was filtered
through Whatman

#1

filter paper. The filtrate was considered the crude com

extract.
6.

Aflatoxin purification
For the 15 day samples, aflatoxin clean-up and purification was performed

according to the method reported by Thean et al. (1980). Seventy five ml of the
crude com filtrate were placed in a 250 ml

beaker with 75 ml of 0.61 M

(NH4 )aS0 4 solution and 5 g of celite 545 analytical filter aid. The solution was
mixed for 2 minutes and then filtered through Whatman #2 fluted filter paper.
Then, 100 ml of this filtrate were placed in a 250 ml separatory funnel and 5 ml
CHCI3 were added. The mixture was shaken vigorously for 2 min. The phases were
allowed to separate and the CHCI3 fraction was drained into a 20 ml scintillation
vial. This process was repeated with a second 5 ml CHCI3 . Both CHCI3 fractions
were collected in the same vial. The CHCI3 extract was evaporated to complete
dryness under a N 2 stream.
To purify the aflatoxin from the CHCI3 extract, commercially available C18 solid phase extraction columns (Bond Elut, Varian, Harbor City, CA) were used.
The columns were pre-conditioned with 3 ml

hexane. The dry extract was
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dissolved in 0.5 ml CHCI3 using a Vortex mixer. Care was taken to wash all the
vial walls. The extract was then diluted with 0.5 ml hexane, and applied to the pre
conditioned C-18 solid phase extraction column. The vial was rinsed with 1 ml
CHCL3 :C6 H6 (1:1) and the rinse solution was also applied to the column. The
column was then washed with 5 ml hexane and 5 ml ethyl ether anhydrous. Finally,
the aflatoxins were eluted with 3 ml chloroformrethanol (95:5) into clean
scintillation vials. The eluted extracts were evaporated to dryness in a warm water
bath (ca. 40°C) under N 2 .
The 30 and 45 day samples had copious mold growth. When this extraction
procedure was used, the presence of interfering compounds was observed. Mold
apparently produced a multitude of unidentified compounds, some of these seem to
have emulsifying properties that prevented the separation of the organic phase
(CHCI3 ). Several attempts were made to break the emulsion (/. e., addition of NaCl,
increasing the volume of CHCI3 , adding octanol, freezing to -20°C and
centrifuging). However, even when part of the CHCI3 phase was separated,
recovery from extracts spiked with 100 ng pure AFBiwas below detectable levels.
Therefore, it was decided to use a purification method that did not involve
liquid: liquid extraction. These samples had to be extracted and purified following
the method reported by Wilson and Romer (1991) with slight modifications. The
recovery of spiked solutions using this method was 90-95%. Briefly, 0.5 ml of the
crude methanokwater extract were mixed with 4.5 ml acetonitrile:water (9:1) in a
capped culture tube and vortexed for 1 min. Multifunctional cleanup (MFC)
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columns (Mycosep #224-Romer Labs., Inc.. Washington. MO) were used to purify
this extract. The Mycosep column was fitted over the culture tube and the flangedend was pushed into the solution, letting the crude extract pass through the column.
Approximately 1 ml o f the purified extract was collected and stored (4°C) until
HPLC analysis.
7.

Quantification of aflatoxins by liquid chromatography (HPLC)
The samples were analyzed following the method reported by Wilson and

Romer (1991). The 15 day dry extracts were reconstituted in 1 ml acetonitrilerwater
(9:1). Thirty and 45 day samples were already in an acetonitrilerwater (9:1)
solution. To derivatize the aflatoxins, a 200 pi aliquot o f the purified extracts was
transferred into an HPLC auto-injector vial (Waters, Milford, MA), and 700 pi of
trifluoroacetic acid derivatizing reagent (distilled water:trifluoroacetic acid:acetic
acid - 7:2:1) were added. The samples were then placed in a 65°C water bath for
8.5 min. The vials were then cooled in an ice-water bath.
The samples were placed in an HPLC autosampler (Waters 717 plus
autosampler - Waters, Milford, MA). The analysis was carried out using a Waters
modular system with a Waters 470 scanning fluorescence detector (360 nm
excitation and 440 nm emission) and a Novapak C | 8 reverse phase column. Fifty
pL of sample were injected and analyzed using a watenacetonitrile (8:2) mobile
phase with a 2.0 ml/min. flow rate. Approximate retention times for pure aflatoxins
Gi (G2 a), Bi (B2 a), G2 and B2 were 2.6, 3.5, 7 and 9.8 min., respectively under these
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particular experimental conditions. Aflatoxin concentrations were calculated using
the Millenium Chromatography Manager Software (Waters, Milford, MA).
8.

Fumonisin purification
Fumonisins were purified following the AOAC official method 995.15

(1996). Solid-phase extraction (SPE) was performed using 500 mg silica-based
strong anion exchange (SAX) columns (Varian BondElut - Varian, Harbor City,
CA). The SPE cartridges were fitted to a SPE manifold and conditioned by washing
with 5 ml methanol followed by 5 ml methanol .-water (3:1). A 10 ml aliquot of the
crude com extract (pH adjusted ton 5.8-6.5 if necessary) was applied to the
cartridge while maintaining a flow rate < 2.0 ml/min. The cartridge was then
washed with 5 ml methanol:water (3:1) followed by 3 ml methanol. Special care
was taken to avoid cartridge drying at this stage. Fumonisins were eluted with 10
ml methanol:acetic acid (99:1) at a flow rate <1.0 ml/min. The eluate was collected
in a 20 ml scintillation vial. The solvent was evaporated to dryness under N2 at ca.
60°C. The vial was then washed twice with 1 ml methanol and the resulting
solution was transferred to a 4 ml amber vial. The methanol was evaporated to
dryness. Dried sample residues were stored at -20°C until liquid chromatography
(LC) analysis.
9.

Quantification of fumonisins by liquid chromatography (HPLC)
Fumonisins were quantified using the same HPLC system described for

aflatoxin analysis. The fluorescence detector was set at 335 nm excitation and 440
nm emission wavelengths. The analysis was carried out using a Novapak Cis
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reverse-phase (3.9x150 mm) column with a reverse-phase guard column. The flow
rate was set at 1 ml/min. using a acetonitrile:water:acetic acid (50:50:1) mobile
phase.
The dried purified residues were redissolved in 200 pi methanol. A 50 pi
aliquot was transferred into an autoinjector vial and 450 pi of orto-pthaldehide
(OPA) derivatizing reagent (40 mg ortho-pthalehide + 1 ml methanol + 5 ml 0.1 M
disodium tetraborate solution + 50 pi mercaptoethanol). The derivatized solution
was mixed and injected (10 pi) within 1 min. o f adding the OPA solution. The
approximate retention times for fumonisin Bi an B2 were 4.1 and 12.8 min.,
respectively.
10.

Mutagenic potential of raw corn extracts
Composite samples were prepared by mixing 1 ml of each of the three raw

extracts from samples described in Table 3.1. The mixture was then filter-sterilized
using a 0.22 p-Millipore syringe filter (Millipore, New Bedford, MA) and
sequentially diluted 3 times using dimethyl sulfoxide (DMSO) to obtain a total of four
solutions test solutions ( 1 0 °,

10

' 1,

10

'2and

10

'3).

The samples were tested using Salmonella typhimurium tester strains TA-100
and TA-98 according to the standard plate incorporation method described by Maron
and Ames (1983). Frozen cultures were plated onto ampicillin master plates and
incubated for 48 h at 37°C. A single colony was then inoculated into 50 ml sterile
Oxoid Broth No. 2; and incubated in the dark at 37°C for 10-14 h using a gyratory
(200-250 rpm) shaker water bath. After incubation, growth was confirmed by
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checking the turbidity using a spectrophotometer (Spectronic 20D, Spectronic
Instruments, Rochester, NY) at 650 nm using Oxoid Broth No. 2 as a blank.
Absorbance readings ca. 0.8 indicated an optimal cell density of 1-2 * 109 cells/ml.
The tester strains were tested to confirm the presence of the genetic markers using the
following assays:
Histidine

requirement:

A positive result of this

test (growth in

histidine/biotin plates; no growth in non-histidine/biotin plates) showed that
bacteria had not been altered as a result of handling or storage conditions and that
the mutant form was present.
Crystal violet: The results of this test showed a zone of inhibition around a
disk impregnated with crystal violet. The positive test results indicated that the
permeability of the membrane was present.
Ampicillin resistance (R-factor): Tester strains that grew on ampicillin
plates indicating that the genetic markers were intact.
After the bacteria tested positive for all the genetic markers, the assay was
performed. Two ml top agar were placed in sterile culture tubes and kept at
approximately 40° C in a water bath. One hundred pi of sample were placed in
each tube, 100 pi of bacteria (tester strain TA-100 or TA-98) and 500 pi S-9 mix
were added. The tubes were mixed and poured into minimal glucose agar plates.
All samples were tested in triplicate. DMSO was used as a negative solvent control
and pure AFBi (1, 10, 100 and 1000 ng/plate) was used as a positive control. The
plates were left at room temperature until the top agar solidified; then were inverted
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and incubated at 37° C for 48 hours. After incubation, revertant colonies were
counted. Samples that presented over double the number of natural revertant
colonies were considered mutagenic.
11.

Toxicity to Salmonella typhimurium
The most concentrated samples (10°) described in the previous section

were also tested to determine if the extracts were toxic to the S. typhimurium tester
strains. The assay was performed following a modified mutagenicity assay
protocol. After the 10-14 h incubation, the 109 cells/ml bacterial suspension was
serially diluted with sterile nutrient broth to obtain a

102

cells/ml suspension..

Samples were tested using nutrient agar plates instead of minimal glucose agar
plates.
12.

Statistical analysis
Statistical analysis was performed using the SAS software (SAS, 1988).

One-way analysis of variance (ANOVA) was used to determine differences in toxin
production and toxicity to S. typhimurium. Scheffe’s test with an alpha value of
0.05 was used to compare differences among the different treatments.
C.

Results and discussion

1.

Aflatoxin production
Within the first days abundant mold growth was evident in all flasks except

for the control. A. flavus produced a very high amount of aflatoxin Bi in the first
15 days (Table 3.2). When A. flavus and F. moniliforme were together, the amount
o f AFBj produced during the first days was significantly (p<0.05) lower than when
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A. flavus grew by itself. It is interesting to observe that the naturally contaminated
sample had an apparently higher toxin production than the combined A. flavus!F.
moniliforme sample. However, these values were not significantly different
(p>0.05). There are several explanations why there was higher toxin production in
naturally contaminated com. One explanation could be that the naturally
contaminated com may have contained a higher initial amount o f toxigenic A.
flavus and/or A. parasiticus spores than the inoculated sample. On the other hand,
the presence o f other mold species may have had an influence on the production o f
aflatoxin in the naturally contaminated com. However, since the difference was not
significant, it could be assumed that AFBi production was independent of the mode
o f infection {i.e., naturally occurring or inoculated).
It is interesting to observe that the concentration of AFBi decreased over
time. When the results were analyzed, a pattern was observed. Every 15 days, the
toxin concentrations were reduced by approximately 90-95% in all samples. This
was more evident in the A. flavus samples were AFBi was detected in all three time
periods.
The constant decrease in AFBi concentration over time suggests that the A.
flavus by itself degraded AFBi. The same pattern was observed in the
production/degradation o f AFB2 (Table 3.3). The significant difference (p<0.05)
between the initial aflatoxin production by A. flavus and the other samples excludes
the possibility that the aflatoxins (Bi and B2 ) reached a toxic level beyond which,
they were degraded. Therefore, the degradation pattern may be attributed to the
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mold metabolizing the toxin when it reached a certain growth stage or to the
presence o f another metabolite interfering with AFBi and promoting its
degradation.

Table 3.2 Aflatoxin B| (ng/g) production during storage
Sample
A. flavus

30 days
15 days
10.5xl0 4 ±0.6xl0 4 4.8x1 03±0.4x103
a
b
F. moniliforme
ND
ND
b
b
A. flavus+F.
ND
5.2xl0'±0.4xl0‘
moniliforme
b
b
Naturally
3.8x10^1.4x10'
5.6xl0z±0.6xl0 2
contaminated
b
b
Control
ND
ND
b
b
Values are mean±standard error of three replications
ND: Non-detectable (Detection limit=lng/g)
Values with the same letter are not significantly different (p<0.05)

45 days
2 .2 x 1 0 2
b
1.9±1.9
b
ND
b
ND
b
ND
b

These results are consistent with earlier observations reported by Doyle and
Marth (1978a; 1978b; 1978c; 1978d). The reports by these authors showed that the
ability of Aspergilli to degrade aflatoxin depended on several factors. They reported
that 8 - 1 0 day old mycelia were the most effective in degrading aflatoxin. This is
consistent with the fact that the aflatoxin concentration decreased after 15 days
incubation. Huyn and Lloyd (1984) also reported that Aspergillus parasiticus
synthesized large amounts of aflatoxin when young mycelia (4 days old) were
present. This synthesis peaked and then started to decline when mycelia aged (14
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days old). It would be interesting to quantify aflatoxin production during the first
15 days under the same conditions, using the same A. flavus strain.

Table 3.3 Aflatoxin B2 (ng/g) production during storage
Sample
A. flavus

45 days
15 days
30 days
l .l x l 0 4 ±0 .6 x l 0 J
4.4x10"±2xl0z 4.1xl0'±3.8xl0‘
b
a
a,b
F. moniliforme
l.SxlO'iO.OxlO 1
2.2xl0'±0.5xl0‘ 0 .2 x l 0 '± 0 .2 x l 0 *
b
b
b
A. flavus+F.
ND
ND
5 .8 x l0 '± lx l0 ‘
moniliforme
b
B
a,b
Naturally
ND
1.3xl0z±0.14xl02 0.5xl0'±0.3xl0'
contaminated
b
a,b
b
Control
ND
ND
ND
b
b
B
Values are mean±standard error of three replications.
ND: Non-detectable (Detection limit=lng/g)
Values with the same letter are not significantly different (p<0.05)

Doyle and Marth (1978) and Hyun and Lloyd (1984) also reported that
disrupting the fungi, blending or fragmenting the mycelia, actively increased the
degradation of aflatoxin, while leaving the mycelia intact did not. In the current
study, the samples were mixed thoroughly with a metallic spatula every other day,
this might have damaged the mycelia. Therefore, aflatoxin degradation could have
been promoted in this experiment.
It has also been reported that substrates that support substantial mold
growth yield mycelia with the greatest ability to degrade aflatoxin. The current
study used com as the substrate. Since com is frequently colonized by A. flavus, it
would be considered ideal to promote copious mold growth. In this study,
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substantial mold growth was evident within the first 48 hours of incubation;
especially in the A. flavus samples.
From a metabolic point of view, there are literature reports that state that
fungi have developed survival mechanisms that allow them to rapidly adapt their
metabolism to varying environmental conditions. This metabolic flexibility is
achieved through the synthesis of a large set of intra-and extracellular enzymes that
are able to degrade complex biopolymers. Filamentous fungi are also capable of
secreting a diverse range of primary and secondary metabolites and performing
several complex transformations. There is biochemical evidence that some of these
transformations are performed by fungal cytochrome P450 enzymes (Van der Brink
et al., 1998). There is limited information on the specific activities o f fungal P450s
because purification of these enzymes is hampered by protein instability and low
expression levels (Van der Brink et al., 1998). However, it has been determined
that some A. flavus and A. parasiticus

cytochromes (cyp64 and cyp60Al,

respectively) are actively involved in aflatoxin biosynthesis and degradation
pathways. Hamid and Smith (1987) reported that an increase in aflatoxin
production was paralleled by an increase in NADPH-cytochrome P450 reductase
and cytochrome P450 levels in fungal microsomes. The use of cytochrome P450
inhibitors, such as, SKF 525-A, metyrapone and cyanide inhibited aflatoxin
biosynthesis. These results suggested that aflatoxin biosynthesis by A. flavus is
mediated by cytochrome P450 monooxygenase enzymes. These authors also
studied the ability of mycelial homogenates to degrade aflatoxin. In this case the
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addition of P450 inhibitors, cycloheximide, SKF 525-A and metyrapone to 6 - and
8

-day old cultures inhibited aflatoxin degradation. Thus, it was suggested that the

enzymes involved in the degradation of aflatoxin belong to the cytochrome P450
enzymes.
The significant difference (p<0.05) between aflatoxin production by A.
flavus as compared to the combined samples and the naturally contaminated
samples, suggested that the presence of F. moniliforme or other fungal species
affected the aflatoxin synthesis or its degradation. In this study, a significant lower
amount of AFBi and AFBi was noted in the combined samples in the first 15 days.
However, there is not enough information to determine what happened between
days 1 and 15. Therefore, the lower amount could be due to decreased aflatoxin
biosynthesis or enhanced degradation. It is important to mention that in a
mammalian system (male Wistar rats), intraperitoneal exposure to fumonisin B|
induced cytochromes P4501 A, P4503A and P4504A subfamilies with 1Al and 4A1
predominating (Martinez-Larranaga et al. , 1996). Although fungal and mammalian
metabolism differ considerably, this evidence suggests that it would be interesting
to investigate the role of fumonisin in the ability of Aspergillus to synthesize and
degrade aflatoxins. This information brings out the importance o f understanding the
role of mycotoxins in fungal physiology and plant pathogenesis.
Furthermore, Doyle and Marth (1978d) reported that (a) steaming A.
parasiticus mycelium for

6

minutes resulted in loss of ability to degrade aflatoxin

(b) broth mold cultures were not able to degrade aflatoxin; and (c) the supernatant
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fluid from mycelial homogenates degraded aflatoxin. These results suggested that a
heat-labile, intracellular factor was responsible for toxin degradation. Doyle and
Marth (1978d) reported that although conditions affecting degradation of aflatoxins
by mold mycelia implied that an enzyme might be involved. However, the rates at
which aflatoxins were degraded did not support the idea that the toxin was being
degraded directly by enzymatic activity. Therefore, it was hypothesized that one or
more enzymes produced by-products that would react with aflatoxin. Doyle (1979)
speculated that peroxidase may be such an enzyme since it catalyzes decomposition
of hydroperoxides resulting in the generation of free radicals. Hence, Doyle and
Marth (1982) designed a study to determine peroxidase activity in mycelia of A.
parasiticus that degraded aflatoxin. Results from this study showed that substantial
amounts of fungal peroxidase were present in cultures where aflatoxin was
degraded. These results were supported by Applebaum et al. (1980) and Doyle and
Marth (1978) who showed that lactoperoxidase is involved in aflatoxin
degradation. Doyle and Marth (1978h) observed that at a given concentration of
this enzyme,

aflatoxin degradation was independent

of initial

aflatoxin

concentration. The authors reported the formation of aflatoxin derivatives that co
chromatographed with aflatoxin B 2 a, and other water soluble by-products.
This information also relates to the findings of fumonisin Bi toxicity in
vivo. Martinez-Larraiiaga (1996) reported that 0.25 and 2.5 mg/kg body weight FBi
administered intraperitoneally to male Wistar rats, produced an increase in the
peroxisomal P-oxidation of fatty acids and induction of the cytochrome P4504A
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subfamily. Although, these studies show metabolic alteration in a mammalian
system, the involvement of peroxidase in aflatoxin degradation by Aspergillus
suggests the possibility of similar effects in a fungal system.
Tables 3.4 and 3.5 show the production of aflatoxins Gi and G2 ,
respectively. In this case, no significant toxin production was observed. This
indicates that the A. flavus strain used in this study does not produce G aflatoxins.
This is consistent with the fact that only A. parasiticus produces G aflatoxins. The
low levels of G aflatoxins detected in several of the samples, including the F.
moniliforme samples, could be due to original com contamination. This emphasizes
the fact that aflatoxin contamination is heterogenous and that “hot spots” may be
present. Even when the cracked com was thoroughly homogenized before
sampling, some contaminated kernels could have gone to different flasks. This
could explain why the Fusarium samples had low levels of aflatoxins Bi and G2 .

Table 3.4 Aflatoxin Gi (ng/g) production during storage
Sample

15 days

30 days

45 days

A. flavus

ND

ND

6± 6

F. moniliforme

ND

ND

ND

A. flavus+F. moniliforme

ND

ND

ND

Naturally contaminated

28±14

ND

2 ± 2

Control

ND

ND

ND

Values are mean±standard error o f three replications
ND: Non-detectable (Detection limit=lng/g)
Non of the samples are significantly different (p<0.05)

104

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Table 3.5 Aflatoxin G2 (ng/g) production during storage
Sample

15 days

30 days

45 days

A. flavus

ND

ND

ND

F. moniliforme

4±1

2±1

ND

A. Jlavus+F. moniliforme

12±5

ND

ND

Naturally contaminated

10+1

ND

ND

Control

ND

ND

ND

Values are mean±standard error o f three replications.
ND: Non-detectable (Detection limit=lng/g)
Non o f the samples are significantly different (p<0.05)

It is also important to consider the com substrate. It is possible that there is
more than a bilateral interaction between molds. Com is a complex chemical
matrix, therefore, multilateral chemical interactions might have occurred during
this storage period. It could be possible that fungal metabolites interacted with com
compounds and that the new by-product(s) inhibited or degraded the aflatoxin.
Also, there could have been bacterial activity that affected toxin production or
degradation, or bacterial metabolism could have also influenced the toxin
degradation patterns.
It was also observed that the 30 and 45 days samples had copious mold
growth that in some cases interfered with the aflatoxin extraction and purification
procedures. This led to the use of a different purification method (described in the
materials and methods section). This may have contributed to incomplete toxin
extraction, and may also be a reason for the lower quantities detected in these
samples. The difficulty in extraction resided in the fact that there was some
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interference from compound(s) that acted as surfactants; therefore, when organic
extraction (CHCI3) was attempted, a very stable emulsion was formed. It would be
interesting to characterize these compounds and determine if they play a role in
aflatoxin degradation.
It is important to point out that even if the combined and the naturally
contaminated samples had much lower toxin production, they still had high levels
of aflatoxins within the first 15 days. This shows that under favorable conditions,
aflatoxins can be produced regardless of the presence o f other molds, i.e., F.
moniliforme. This emphasizes the fact that co-contamination can occur and that
simultaneous exposure to several toxins is possible.
2.

Fumonisin production
FBi production followed a different pattern than aflatoxin. Fumonisins are

produced in higher quantities usually

103

times more than aflatoxins, so they are

usually quantified in pg/g instead of ng/g. Table 3.6 shows FBi production over
time. Unlike aflatoxin, these samples do not show a defined pattern. In the F.
moniliforme sample, a significant increase (p<0.05) of FB[ was observed over time.
The combined samples and the naturally contaminated com did not produce
significantly different amounts (P<0.05) of FB| during the first 15 days. These
results contrast with those obtained from aflatoxin. FBj production was not initially
affected by the presence of Aspergillus or other mold species.

106

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Table 3.6 Fumonisin Bi (jj.g/g) production during storage
Sample
A. flavus

15 days
30 days
15±12
8±4
b
b
F. moniliforme
17±3
254±90
b
a
A. flavus+F. moniliforme
8±3
8 ± 2
b
b
Naturally contaminated
18±6
38±4
b
b
Control
ND
1±1
b
b
Values are meantstandard error of three replications
ND: Non-detectable (Detection limit=Tpg/g)
Values with the same letter are not significantly different (p<0.05)

45 days
ND
B
361±131
a
7±1
b
6±3
b
ND
b

It was also interesting to observe that there were different toxin production
patterns. In the F. moniliforme samples, a constant increase of FB i was observed.
However, in the combined samples (A. flavus+F. moniliforme) FBi concentration
was not significantly (p<0.05) altered. In the naturally contaminated com, an
apparent increase followed by a decrease were observed; however this was not
significant (p>0.05).
The FBi concentrations detected in the Aspergillus samples and in the
control, may have been from original contamination. This emphasizes again the
heterogeneity of mycotoxin contamination, and the need to find control
mechanisms that will prevent exposure to these toxins. The consumption of one
contaminated portion ( > 8 pg/g) is sufficient to elicit ELEM in a horse. The fact that
these samples originated from a commercial source stresses the need of a better
understanding of factors that affect toxin production and degradation. This
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knowledge would help in designing better control programs that would minimize
animal and human exposure.

Table 3.7 Fumonisin B2 (pg/g) production during storage
Sample

15 days

30 days

45 days

A. flavus

1±1

14±6

4±2

109±37

104±41

F. moniliforme

10±7

A. flavus+F. moniliforme

8±1

8 ± 6

4±1

Naturally contaminated

9±3

13±3

3±1

Control

1±1

9±9

ND

Values are mean±standard error o f three replications
ND: Non-detectable (Detection limit=lpg/g)
Non of the samples are significantly different (p<0.05)

3.

Mutagenic potential
Figures 3.1 and 3.2 show the mutagenic potential o f the raw com extracts

from the A. flavus inoculated com. A dose-response relationship was observed. As
the samples were diluted, the mutagenicity decreased. Hence, it can be considered
that the compound(s) responsible for the mutagenic response are either not present
in large quantities or their mutagenic potential is relatively low. Also, it can be
observed that mutagenicity decreased over time. This observation is consistent with
the fact that AFBi decreased over time. So, the decline in mutagenicity could be
due to the decline in aflatoxin concentration. However, the 30 and 45 day samples
(initial AFBi=484 and 218 ng/plate) showed much higher mutagenicity than the
positive control, pure AFBi. It was observed that 100 ng/plate AFBi resulted in
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Figure 3.1 Mutagenic potential of Aspergillus flavus inoculated corn during storage. Salmonella tester strain
TA-100 with metabolic activation. Approximate undiluted (1.00E+00) amounts of AFB|=10.5xl0 4 ,4.8xl0 3 and
218 ng/plate for 15, 30 and 45 days, respectively. Approximate undiluted (1.00E+00) amounts of FBi=l500,
766 and 0 ng/plate for 15, 30 and 45 days, respectively. Natural revertants=l 34±9.Values are mean±SEM of
three replicates.
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Figure 3.2 Mutagenic potential of Aspergillus flavus inoculated corn during storage. Salmonella tester strain
TA-98 with metabolic activation. Approximate undiluted (1.00E+00) amounts of AFBi=10.5xl04, 4.8xt0 3 and
218 ng/plate for 15, 30 and 45 days, respectively. Approximate FB|=1500, 766 and 0 ng/plate for 15, 30 and 45
days, respectively. Natural revertants=29±2. Values are mean±SEM of thre replicates.

173±2 revertants per plate; therefore, the results shown in Figure 3.1 could be the
result of AFBi mutagenic potential combined with the response elicited by other
compound(s). This effect was not as evident in TA-98 (Figure 3.2) where 100
ng/plate pure AFBi produced 532±91 revertants/plate. These differences could be
explained by the different sensitivities of each organism.
In the case of the F. moniliforme com extracts (Figures 3.3 and 3.4), an
interesting fact was observed. These samples did not contain any detectable AFBi;
however, a mutagenic response was observed for all three time periods. Even if
there were high concentrations of FBi in the extracts, this toxin is not considered to
be mutagenic in this assay (Gelderblom et al„ 1991, 1992; Park et al., 1992).
Furthermore, a FBi control was used in this experiment. No mutagenic response
was observed in a concentration ranging from 1 to 100,000 ng FB i/plate.
The mutagenic response of F. moniliforme raw com extract was more
evident on the 15 day samples indicating that the unknown factors that elicited this
response were degraded over time. A dose response was also observed. Dilution of
the samples decreased their mutagenic potential. These results show that a diverse
variety of chemically active compounds can be produced at the same time. F.
moniliforme is known to produce mutagenic toxins such as fiisarin C and
moniliformin (Bacon and Nelson, 1994). These toxins may have been responsible
for this response. However, it is possible that other unidentified mutagenic
compounds may have been produced. This emphasizes the fact that when a raw
extract is studied, multiple interactions may take place. The ultimate response may
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Figure 3.3 Mutagenic potential of Fusarium moniliforme inoculated corn during storage. Salmonella tester
strain TA-100 with metabolic activation. No AFBi was detected on any of the samples. Approximate FB|=17,
254 and 361 pg/plate for 15, 30 and 45 days, respectively. Natural revertants=139±9. Values are mean±SEM of
three replicates.
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Figure 3.4 Mutagenic potential of Fusarium moniliforme inoculated corn during storage. Salmonella tester
strain TA-98 with metabolic activation. No AFBi was detected on any of the samples. Approximate FBi=17,
254 and 361 ng/plate for 15, 30 and 45 days, respectively. Natural revertants=29±2. Values are mean±SEM of
three replicates.

depend on an equilibrium of the effect of all compounds present in the system.
Some of these compounds may have a direct effect while others may interact and
either inhibit each other or have a synergistic response.
Figures 3.5 and 3.6 show the mutagenic response to raw A. flavus/F.
moniliforme com extracts. These samples also showed a mutagenic response to
both, TA-100 and TA-98. A dose-response type of relationship was also observed,
and the mutagenic potential tended to decrease over time.
These results also show several interesting facts. AFBi concentrations were
relatively low at 15 days, and there was no detectable aflatoxin in the 30 and 45
days samples. So, these mutagenic responses bring out the same issues as the F.
moniliforme samples. Are other mutagens being produced, or is fumonisin
interacting with other compound(s) to produce a mutagenic by-product? Another
important factor to point out is that all of these assays were carried out with
metabolic activation (S9).

Therefore, these responses reflect the effect of

compound(s) that may have been metabolized. Some of these activated compounds
may have caused this response, or they may have reacted with other compounds
present in the system to render a mutagenic by-product.
The raw com extract is considered a complex mixture, so a multitude of
reactions may have taken place during this assay.

These results indicate that

Aspergillus and Fusarium may produce more than one toxic compound when they
grow together. Understanding the relationship of these molds in the com plant and
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Figure 3.5 Mutagenic potential of Aspergillus jlavus/Fusarium moniliforme inoculated corn during storage.
Salmonella tester strain TA-100 with metabolic activation. Approximate undiluted (1.00E+00) amounts of
AFBj=5.2, 0 and 0 ng/plate for 15, 30 and 45 days respectively. Approximate undiluted amounts of FB|= 8 , 8
and 7 pg/plate for 15, 30 and 45 days, respectively. Natural revertants=139±9. Values are mean±SEM of three
replicates.
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Figure 3.6 Mutagenic potential of Aspergillus flavus/Fusarium moniliforme inoculated corn during storage.
Salmonella tester strain TA-98 with metabolic activation. Approximate undiluted (1.00E+00) amounts of
AFB|= 5.2, 0 and 0 ng/plate for 15, 30 and 45 days respectively. Approximate undiluted amounts of FB| = 8 , 8
and 7 jig/plate for 15, 30 and 45 days, respectively. Natural revertants = 29±2. Values are mean±SEM of three
replicates.

during storage, may help in elucidating some of the potential toxic responses that
would result from dietary exposure to com contaminated with these fungi.
Figures 3.7 and 3.8 show the mutagenic potential o f naturally contaminated
com extracts. These results are similar to those discussed for Figures 3.5 and 3.6. In
this case, there is a higher initial AFBi concentration that could be responsible for
the mutagenicity. However, the AFBi content decreased over time. Another
possible explanation for this mutagenic response may be that some of the AFBi
fungal degradation by-products retain some mutagenic potential. It would be
interesting to follow AFBi degradation over shorter periods of time (<15 days) and
isolate and identify some of the by-products, subsequently testing their mutagenic
potential.
These results show the need for more research in this area. The possible
effect o f FBi on AFBi degradation was discussed earlier. If fumonisin is
responsible for enhancing aflatoxin degradation, does it affect the amount and type
of residual by-products? Is it possible that the presence of fiimonisins shift
aflatoxin degradation pathways to yield different by-product(s) than those produced
by Aspergillus itself? Is Fusarium metabolizing some o f the aflatoxins? The answer
to some o f these questions may help shape our understanding of the relationship
and interactive potential between these com contaminants, and perhaps help define
better mechanisms of biological control to prevent toxin formation.
Since com is a complex matrix and is considered a living system,
incubating it in the presence of moisture may have also contributed to the responses
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Figure 3.7 Mutagenic potential of naturally-contaminated corn during storage. Salmonella tester strain TA-100
with metabolic activation. Approximate undiluted (1.00E+00) amounts of AFBi = 563, 38 and 0 ng/plate for
15, 30 and 45 days respectively. Approximate undiluted (1.00E+00) amounts of FB| = 18, 38 and 6 pg/plate
for 15, 30 and 45 days, respectively. Natural revertants = 139±9. Values are mean±SEM of three replicates.
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Figure 3.8 Mutagenic potential of naturally-contaminated corn during storage. Salmonella tester strain TA-98
with metabolic activation. Approximate undiluted (1.00E+00) AFBi = 563, 38 and 0 ng/plate for 15, 30 and 45
days respectively. Approximate undiluted amounts of FBi = 18, 38 and 6 pg/plate for 15, 30 and 45 days,
respectively. Natural revertants = 30±2. Values are mean±SEM of three replicates.

shown previously. Therefore, it was important to determine if the control com
extracts elicited a response on this assay.
Figures 3.9 and 3.10 show that the control com extracts did not present
mutagenic potential. This suggests that the responses observed in the other samples
were due to fungal activity in the com. It is important to note that some
compound(s) in the com may have been altered by the mold growth. Therefore,
consideration of factors present in the com is also important when considering the
risk associated with fungal growth in com even if the com by itself did not show a
response.
4.

Toxic potential
The raw com extracts were complex mixtures. Therefore, the evaluation o f

their mutagenic potential may have been hampered by other responses. If the
samples were toxic to the bacteria, then some of the results could have been false
negatives. A reduction in response could have been due to a toxic response rather
than to a lack of mutagenicity. Furthermore, toxic responses could give false
evidence of interaction between compounds in the extract. Thus, it was important
to determine if these samples exerted toxic effects on either of the Salmonella tester
strains. Since most of the mutagenic differences were observed in the most
concentrated samples (10°), only this dilution was tested for toxic potential. Instead
o f challenging the bacteria to mutate by using minimal glucose agar plates, the
assay was carried out using nutrient broth.
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Figure 3.9 Mutagenic potential of control corn during storage. Salmonella tester strain TA-100 with metabolic
activation. No AFBi was detected in the samples. Approximate undiluted amounts of FB| = 0, 73 and 0
ng/plate for 15, 30 and 45 days, respectively. Natural revertants = 134±9. Values are mean±SEM of three
replicates.
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Figure 3.10 Mutagenic potential of control corn during storage. Salmonella tester strain TA-98 with metabolic
activation. No AFBi was detected in the samples. Approximate undiluted (1.00E+00) amounts of FB| = 0, 73
and 0 ng/plate for 15, 30 and 45 days, respectively. Natural revertants = 30+2. Values are mean±SEM of three
replicates.

Figure 3.11 shows Salmonella TA-100 toxic response to the different com
extracts. In the Fusarium and the combined samples {Aspergillus+Fusarium), the
toxic potential seemed to increase with storage time. These results could explain
part of the reduction in mutagenicity observed previously. However, none of these
samples were significantly different (p<0.05) form the control. Conversely, the
toxicity of the Aspergillus samples seemed to decrease over time. In this case, the
15 day storage extract was significantly different from the control. This implies that
under these experimental conditions, this sample was toxic to Salmonella TA-100.
Although the toxicity seemed to decrease in the 30 and 45 day samples, these
results were not significantly (p<0.05) different from the 15 day extract. It can be
noted that these same samples had an apparent reduction in mutagenicity over
storage time (Figure 3.1). Even if the decrease in toxicity is not significant, the
results suggest that detoxifying reactions may have taken place as the Aspergillus
culture grew older. The decrease in AFBi content discussed earlier, coupled with
the decline in mutagenic potential and the apparent decline in toxic potential
suggest that A. flavus shifted to detoxifying pathways that may have included toxic
compounds other than aflatoxin.
An interesting fact is that the control com extracts (15 and 30 days)
exhibited significant toxicity when compared to the control (p<0.05). These
samples did not have any fungal activity. These results imply that com by itself is a
dynamic system and that different reactions may have taken place in the com.
Some of the by-products may have been toxic to the Salmonella TA-100. This

123

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

7.00E+08
6.00E+08

| Control

<u
is,

H i 5 days
5.00E+08

□ 30 days

2

□ 4 5 days
g>

4.00E+08
3.00E+08

oc
o
U

fi

2.00E+08

to
1.00E+08

I

0.00E+00
Negative

Positive

A+F

NC

Control
corn

Sample

Figure 3.11 Toxic potential of corn samples during storage. Salmonella tester strain TA-100 with metabolic
activation. Negative control=DMSO, Positive control= 10,000 ng AFB,, A=Aspergillus, F=Fusarium,
A+F=/lspergillus+Fusarium, NC=Naturally contaminated. Values are mean±SEM of three replicates.

toxicity decreased significantly (p<0.05) over time. The toxic potential shown by
the control com extracts brings attention to the fact that reactions not related to
fungal growth, i.e. lipid oxidation, could have also occurred in the com. These
reactions could have generated by-products that were toxic, but not mutagenic. The
involvement o f other microorganisms such as bacteria is also possible. Bacteria
could have produced bacteriocins that inhibited Salmonella growth.
Salmonella TA-98 was less sensitive to the com extracts. Thus, it showed
higher colony counts than TA-100 (Figure 3.12). In this case, the 15 day Fusarium
extract was significantly toxic. This sample had a high FBi concentration (ca.
1.7xl0 3 pg/plate). However, even if the FBi concentration increased over storage
time (ca. 2.5x104 and 3.x 104 pg/plate for 30 and 45 days, respectively), these
samples were not significantly different from the control. Therefore, the toxicity
cannot be attributed to FBi but to other compounds present in the extract. Another
hypothesis is that maybe

the

higher

concentrations

of fumonisin

trigger

detoxification reactions in older cultures. More research is needed to understand the
role of fumonisin from a fungal physiology and plant point of view.
Another significantly toxic sample was the naturally contaminated extract
(45 days). In this case, aflatoxin and fumonisin concentrations decreased over
time. So, this extract had the least amount of AFBi and FBi when compared to the
15 and 30 days samples. Again, other compounds may be responsible for the
toxicity. Moreover, aflatoxin and fumonisin may have an interactive relationship
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Figure 3.12 Toxic potential of corn samples during storage. Salmonella tester strain TA-98 with metabolic
activation. Negative control=DMSO, Positive control= 10,000 ng AFBi, A=Aspergillus, F=Fusarium,
A+F=Aspergillus+Fusarium, NC=Naturally contaminated. Values are mean±SEM of three replicates.

that changes depending on the concentration ratio or at different concentration
levels.
No definite pattern to relate toxin production, mutagenic potential and toxic
potential could be established. However, there is some evidence that indicates that
many factors can be simultaneously involved in these processes. This experiment
did show that A. flavus and F. moniliforme can co-exist in the same environment
and produce aflatoxins and fumonisins, respectively. Thus, they present a risk to
consumers and new research concerns. If these toxins co-contaminate com and
there is evidence of fungal interaction that shifts toxin concentrations over storage
time, what are the potential toxic effects of simultaneous exposure at different
concentration levels. Do they interact; if so, what relationship do they have? Is
there potential for inhibitory or synergistic reactions? These questions prompted
further research in this area. Therefore, the next sections will explore some of these
possible interactions.
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IV.

Interactive effects between aflatoxin Bi and fumonisin Bi

A.

Introduction
Results from the previous section suggested that AFBi and FBi can be

produced simultaneously by A. flavus and F. moniliforme. Furthermore, the data
obtained suggested that mold growth and toxin production are dynamic processes
where multiple interactions are possible. These interactions yielded different levels
of toxins at different storage times. This implies that when com is consumed,
humans and animals could be exposed to a wide range o f toxic compounds that
could be present in different combinations or ratios.
The previous experiment concentrated on studying toxin production under
optimal mold growth conditions. The high moisture levels yielded copious mold
growth, and may have promoted some of the interactive reactions. However, these
reactions could take place over longer periods of time with com held at storage
moisture and temperature conditions. This is evidenced by several reports of
AFB 1/FB 1 co-contamination of commercial com that did not have apparent mold
growth (Park et al., 1996; Chamberlain et al., 1993; Zummo and Scott, 1992).
Aflatoxins and fumonisins are produced in nature in a different range of
concentrations. Aflatoxins usually occur in the ng/g range (Schroeder and Botler,
1973) while fumonisins generally occur at higher levels, in the |ig/g range. Thus,
simultaneous exposure to a combination of these toxins at these levels should be
explored. The assessment o f the potential effects of complex mixtures is a difficult
task. However, the potential of joint action of chemicals has long been recognized
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by physicians, public health specialists, toxicologists, health risk assessors and
statisticians (Mumtaz, 1995). There are several methods to assess the effects of
diverse mixtures encountered in the environment. One approach often used to
evaluate chemical mixtures is to consider the effect of known xenobiotics present
in the mixture. In this case, although all the information may not be available for
the mixture (i.e.. raw com extract) toxicological properties of some of the
compounds (i.e.. aflatoxins) have been investigated. In the current study, both,
aflatoxins and fumonisins are known to be present in the com. and the relative
concentrations in which they occur has also been reported. Therefore, the use of a
combination of these two compounds may yield more useful information on the
toxic potential of the mixture.
The objective o f this phase of the study was to determine if different levels
o f pure AFBi (0-1000 ng/plate) combined with varied levels of FBi (0-100,000
ng/plate) show different effects in the Salmonella/microsomal mutagenicity assay
using tester strains TA-98 and TA-100. Since fumonisin does not yield positive
results in this assay, this study mainly evaluated the effect o f fumonisin on
mutagenic potential o f aflatoxin.
B.

Materials and methods

1.

Bacterial cultures
Salmonella typhimurium tester strains TA-100 and TA-98 were kindly

provided by Dr. Bruce N. Ames (University of California Berkley, Berkley, CA).
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2.

Chemicals
Ampicillin, D-biotin, disodium hydrogen phosphate, glucose-6-phosphate,

L-histidine, magnesium sulfate, sodium ammonium sulfate, sodium chloride,
sodium dihydrogen phosphate, and B-nicotinamide adenine-dinucleotide phosphate
(NADP) were purchased from Sigma Chemical Co. (St. Louis, MO). Citric acid
monohydrate, dimethyl sulfoxide, potassium chloride, potassium phosphate dibasic
anhydrous and water (HPLC grade) were acquired from Mallinckrodt Baker, Inc.
(Paris, KT). Bacto agar and crystal violet were ordered from Difco Laboratories
(Detroit, MI); glucose from Fisher Scientific (Fair Lawn, NJ). Ethanol was
obtained from Aaper Alcohol and Chemical Co. (Shelbyville, KT). Oxoid nutrient
broth No. 2 was from Unipath LTD (Basingstoke, Hampshire, England). Postmitochondrial supernatant (S9 mix) was purchased from Molecular Toxicology,
Inc. (Boone, NC).
Pure fumonisins Bi and B2 were kindly provided by Dr. Robert M. Eppley
(Center for Food Safety and Applied Nutrition - CFSAN, U. S. Food and Drug
Administration-FDA, Washington, D.C.). Pure aflatoxin

Bj was generously

provided by Dr. Mary Trucksess (CFSAN-FDA, Washington, D. C.).
3.

Sample preparation
Toxin dilutions were always prepared fresh immediately before running an

assay. Stock solutions of AFBi (lpg/pl) and FBi (10(ig/pl) were prepared by
diluting dry pure toxins in DMSO. These solutions were then combined and diluted
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to obtain solutions that would follow the experimental design presented in Table
4.1.

Table 4.1 Combinations of AFBi and FB| tested for toxic/mutagenic potential
Aflatoxin Eti (ng/plate)
(2)
(3)
101
102
(2A)
(3A)

Fumonisin B|
(4)
(1)
(ng/plate)
10°
103
(1A)
(4A)
(A)
10°
(2B)
(3B)
(4B)
(IB)
(B)
10‘
(1C)
(2C)
(4C)
(3C)
(C)
102
(ID)
(2D)
(3D)
(D)
(4D)
103
(IE)
(2E)
(3E)
(4E)
(E)
104
(IF)
(2F)
(3F)
(4F)
(F)
105
Values in parenthesis indicate the labels used to identify each sample.
Combinations are expressed as ng AFBj/plate / ng FBj/plate. Samples were
prepared and analyzed in triplicate

When FB2 was also evaluated and the concentration of AFBi was fixed at
1000 ng/plate and FB 2 was varied from 0 to 100, 000 ng/plate. Samples were also
prepared fresh immediately before the assay. AFB 1/FB2 combinations were
evaluated using the experimental design presented in Table 4.2.
4.

Mutagenic potential of aflatoxin/fumonisin combinations
The samples were tested using Salmonella typhimurium tester strains TA-

100 and TA-98 according to the standard plate incorporation method described by
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Maron and Ames (1983). A detailed description of this method was presented in
Chapter III. An S9 cocktail without the postmitochondrial supernatant was used for
the samples without metabolic activation. Although the S-9 cocktail did not contain
the rat liver metabolizing enzymes, it included all the other co-factors including
NADP and glucose-6-P. These compounds could have been incorporated to
bacterial metabolism and affected the response. This control only tests whether the
metabolic activation by mammalian liver enzymes is required to generate a
mutagenic metabolite. For the purpose of this experiment, all other potential
interactions with the components o f the S-9 cocktail were disregarded.
Table 4.2 Combinations of AFBi and FB2 tested for toxic/mutagenic potential
Aflatoxin Bi
(ng/plate)
(4)
103
(4G)

Fumonisin B2
(ng/plate)
(G)
10°
(H)
101

(4H)
(41)

(I)
102

(4J)
(J)
103
(4K)
(K)
104
(4L)
(L)
105
Values in parenthesis indicate the labels used to identify each sample.
Combinations are expressed as ng AFBi/plate / ng FB2 /plate.
All samples were prepared and anlalyzed in triplicate.
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5.

Toxic potential o f the aflatoxin/fumonisin combinations
Salmonella TA-98 and TA-lOO’s toxic response to the aflatoxin/fumonisin

combinations was evaluated using the same modified procedure described in
Chapter III. Statistical analysis of toxicity results was carried out using SAS
software (SAS, 1988). Scheffe’s test was used to determine differences between
controls and samples.
C.

Results and Discussion

1.

Aflatoxin Bt/fumonisin B( mutagenicity
The representative results of a series of experiments are presented in this

section. Raw data and results from repetitions of this experiment are presented in
Appendix A. Figure 4.1 shows the mutagenic potential o f AFBi/FBi combinations
using Salmonella tester strain TA-100 without metabolic activation. These samples
were not tested with Salmonella tester strain TA-98. The results indicated that none
of the samples were mutagenic. This was expected since AFBi needs metabolic
activation to become a mutagen, and FBt is not considered a mutagen in this assay
with or without metabolic activation. However, this results show that when both
toxins are in the same system without metabolic activation, they do not interact to
produce mutagenic by-products at any of the combinations tested. This indicates
that metabolic activation is essential for the potential o f aflatoxin to react with other
biological molecules. Therefore, the potential to interact with fumonisin will
depend on activation of AFBi to more reactive compounds. Since these results
were negative, all further testing was performed with metabolic activation.
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Figure 4.1 Mutagenic potential of AFBi/FBj combinations. Salmonella tester strain TA-100 without metabolic
activation. Natural revertants=154±5. Values are mean±SEM of three replicates.

When the samples were tested with metabolic activation, a pattern emerged
(Figures 4.2 and 4.3). No mutagenic response was observed at AFBi levels (10° to
101 ng/plate) alone or in combination with the whole range of FBi concentrations.
In general such low amounts of AFBi do not show a response in this assay.
Therefore, FBi did not show potential for increasing the mutagenicity of low levels
of AFBi. However, at doses where mutagenicity is usually observed (102 and 103
ng/plate), an interesting pattern was noted. In both tester strains, it was observed
that the mutagenic potential varied as fumonisin concentrations increased. These
results suggested the possibility of an interaction between both toxins. However,
the pattern implied that the potential interaction is complex in nature. It was
observed that the mutagenic potential decreased in a dose-dependent fashion when
10°-102 ng FBi were present. However in the 102- 105 ng FBj/plate range, the
mutagenicity increased back to its original level; and sometimes the increase
surpassed the original level (data not shown). This behavior was consistent in both
tester strains.
These results suggested that fumonisin may affect one or more of the steps
involved in the mutagenicity process. This assay does not give information on the
mechanism involved except for the fact that metabolic activation is needed to
observe an effect. This leads to several hypothesis that can be divided in two
general groups. The first one is that one or more reactions directly involving the
toxins are taking place; and the second one is that FBi is affecting AFBi’s
metabolic transformation.
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a.

Direct interaction hypothesis

AFBi biotransformation (Figure 2.3) yields several by-products. Some of
them are considered detoxification compounds since their mutagenic potential is
lower than that of the parent compound. However, virtually all the toxic effects of
AFBi are now recognized to be attributable to the action of activated AFBi
metabolites (i.e., AFB 1- 8 ,9-epoxide) that are capable of reacting with several
macromolecules. The cytochrome P450 epoxidation of AFBi's terminal fiiran ring
double bond yields a very potent electrophile (Essigmann et al., 1977; Swenson et
al., 1977; Baertschi et al., 1989). This compound is not stable and is rapidly bound
to a nucleophilic species or transformed to the AFB[-8.9- dihydrodiol. The diol can
exist in a resonance form as a phenolate ion that is capable of forming Schiff base
adducts with amino groups (i.e., lysine in protein). On the other hand, FBi contains
one such primary amine group (Figure 2.4). Dantzer et al. (1997) and Murphy et
al. (1996) reported that FB| can undergo Maillard type reactions to form Schiff
base adducts, and these adducts can undergo an irreversible dehydration reaction .
These authors report that formation o f Maillard-type compounds by this reaction
blocks the toxic potential of fumonisin. This implies that, theoretically, if the
AFBi-8,9-dihydrodiol and FBi are present in the same system they could undergo a
Maillard-type reaction. This reaction would block the functional groups considered
most responsible for the toxic potential of these xenobiotics.
In the current study, both toxins were present at the same time in the same
solvent system. So, in this case, this reaction could be possible. However, in an in
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vivo system pharmacokinetic factors such as absorption and residence time should
be considered for both toxins. The possibility that they can have direct chemical
reaction in vivo is less than that of the in vitro system. Direct chemical interaction
will be explored further in the next chapter,
b.

Mechanistic interaction hypothesis
The results shown in Figures 4.2 and 4.3 suggest that there is more than one

mechanism responsible for the shift in the mutagenic potential of aflatoxin Bt.
Therefore, it is possible that fumonisin interacted with the activation/detoxification
pathways rather than directly with AFBi. There are several possible mechanisms
that could be either inhibited or induced by fumonisin B|.
Cytochrome P450 enzymatic activity is considered the main pathway
responsible for aflatoxin biotransformation. Several of the P450 enzymes have been
reported to be involved in AFBi metabolism. The relative quantities of different
metabolites produced depend largely on the relative activities of each isozyme. The
major AFBi detoxification metabolites include aflatoxins Mi, Pi and Qi as
detoxification by-products; and AFBi-8,9-epoxide as an activation product.
Furthermore, the 8,9-epoxide has been shown to exist in two stearically different
forms: the 8,9 exo-epoxide and the 8,9-endo epoxide. These molecules have been
shown to have different affinity for DNA and glutathione (Gallagher et al., 1996).
Guenguerich et al. (1996) reported that the exo isomer is 103 times more mutagenic
than the endo-epoxide. Furthermore, Gallagher et al. (1992) reported that the 1A2
and 3A4 isozymes appear to be the predominant catalysts of AFBi epoxidation in
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human liver in vitro. Relative to 3A4, 1A2 produces a higher ratio of activation to
detoxification products. The differences in potential activation and detoxification
metabolites suggest that there may be some agents that could shift the equilibrium
to either a detoxification or an activation pathway.
In the case of FBi, its role in cytochrome P450 activity is not clear. It has
been reported that it is not a substrate for the microsomal P450’s, estearases or
hepatic lipase systems. Therefore, direct competition with AFBi should not be an
issue. However, Martinez-Larranaga et al. (1996) reported a marked induction of
hepatic and renal P450 1A, 3A and 4A families in rats fed with FBi. However,
although in Western blot analyses of both 1A isozymes (1A1 and 1A2) showed
marked increase in P450 enzymes, only the activity of the 1A1 isozyme was
increased. The amount o f 1A2 increased, but its activity was not different from the
control. This effect on 1A2 was could not be explained by the authors. Relating
these results to the present study, it cannot be assumed that induction was a
mechanism in an in vitro system. However, the possibility that FBi affects
cytochrome P450 1A2 activity could be relevant to the changes in mutagenicity
observed here.
Studies on primary hepatocyte cultures have shown that FBi alters the
incorporation o f 14C palmitic acid into cellular lipids indicating, that added to its
effect on sphingolipid metabolism, it also affects synthesis of cellular lipids
(Gelderblom et al., 1996). In addition to fatty acid changes, membrane associated
cholesterol was markedly decreased. This study suggested that FBi has important
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effects on the structure of the major membrane components. Changes in the
membrane structure and function could lead to several toxic effects, and could
finally lead to the disintegration o f membrane continuity. From the xenobiotic
metabolism point of view. Kim (1987) and Meydahl et al. (1985) reported that
changes in fatty acid content o f hepatic endoplasmic membranes have been
accomplished by altering dietary lipids. It has also been reported that phospholipids
may enhance the binding of substrates to cytochrome P450’s (Tsai and Pence,
1992). Therefore, changes in membrane lipid composition may alter substrate
specificities and participation in various pathways. Hence, the activation and
detoxification o f numerous xenobiotics in liver microsomes may be altered.
Whether FBi can exert a similar effect in an in vitro system, such as. the
Salmonella/microsomai mutagenicity assay is yet to be determined.
Although P450 activity is considered the major enzyme system involved in
the metabolic activation of AFBi, other enzyme families may also be involved.
There is an increasing number of reports that have documented that, in general,
polyunsaturated fatty acids cause a marked reduction in the rate o f the NADPHdependent cytochrome P450 oxidation of aflatoxin (Burgos-Hemandez, 1998;
Nemoto and Takayama, 1983; Stohs and Wu, 1981). Specifically, linoleic and
linolenic acids were reported to strongly inhibit AFBi activation by rat liver
microsomes (Burgos-Hemandez, 1998; Firozi et al., 1986). Also, an inhibition of
AFBi activation mediated by hepatic microsomes in the presence of arachidonic
acid has been reported (Ho et al., 1992). These data have led to question the role of
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P450 as the sole catalyst of AFBi activation. Battista and Mamett (1985) reported
that the enzyme prostaglandin synthetase is capable of mediating the epoxidation of
AFBi through a co-oxidation mechanism. Thus, the relative contribution of other
pathways to AFBi's ultimate mutagenic outcome has gained interest from the
scientific community.
Enzymes, such as, prostaglandin synthetases (PHS), lipoxygenases (LO)
(cyclooxygenases) and peroxidases can have dual functions, they can act as
dioxygenases and as co-oxidases. Furthermore, studies have shown that soybean
LO can co-oxidize a wide range of endogenous chemicals and xenobiotics in the
presence of suitable polyunsaturated fatty acids (Kulkami, 1996). Regarding animal
systems, several studies have reported that LO are present in the liver of several
mammalian species (Roy and Kulkami, 1997; Rosello-Catafau, et al., 1994; Roy
and Kulkami, 1994; Shiratori et al., 1992; Hughes et al., 1992; Liu and Massey,
1992; Pereira and Das, 1991; Kawada et al.. 1990; Maruyama et al., 1989; Tiegs
and Wendel, 1988; Hagmann et al., 1987; Macias et al., 1987; Roll et al., 1986;
Perez et al., 1984; Nemoto and Takayama, 1984). Liu and Massey

(1992)

presented evidence that guinea-pig liver cytosolic LO can bioactivate AFBi, and
when compared to the P450-catalyzed reaction, a relatively low Km for the DNA
binding of AFBi was observed. These results implied the importance of the LO
pathway in AFBi bioactivation.
On the other hand, there have been reports that FBi can induce peroxisomal
and

microsomal

fatty

acid-oxidizing

enzyme activities.

Peroxisomes
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(or

"microbodies”) are single membrane-limited cytoplasmic organelles, which are
characterized by their content of catalase and a number of hydrogen peroxidegenerating enzymes. Peroxisomes contain the same fatty acid beta-oxidation cycle
enzymes as mitochondria; therefore, the are metabolically competent to oxidize this
type of compounds. While enzymes o f the P-oxidation cycle (normally assessed as
cyanide insensitive palmitoyl-CoA oxidation) are markedly induced, only small
changes are observed in other peroxisomal activities such as catalase and D-amino
acid oxidase. Apart from stimulating peroxisomal fatty acid metabolism,
peroxisome proliferators also increase microsomal fatty acid (co-1)- and particularly
co-hydoxylase activities. This is due to induction of cytochrome p-450 isoenzymes
in the CYP4A subfamily and is normally measured as lauric acid 12-hydrolase
(Lake, 1995). Martinez-Larranaga et al. (1996) reported that treatments o f rats with
FBi gave rise to a concentration-dependent increase in hepatic microsomal lauric
acid hydroxylase activity, which is closely associated with the CYP4A subfamily
of hemoproteins. Furthermore, the role of FBi in fatty acid metabolism has already
been discussed. Short-term in vivo and in vitro studies have shown that exposure to
FBi caused major changes in the phospholipid fraction of cells. There was a
significant increase o f hepatic C l8:2 (linoleic acid) and arachidonic acid (AA)
(Gelderblom et al., 1995). In vitro studies in different cell lines have shown that
FBi interferes with arachidonic acid conversion to other metabolites, such as
prostaglandins. In primary hepatocyte cultures, exposure to FBi caused an
accumulation of AA suggesting that FBi inhibits the release and/or the
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transformation of AA in primary hepatocytes. an effect that is greatly enhanced at
high (cytotoxic) doses of FBi (Gelderblom et al.. 1996). This fact could be related
to the relative increase in mutagenicity observed at the higher FB i doses.
The studies described above provide evidence that primary hepatocytes
exposed to FBi show an accumulation of polyunsaturated fatty acids (PUFA)
(Gelderblom et al., 1996). The cytotoxic effects of PUFA have been studied
extensively (Gavino et al., 1981; Begin et al., 1988). The data provided by these
studies suggest that the cytotoxicity of PUFA is associated with an increase in the
extent of lipid peroxidation. In conjunction, these observations imply that FBi
treated cells could be more susceptible to lipid peroxidation than normal cells
(Gelderblom et al., 1996).
The role of peroxidases in aflatoxin degradation was discussed in Chapter
III. Prostaglandin H synthetase (PHS) is the most extensively studied peroxidase. It
has been reported that it possesses two distinct catalytic

activities. A

cyclooxygenase that converts AA to a cyclic endoperoxide-hydroperoxide (PGG2 ),
and a peroxidase that converts the hydroperoxide to the corresponding alcohol
(PGH2 ) (Parkinson, 1996).
In summary, cytochrome P450 and peroxyl-radicals formed by PHS,
lipoxygenase, and/or lipid peroxidation may all play a role in activating aflatoxin
Bj. Fumonisin has been shown to be involved in several o f these oxidation
mechanisms. More information on the mechanistic implications o f FBi’s role in the
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multiple pathways that can oxidize AFBi could help understand the changes in
mutagenicity observed in this study.
Another possibility is that FBi affected the activity of phase II
conjugation/detoxification pathways rather than the P450 enzymes. If FBi affects
enzymes, such as, glutathione-S-tranferases, then the ultimate mutagenic outcome
could be affected. At some point (approximately 100 ng FBi/plate), the system
could have become saturated; therefore, the mutagenicity could return to its original
level. In vivo studies have suggested that FBi changes the level and activities of
glutathione-S-transferases (Lebepe-Mazur et a l 1995). These results give
supportive evidence for this hypothesis. However, since the metabolic activation in
this study was provided by the S9 mix, the main role of fumonisin in this study
needs to be related to enzyme activity rather than to enzyme induction.
In addition, glutathione plays a key role in detoxification by reacting with
hydrogen peroxide and organic peroxides. This reaction is catalyzed by glutathione
peroxidase. This enzyme needs two glutathione molecules to complete its cycle. Its
active site contains a covalently attached Selenium ion (Se) which forms a
selenium analog of cysteine (the sulphur has been replaced by Se). The reduced
form of this enzyme (E-Se') reduces the peroxide substrate to an alcohol and in turn
is oxidized to selenic acid (E-SeOH). Glutathione is then conjugated to form a
selenosulfide adduct (E-Se-S-G). Subsequently, a second glutathione molecule
regenerates the active form o f the enzyme by attacking the selenosulfide and
forming oxidized glutathione (Stryer, 1988). This information can also be related to
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the results observed in this study. Since glutathione plays an important role in
detoxification of both, electrophiles and free radicals, the generation of free radicals
caused by higher levels o f FBi, may have depleted glutathione. Therefore, free
radicals may have interfered with the major AFBi detoxification pathway. This is a
plausible account for the increase in mutagenicity observed at higher FB| levels.
Initially, the lower FBi levels may have generated some free radicals that were
able to react with a multitude of compounds, including the AFB 1- 8 ,9-epoxide. This
could explain the decrease in mutagenicity. Then, at higher concentrations, the
generation o f higher quantities of free radicals, coupled with enhancement o f co
oxidation mechanisms and glutathione depletion may have promoted the return to
increased mutagenicity.
The involvement o f FBi in the oxidation pathways should be explored to
determine its ability to inhibit and/or enhance toxic responses. This information
would give better tools to estimate the risk of dietary exposure to fumonisin and
evaluate it from the perspective of food safety.
2.

Aflatoxin Bi/fumonisin B2 mutagenicity
Since in Chapter III a high production of FB2 by Fusarium moniliforme was

reported, and chemical differences between FBi and FB2 are minimal (Figure 2.4).
The ability o f FB2 to affect AFBi mutagenicity was also tested. Due to the dosedependent fashion of the shift in mutagenicity, it was considered that if FB2 exerted
a similar effect, an additive response could occur during dietary exposure to co
contaminated com.
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Figures 4.4 and 4.5 show the effect of FB2 on AFBi mutagenicity. It can be
observed that the effect was less marked than that of FBi. Salmonella tester strain
showed a tendency to exhibit the same behavior, but a definite effect could not be
established. However, there is some evidence that FB2 could elicit the same
response as FBi even if the response is weaker. Potential synergistic or additive
effects should be explored.
3.

Toxicity of AFB 1/FB 1 and AFB 1/FB 2
The toxicity of all of the samples tested for mutagenicity was evaluated to

determine if the decrease in mutagenicity was indeed due to an interaction that
favored detoxification, or was it due to toxicity to the tester strains. Results from
the toxicity assay are presented in Figures 4.6-4.8. Although some variation was
observed, none o f the values were significantly different when compared to the
control. This assay had high variability that could be attributed to the fact that at
some concentrations, the bacterial suspension was highly diluted. Each plate
presented between 1 and 10 colonies. When the dilution factor was considered,
difference in one colony/plate in reality meant 1x10s colonies. Although the results
from this assay may be considered inconclusive due to high variability, the lack of
significant difference may imply that the effect observed in the mutagenicity assays
was due more to an interactive behavior that enhanced detoxification rather than to
an acute toxicity response. Other acute toxicity assays should be employed to
determine the toxic potential of these samples.
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Figure 4.4 Mutagenic potential of AFB 1/FB2 combinations. Salmonella tester strain TA-100 with metabolic
activation. Natural revertants=153±l Values are mean±SEM of three replicates.
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This experiment showed that simultaneous exposure to AFBi and FB| may
elicit different responses than exposure to the individual toxins. This effect could
be due to a combination of a multitude of factors that may include direct chemical
interaction or enhancement/inhibition of different metabolic pathways. The overall
response may be due to an equilibrium of all these reactions. The possible chemical
interaction as well as the involvement in mechanistic pathways will be further
explored in subsequent sections.
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V.

Possible mechanisms
fumonisin Bi

A.

Introduction

of

interaction between aflatoxin Bi and

In the previous chapter, it was observed that FBi changed the mutagenicity
elicited by AFBi in a dose-dependent fashion. In an attempt to understand these
results, several hypothesis were presented. Therefore, further experiments were
performed to get more information on the possible interactions that might have
taken place. The first approach was to determine if the interaction was due to a
direct chemical reaction between both toxins.
The objective of this study was to determine the recovery of a fixed amount
of AFBi (1 x 103 ng=3 nmol) after reaction with a range of different amounts of FBi
(1 to IxlO5 ng= 1.4x1 O'3 to 1.4xl02 nmol) with metabolic activation. In addition, the
recovery of a fixed amount of FBi (lxlO ' ng=l.4xl02 nmol) after exposure to a
range of AFBi (3x1 O'3 to 3 nmol) was also determined. The null hypothesis on this
experiment was that the recovery of both AFBi and FBi decreases as the
concentration of the other toxin increases. These results would show that there is a
direct chemical reaction either between the two toxins or with other toxin
metabolite(s).
A second approach was taken to determine if the changes were due to a
direct effect on the metabolic pathways rather than to direct chemical reactions.
The objective of this portion of the study was to determine the effect of FB i on the
mutagenic potential of a different mutagen, 2-aminofluorene (2-AF). This
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compound is considered a positive control for the Salmonella!microsomal
mutagenicity assay with metabolic activation (Maron and Ames. 1983).
2-AF was considered the ideal candidate since its mutagenicity requires
metabolic activation and involves a different mechanism than that of AFBi- 2-AF
does not form DNA adducts through the formation of an epoxide (Figure 5.1). This
fact was important since that would rule out the potential Maillard type reaction
with fumonisin, and therefore, give a better understanding on the effect of FBi
directly on activation/detoxification pathways, without direct chemical reaction
interference.
It has been reported that in mammalian systems, the in vitro N-oxidation o f
2-AF is mediated through pathways involving cytochrome P450, specifically P450
1A2 (Wolfel et al., 1991), flavin containing monooxygenase (FMO) (Hammons et
al., 1985), and co-oxidation via the peroxidase, prostaglandin synthetase (Wolfel et
al., 1991). These mechanisms are similar to some of the mechanisms shown to
bioactivate AFBi. Therefore, it was considered that the evaluation of FBj's role in
2-AF mutagenicity would be a useful tool to elucidate potential mechanisms
involved in the change of AFBi mutagenicity observed in Chapter IV.
B.

Materials and methods

1.

Bacterial cultures
Salmonella typhimurium tester strains TA-100 and TA-98 were kindly

provided by Dr. Bruce N. Ames (University of California Berkley, Berkley, CA).
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Figure 5.1 Metabolic transformation of 2-Aminofluorene. R=Fluorene group
(Kriek, 1992)
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2.

Chemicals
Acetic acid. 2-aminofluorene, ammonium sulfate, ampicillin, D-biotin,

disodium
sulfate.

hydrogen phosphate, gIucose-6-phosphate, L-histidine, magnesium
2-mercaptoethanol,

ortho-phtaldehide,

disodium tetraborate, sodium chloride,

sodium

ammonium

sulfate,

sodium dihydrogen phosphate,

B-

nicotinamide adenine-dinucleotide phosphate (NADP) and trifluoroacetic acid were
purchased from Sigma Chemical Co. (St. Louis, MO). Chloroform (HPLC grade),
citric acid monohydrate, dimethyl sulfoxide (DMSO), ethyl ether anhydrous,
hexane (HPLC grade), methanol (HPLC grade), potassium chloride, potassium
phosphate dibasic anhydrous and water (HPLC grade) were acquired from
Mallinckrodt Baker, Inc. (Paris, KT). Bacto agar and crystal violet were ordered
from Difco Laboratories (Detroit, MI); glucose from Fisher Scientific (Fair Lawn,
NJ). Acetonitrile (HPLC grade) was from Baxter Co. (Muskegon, MI). Ethanol was
obtained from Aaper Alcohol and Chemical Co. (Shelbyville, KT). Oxoid nutrient
broth No. 2 was from Unipath LTD (Basingstoke, Hampshire, England). Postmitochondrial supernatant (S9 mix) was purchased from Molecular Toxicology,
Inc. (Boone, NC).
Pure fumonisin Bi was kindly provided by Dr. Robert M. Eppley (Center
for Food Safety and Applied Nutrition-CFSAN-, U. S. Food and Drug
Administration-FDA-, Washington, D.C.). Pure aflatoxin

B| was generously

provided by Dr. Mary Trucksess (CFSAN-FDA. Washington, D. C.). Aflatoxin Bi,
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B2 , Gi, and Gt HPLC standard 50 pg/g mixture was purchased from Romer
Laboratories, Inc. (Union, MO).
3.

Chemical interaction

a.

Effect of fumonisin B| on aflatoxin B| recovery after metabolic
activation
Pure AFBi and FBi stock solutions (lpg/pl and lOpg/pI, respectively) were

prepared by solubilizing pre-weighed purified toxins in a methanol:water (30:70)
solution. The samples were prepared and placed in amber vials immediately before
the assay. Stock solutions were combined and diluted to obtain concentrations that
would yield the final test amounts shown on Table 5.1.

Table 5.1 AFBi/FBi combinations tested for potential chemical interactions with
metabolic activation
Aflatoxin Bi (nmol)
Fumonisin Bi (nmol)
0
3
0/0
3/0
0
1.4x1 O'3
0/1.4x10°
3/1.4x10°
1.4x1 O'2
0/1.4x1 O'2
3/1.4x10°
1.4x10''
0/1.4x10 '1
3/1.4x10'*
1.4
0/1.4
3/1.4
1.4x10'
0/1.4x10*
3/1.4x10*
1.4xl02
0/1.4xl02
3/1.4x10"
Combinations are expressed as nmol AFBi/nmol FBi. Samples were prepared in
triplicate.
100 pi of test solutions were placed in sterile disposable capped culture
tubes and 500 pi S9 cocktail prepared according to Maron and Ames (1983) were
added unless otherwise indicated (negative control). Pure AFBi (3 nmol) without
metabolic activation (500 pi S9 cocktail without postmitochondrial supernatant
fraction) was used as a recovery control. Sample 0/0 only contained 500 pi S-9 to
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determine if the S-9 mix contained compounds that would interfere with the liquid
chromatographic analysis.
The tubes were incubated in a water bath at 37°C with shaking (180-200
rpm) for 90 minutes. After incubation, the samples were placed in ice to stop the
reactions. Aflatoxin and/or metabolites were extracted by adding 1 ml CHCU to the
culture tubes and vortexing. The aqueous and organic phases were allowed to
separate and the CHCI3 phase was separated and collected in an amber vial. This
procedure was repeated three times to obtain ca. 3 ml CHCI3 extract. The samples
were evaporated to dryness under a N 2 stream. AFBi was then purified according to
the method reported by Thean et al. (1980). The purified extracts were analyzed by
liquid chromatography following the method reported by Wilson and Romer
(1991). The purification and quantification methods were described in detail in
Chapter III.
b.

Thin layer chromatography (TLC) of recovered aflatoxin Bi and/or
metabolites
Since the HPLC analytical method used in the previous section requires

AFBi derivatization with trifluoroacetic acid (TFA) to yield the more fluorescent
AFB2a, thin layer chromatography was used to qualitatively determine the presence
o f metabolites that would be converted to AFB2a when exposed to TFA.
Pre-coated aluminum silica gel plates (0.25 mm) were activated by placing
them in a dry incubator at 60°C for at least 3 hours. A 1 pg AFBi/pi
benzene:acetonitrile (98:2) solution was used as a control. 5 pi of pure AFBi and 5
pi of the same samples that were injected into the HPLC (described in the previous
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section) were spotted at 1.0 cm distance and at 1.5 cm. from the lower edge of the
TLC plate. The spots were allowed to dry. Then, 5 pi of TFA derivatizing agent (1
ml trifluoroacetic acid+4 ml hexane) were applied directly over the samples
previously spotted. After the spots dried, the plate was placed in an incubator at
65°C for 10 minutes to allow for derivatization reaction. The plates were allowed to
cool down, and 5 pi of underivatized pure AFBi and underivatized samples were
spotted at 1.0 cm from each other and from the derivatized spots. The plate was
developed in a TLC chamber using chloroform.acetic acid:water (98:1:1) as a
mobile phase. The solvent front was marked and the plate was removed from the
chamber and allowed to dry under the hood. The dried plate was observed under a
long wavelength UV light. Fluorescent spots were marked to calculate the

Rf

values.
c.

Effect of aflatoxin Bi on fumonisin Bi recovery after metabolic
activation
Pure AFBi and FBi stock solutions (lpg/pl and lOpg/pl, respectively) were

prepared by solubilizing pre-weighed purified toxins in a methanol:water (3:1)
solution. The samples were prepared in amber vials immediately before the assay.
Stock solutions were combined and diluted to obtain concentrations that would
yield the final test amounts shown in Table 5.2.
100

pi of test solutions were placed in sterile disposable capped culture

tubes and 500 pi S9 cocktail prepared according to Maron and Ames (1983) were
added unless otherwise indicated (negative control). Pure FBj (1.4xl0 2 nmol)
without metabolic activation (500 pi S9 cocktail without postmitochondrial
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supernatant fraction) was used as a recovery control. Sample 0/0 only contained
500 pi S-9 to determine if the S-9 mix contained compounds that would interfere
with the liquid chromatographic analysis.

Table 5.2 FBi/AFBi combinations tested for potential chemical interactions with
metabolic activation
Fumonisin Bi (nmol)
Aflatoxin B[ (nmol)
0
140
0
0 /0
3/0
3x1 0°
0/3x10°
140/3x10°
3x1 O’2
0/3x1 O' 2
140/3xl0‘2
3x10''
0/3x10' 1
140/3x10**
3
0/3
140/3
Combinations are expressed as nmol FBi/nmol AFB|. Samples were prepared in
triplicate.
The tubes were incubated in a water bath at 37°C with shaking (180-200
rpm) for 90 minutes. After incubation, the samples were placed in ice to stop the
reactions. Fumonisin and/or metabolites were extracted by adding 2.5 ml
methanol:water (3:1) to the culture tubes and vortexing. The resulting solution was
placed in a 20 ml scintillation vial. The reaction tubes were washed a total o f 4
times with methanol:water (3:1) to obtain a total volume of 10 ml/sample. This
final solution was mixed thoroughly (vortex - 1 min) and the pH was adjusted to
5.8 -6 .5, if necessary. This solution was then applied to pre-conditioned anion
exchange (SAX) columns and FBi/metabolites were purified and quantified by
liquid chromatography according to AO AC official method of analysis 995.15
(1996). This method was described in detail in Chapter III.
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d.

Statistical analysis
Statistical analysis was performed using the SAS software (SAS. 1988).

One-way analysis of variance (ANOVA) was used to determine differences in toxin
recovery. Scheffe's test with an alpha value of 0.05 was used to compare
differences among the different treatments.
4.

Effect of fumonisin Bi on 2-aminofluorene mutagenic potential
The mutagenic potential of 2-AF and 2-AF/FBi combinations was

determined following the methods for the Salmomllalmicxosovnal mutagenicity
assay reported by Maron and Ames (1983) using Salmonella tester strains TA-100
and TA-98 with and without metabolic activation. A detailed description o f this
procedure was provided in Chapter III.
a.

Mutagenic potential of 2-aminofluorene
A preliminary dose range finding assay was performed to determine an

ideal 2-AF dose to combine with FBi. 2-AF was tested in a range from lxlO 2 to
lxlO 6 ng/plate using Salmonella tester strains TA-100 and TA-98 with and without
metabolic activation.
b.

Effect of Fumonisin Bi on 2-aminofluorene mutagenicity
A fixed dose of lxlO 4 ng 2-AF/plate was selected to determine FBi’s effect

on 2-AF mutagenic potential. FBi was tested using the same concentration range
used to determine its effect on AFBi’s mutagenic potential (1 -lx l0 5 ng/plate).
Samples were prepared in amber vials immediately before the assay using DMSO
as the carrier solvent. Dilutions were made from 10 jig FBj/pl DMSO and 100 pg
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2-AF/jil DMSO slock solutions to yield the sample combinations presented in
Table 5.3.
c.

Safety precautions
Since 2-AF is considered a mutagen and the Material Safety Data Sheet

information on its potential toxic effects was limited, the assay was carried out with
extreme caution using appropriate personal protection equipment that included
body suits, double nitrile gloves, half face negative pressure organic vapor
respirator and safety glasses. Sample size and number of assays performed were
kept to a minimum to limit waste generation. 2-AF was handled using disposable
glassware that was properly decontaminated and disposed o f at conclusion o f the
assay. Waste material generated from this experiment was autoclaved and disposed
through Louisiana State University Department o f Occupational and Environmental
Safety once the assay was concluded.

Table 5.3 2-aminofluorene/fumonisin Bi combinations used to evaluate the effect
of FBi on 2 AF mutagenic potential.
2-AF (ng/plate)
FBj (ng/plate)
1x1 0 “
0
0
l x l 0 4/ 0
0 /0
1
0 /1
lx l 0 4 / 1
1x1 0 *
0 /1x1 0 *
lx l 0 4 / 1 x 1 0 1
lxlO 2
0/1 xlO2
Ix l0 4/lx l0 z
lxlO 3
0 /lx l0 J
1 x 1 0 4/ 1 x 1 0 j
lxlO 4
O/lxlO4
Ix l0 4/lx l0 “
lxlO 3
O/lxlO 3
lxlO’VlxlO3
All samples were tested in triplicate with and without metabolic activation.
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C.

Results and discussion

1.

Effect of fumonisin Bi on aflatoxin Bi recovery after metabolic
activation
When APBi was exposed to varying FBi concentrations, it was observed

that the results (Figure 5.2) emulated the mutagenicity behavioral pattern shown in
Figures 4.2 and 4.3. The amount of aflatoxin recovered decreased as FBi increased
until FBi reached lxlO 2 ng (1.4x1 O' 1nmol). At this point, AFBi recovery started
increasing. Although the only treatments that were significantly different (p<0.05)
from the control were observed when l.4xl0 4 and 1.4 nmol FBi were added, the
pattern was evident. This behavior suggested that direct chemical interaction was
not involved, at least not in all the FBj concentration range. If there had been a
chemical reaction, a single dose-response would have been observed. AFBi
recovery would have decreased as FBi increased.
Analysis of the controls indicated ca. 90% recovery from the extraction
procedure. This showed that the extraction method was suitable for this assay and
that the variations observed were due to chemical interaction. No peaks were
detected in the chromatograms of the controls, FBi without AFBi and S9.
Therefore, it was assumed that neither FBj nor S9 interfered with the results.
It is noteworthy that chromatograms showed a peak for the AFB i derivative
AFB2a. These results were not expected since AFBi had been exposed to S9
enzymatic activity. AFB2 a is formed when AFBi is exposed to TFA. Hence, in
theory, AFBi in this study should have been transformed to other metabolites.
Since AFB 2 a can be obtained through biotransformation pathways, it was
164
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Figure 5.2 Aflatoxin B| recovery after reaction with fumonisin B| with metabolic activation. Values are
mean±SEM of three replicates.

hypothesized that the exposure to FBi with metabolic activation yielded AFB^a- To
test this hypothesis, an underivatized sample was analyzed in the same HPLC
system. If AFB^a were generated from the S9 metabolic activity, a peak with a
similar retention time as AFB2 a was expected from injection of underivatized
samples. However, there were no detectable peaks in the chromatograms of these
samples. Thus, it was assumed that AFB2 a was not directly generated by S9
metabolic activity in this in vitro system.
It was also hypothesized that some other secondary compound was
generated during the incubation, and this compound was also derivatized to AFB 2 a
or to a compound that co-eluted with AFB2 a. Therefore, the peaks observed for
AFB2a could be a combination of one or more derivatized metabolites plus residual
AFBi that were co-extracted with CHCI3 . It would be assumed that the rest of the
AFBi was biotransformed and/or conjugated to more polar compounds that had a
higher affinity to the aqueous phase and were not extracted with CHCI3 . To
qualitatively test this hypothesis, derivatized and underivatized pure AFBi and
CHCL-extracted samples were fractionated on a TLC plate. The results are shown
in Table 5.4.
Table 5.4 Rf values and description of TLC spots of derivatized and underivatized
samples.
Sample
R f value
Spot description
AFBj+TFA
0.16
Bright blue fluorescence
Sample+TFA
0.16
Bright blue fluorescence
AFBi
0.63
Medium blue fluorescence
Sample
0.71
Faint dark blue
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The results (Table 5.4) suggest that an AFBi metabolite or byproduct was
recovered in the CHCI3 fraction. This metabolite (Rf=0.7l) was transformed either
to AFB2a (Rf=0.16) or to a product that co-eluted with AFB2a (Rf=0.16) after
derivatization with TFA. It is interesting to note that Doyle and Marth (1978)
reported that when lactoperoxidase was used to degrade AFBi, derivatives that
co-chromatographed with AFB2a and derivatives that were water soluble were the
major degradation products of AFBi. This report, coupled with the results
presented in this study, provide evidence for the potential involvement o f
peroxidase activity in AFBi mutagenicity. Further research is needed to
characterize the metabolites produced by this pathway and to determine the direct
effect of FBi on peroxidase-dependent AFBi oxidation.
2.

Effect of aflatoxin Bi on fumonisin Bi recovery after metabolic
activation
When FBj was exposed to AFBi with metabolic activation, no significant

(p<0.05) changes were observed (Figure 5.3). However, it was observed that the
control for the extraction method was ca.

8 8

%. While FBi recovery for all the

samples ranged from ca. 60-75%. Hence, some of the FBi was not recovered after
reaction with AFBi and metabolic activation. No dose-response relationship was
observed. This may be due to the fact that an excess FBi was used for this assay.
This amount of FBi (lxlO 3 ng) was selected to facilitate detection by HPLC. The
excess FBi in the system, may have masked its relationship with S9. However,
from under these experimental conditions, it can be assumed that direct chemical
interaction is not a major contributor to the shift of AFBi mutagenicity caused by
167
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Figure 5.3 Fumonisin B| recovery after reaction with aflatoxin B| with metabolic activation. Values are
mean+SEM of three replicates.

FB[. More research is needed to determine the role of FBi in xenobiotic co
oxidation mechanisms.
3.

Effect of fumonisin Bt on 2-aminofluorene mutagenicity
Figures 5.4 and 5.5 show 2-AF mutagenic potential using Salmonella tester

strains TA-100 and TA-98 with and without metabolic activation. It was observed
that 2-AF exhibited the same behavior in both tester strains. When the activating
enzyme mixture (S9) was present, 2-AF mutagenic potential increased in a doseresponse fashion up to a concentration of 103 ng/plate. Plates containing 106
ng/plate with and without metabolic activation did not show any growth. Toxicity
testing on nutrient agar plates confirmed that 2-AF at this concentration was toxic
to both, Salmonella TA-100 and TA-98.
The results shown in Figures 5.4 and 5.5 implied that a concentration range
o f 104 to 103 would be useful for testing the effect of FBi used to test AFBi
mutagenicity. It was determined that at this level, any potential variation caused by
FBj would be easily identified. This amount of 2-AF showed a marked mutagenic
response and was lxlO 2 fold lower that the amount that showed a marked cytotoxic
response. Therefore, 2-AF was fixed at 104 ng/plate and FBi (10°-103 ng/plate) was
added. These combinations did not show a cytotoxic response when evaluated on
nutrient agar plates.
When the effect of FBi (10°-105 ng/plate) on the mutagenic potential of 2AF (104 ng/plate) was evaluated, an interesting response was observed. FBi
changed 2-AF mutagenic potential in the same way as it affected the mutagenic
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Figure 5.5 Mutagenic potential of 2-aminofluorene. Salmonella tester strain TA-98 with and without metabolic
activation (S9). Values are mean±SEM of three replicates.

potential of AFBi (Figures 5.6 and 5.7). There was a marked decrease up to a point
(102 ng FBi/plate) where the mutagenic response started to return to its original
level. It was interesting to observe that the return occurred around the same FBi
concentrations that elicited a change in AFBi mutagenicity and chemical recovery.
These results suggest that FBi affects one or more of the common metabolic
pathways that are involved in 2-AF and AFBi activation/detoxification.
Leist et al. (1992) reported that enzymes from both, the microsomal and the
cytosolic fractions of hepatic S9 mix are involved in the activation of 2-AF to a
mutagen. Furthermore, there have been reports that show that the cytosolic fraction
of this mix can markedly enhance the mutagenic response of chemicals such as
AFBi (Saccone and Pariza, 1981), benzo[a]pyrene (Saccone and Pariza, 1981), 2acetylaminofluorene

(Forster

et al.,

1981),

2-amino-3-methylimidazo-(4,5-

quinoline) (Abu-Shakra et al., 1986), benzidine (Smith and Ioannides, 1987) and
N-nitrosopiperidine (Ayrton et al.. 1987).
Leist et al. (1992) reported that the first and rate limiting step in the
bioactivation of aromatic amines is the N-hydroxylation catalyzed by microsomal
enzymes and that the hydroxylated amines act as the proximate mutagens. Phase II
conjugation enzymes produce electrophilic species such as the nitrenium ions that
can bind covalently to DNA. The involvement of enzymes, such as prostaglandin
endoperoxide synthetase, peroxidase and the peroxidase-like enzymes in the
bioactivation of 2-AF to a mutagenic species has been reported by several authors
(Isola et al., 1993; Corbett and Corbett, 1988). Leist et al. (1992) also reported that
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TA-98 with and without metabolic activation (S9). Values are mean±SEM of three replicates.

cytosolic oxygenase activity is involved in the bioactivation of 2-AF. These authors
also reported that the cytosolic activation of 2-AF is dependent on the presence of
O2 , and that established oxygen radical scavengers such as DMSO and retinol
inhibit the reaction.
The oxygen radical scavenger potential of DMSO may have interfered with
the results presented in the current study. DMSO could have interfered with the
total response, but other factors may have also been involved. DMSO was used as a
negative control in this study. Therefore, the results can still be evaluated relative to
each other. Moreover, the chemical interaction study reported previously in this
chapter, used a different carrier system (methanol:water; 30:70) and the same doseresponse behavior was observed. If FBi is in fact involved in a free-radical
peroxidation mechanism that affects the biotransformation o f chemicals such as
AFBi and 2-AF, its effect should be evaluated in a system that does not contain
added oxygen scavengers such as DMSO. This could give more marked responses
that would help elucidate the mechanism(s) involved.
The results from this study suggest that FBi affects AFBi and that 2-AF
biotransformation in a dose-response fashion through a similar mechanism. It has
been reported that both, 2-AF and AFBi are mainly activated by the cytochrome
P450 1A2 isozyme and by oxidative reactions mediated by peroxidase and
peroxidase-like enzymes.
From the fumonisin perspective, there is evidence that suggests that FBi
alters P450 1A2 activity (Martinez-Larranaga, 1996) and that it alters the levels and
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fatty acid composition in rat liver in vitro and in vivo systems (Gelderblom et al.,
1996; 1997). The accumulation of polyunsaturated fatty acids coupled with
enhancement of peroxidase and peroxidase-like activities implies that FB i can alter
peroxidase-mediated reactions. Therefore, the evaluation o f the involvement o f FBi
on the activity of microsomal and cytosolic fractions and its specific effect on P450
1

A2 activity would be useful in determining its role in the activation/transformation

of xenobiotics, such as, AFBi. This information would help in assessing the
potential risk and food safety concerns associated with aflatoxin and fumonisin co
contamination in com.
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VI.

Effect of Fumonisin B| on gap-junction intercellular communication of
clone-9 rat liver cells

A.

Introduction
In the previous chapters, the possible interactions between aflatoxin B| and

fumonisin Bi were explored, mainly through the evaluation of the mutagenic
potential of different AFBjrFBi ratios. However, since it does not show a positive
response in the Salmonella/microsomal test and other mutagenicity assays FBi is
considered a non-genotoxic agent. FBi’s lack of mutagenicity has complicated the
development of short term assays that could help monitor its effect on an in vitro
system and facilitate the study of potential interactions. Therefore, the need for
rapid and reliable assays to monitor the effect of fumonisin was identified.
Molecular studies of human cancers have provided abundant evidence that
carcinogenesis requires an accumulation of mutational events before a normal cell
transforms into a malignant tumor (Fearon and Vogelstein, 1990). Therefore, the
use of short-term mutagenesis assays to evaluate chemical carcinogens is well
justified. However, it has been reported that standard short-term mutagenesis test
results identify no more than 65-89% of rodent carcinogens (Ashby and Tennant,
1991). Hence, Yamasaki (1996) has speculated that even if the concept of these
assays is on target, there is a misconception that genetic changes required for
carcinogenesis are always directly induced by exogenous carcinogens and thus,
detected by short term assays such as the Salmonella/microsomal mutagenicity
assay. The general concept that chemical carcinogens directly interact with DNA is
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widely accepted because many environmental carcinogens, i.e., tobacco smoke,
aflatoxin, sunlight, etc.. have been implicated in certain types of cancer and because
the genetic basis of cancer has been supported with extensive evidence. However,
some of these concepts cannot be entirely translated into simple mutation assays. In
support of this idea, it has been reported that exposure to agents that induce cell
proliferation, block intercellular communication, or produce oxygen radicals may
eventually lead to genetic damage, but these mutational events are considered
indirect, and are usually not detected by mutation assays (Yamasaki. 1996). Several
authors have provided experimental evidence to consider that one possible nongenotoxic mechanism of carcinogenesis

is the inhibition of gap-junction

intercellular communication (GJIC) (Holden et al., 1997; Mesnil et al., 1995;
Yamasaki. 1990; Trosko and Chang, 1988; Loewenstein, 1979).
GJIC has been considered an important factor in cell growth and
differentiation. Furthermore, in recent years it has been widely believed that GJIC
plays a pivotal role in cell proliferation (Na et al., 1995). It is believed that
considerable levels o f important biological materials, such as, growth control
factors are exchanged through gap junctions (GJs) (Na et al., 1995). GJs are
composed o f protein channels that permit the exchange of nutrients, ionic signals
and regulatory molecules o f up to 1500 Dalton between adjacent communicationcompetent cells (El-fouly et al., 1987). It has been reported that certain nonpermeable molecules can be introduced into cells via a "scrape-loading” technique
(El-fouly et al., 1987). Scrape-loading has been effectively utilized to introduce
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macromolecules into cells in culture by inducing a transient tear in the plasma
membrane without affecting cell viability or colony forming ability (McNeil et al.,
1984).
Lucifer yellow (3,6-Disulfonate-4amino-naphtalimide; MW=457.2) is a
water soluble, low molecular weight fluorescent dye that does not diffuse through
intact plasma membranes, but readily passes from one cell to another, potentially
revealing molecular relationships between cells (Hermanson, 1996). El-fouly et al.
(1987) determined that Lucifer Yellow transfers from cell to cell through gap
junctions. Therefore, these authors developed a Lucifer yellow scrape-loading and
dye transfer technique to study gap-junction intercellular communication. This
method can be used to determine if certain non-genotoxic chemical carcinogens are
involved in the carcinogenesis process by interfering with GJIC.
FB i non-genotoxic nature combined with the existing evidence regarding its
effect on lipid metabolism and membrane structure and function, led to the
hypothesis that it could affect GJIC. Thus, the objectives of this phase of the study
were (1) to determine if fumonisin inhibits GJIC in vitro, and (2) to determine if
APBi changed FBi effect on GJIC.
B.

Materials and methods

1.

Chemicals
Pure fumonisin B| was kindly provided by Dr. Robert M. Eppley (Center

for Food Safety and Applied Nutrition (CFSAN), U. S. Food and Drug
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Administration (FDA), Washington, D. C.). Pure aflatoxin B[ was provided by Dr.
Mary Trucksess (CFSAN-FDA, Washington, D. C.).
Ham’s F-12K cell culture media and fetal bovine serum were purchased
from American Type Culture Collection (ATCC) (Rockville, MD). Acetic acid,
Dulbecco’s phosphate buffer solution without calcium and magnesium (PBS-Ca,
Mg), Dulbecco’s phosphate buffer solution with calcium and magnesium (PBS+Ca,
Mg), ethanol, 0.25% trypsin, 0.03% versene solution. 30% hydrogen peroxide,
Lucifer yellow, methanol, neutral red, lOOx penicillin/streptomycin solution, trypan
blue, 25 cm 2 cell culture flasks and 35 mm cell culture dishes were acquired from
Sigma chemical company (St. Louis, MO).
2.

Cell line
Clone-9 (CRL-1439) rat liver epithelial cell line isolated in 1968 from

normal liver taken from a young male rat (Gerschenson et al., 1975; Weinstein et
al., 1975) was purchased from ATCC (Rockville, MD). Cells were grown in Ham’s
F-12K medium with 10% fetal bovine serum, and 1% penicillin streptomycin
solution under an atmosphere of 5% CO 2 in humidified air at 37°C. Culture media
was renewed 1 to 2 times weekly. Subculturing was performed by removing old
media and adding fresh 0.25% trypsin, 0.03% versene solution for 2 to 3 minutes.
The trypsin solution was then removed and the culture was incubated at 37°C for
10-15 minutes to permit cell detachment. Fresh medium was then added, aspirated
and dispensed into new flasks in a 1: 6 ratio. Bioassays were conducted with cells
grown in 35 mm culture dishes to confluency after 2-3 days growth.
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3.

Test solutions
Toxin dilutions were prepared immediately before the assay. Stock

solutions 10 pg/pl and lpg/pl of FBi and AFB[, respectively were prepared by
solubilizing pre-weighed pure toxins in a sterile 30% ethanol solution (0.22 pMillipore syringe filter (Millipore, New Bedford, MA)). Combination samples as
shown in Table 6.1 were prepared in sterile capped culture tubes using sterile 30%
ethanol as a solvent carrier. 30% ethanol solution was used as a negative control in
all assays.

Table 6.1 Fumonisin Bi and aflatoxin Bi samples tested for cytotoxicity and effect
on gap-j unction intercellular communication
AFBj (ng/plate)
FBi (ng/plate)

0

0

0 /0

0 /1

1

1 /0

*
*

I

x1 0 *
0 /1x1 0 *
1

*

lx l 0 z
0/1 xlO2
*

*
*
x1 0 *
lx l0 * /0
*
*
*
lxlO3
l x l 0 3/ 0
*
*
*
lxlO3
l x l 0 3/ 0
*
*
*
lxlO4
l x l0 4/0
lxlO5
l x l 0 5/ 0
l x lo V l
I x l 0 3/ l x l 0 * I x l 0 5/ l x l 0 2
Combination values are expressed as ng FBi/pIate / ng AFBi/plate.
*: Combination not tested
All samples were prepared in triplicate
1

4.

0

lx l 0 J
/lxl0 3
*
*
*

*
♦
I x l 0 5/ l x l 0 3

Growth curve
A growth curve to determine cell growth characteristics and standardize all

assays was obtained by growing cells in 25 cm 2 cell culture flask until they reached
a concentration o f 5x104 cells/ml. Cells were counted by staining with trypan blue
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and using an hemocyotmeter. Cell suspensions were added to 35 mm cell culture
dishes at four different concentration levels, 3xlOJ, 7xl03, 13x10J and 27xlOJ>
cells/ml. Volume was brought up to 2 ml/plate. These plates were incubated at
37°C in a 5% CO2 humidified atmosphere. Cells were counted at 0, 55,

8 8

and 120

hours incubation.
5.

Neutral red cytotoxicity assay
Cytotoxicity as determined by the neutral red uptake assay according to the

method reported by Borenfreund and Puemer (1985). Clone-9 cells were grown in
35 mm cell culture dishes at the same conditions and confluency (ca. 4x104
cells/ml) used for the cell communication bioassay (2-3 days). Old growth media
was discarded and 2 ml fresh media were added to each disc.

100

pi test solutions

(Table 6.1) were added to three plates/sample. Plates were incubated for 24 hours
and cytotoxicity was determined.
The neutral red solution was prepared by mixing it with Ham's F-12K
medium. The media containing neutral red was incubated for 2 hours in a water
bath at 37°C. The resulting precipitation was centrifuged at 2000 g and filtered
through a 0.22 p-Millipore syringe filter (Millipore, New Bedford, MA).
The cells were rinsed three times with PBS+Ca, Mg and then 2 ml fresh
growth media containing 0.033% neutral red was added to the cells. Plates were
incubated at 37°C for 1 hour. After incubation, the extracellular neutral red was
rinsed off with PBS+Ca, Mg and the cells were lysed with 2 ml of an aqueous
solution containing 1% acetic acid and 50% ethanol. The lysed cells were measured
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for neutral red at a wavelength of 540 nm. Methanol (200 pi) was used as a positive
control and 30% ethanol was used as a negative control.
6.

Gap-junction intercellular communication
Gap-junction intercellular communication in clone-9 rat liver cells was

measured using the scrape-loading dye transfer method reported by El-Fouly et al..
(1987) with a modification described by Na et al. (1994). Cells were grown to
confluency in 35 mm cell culture dishes (ca. 4xl0 4 cells/ml). Old media was
discarded and replaced with fresh media. Test samples (Table 6.1) were added (100
pi) 24 hours prior to scrape-loading. After 24 hours incubation, media was
aspirated and reserved in sterile capped culture tubes at 37°C. Cells were washed
twice with PBS-Ca, Mg. The plate was then flooded with PBS containing 1%
Lucifer yellow and then scrape loaded with a plastic scraper. The dye solution was
left on the cell monolayers for

1

min. and then the cultures were washed three times

with PBS with Ca and Mg to remove unloaded dye and background fluorescence.
Growth media was replaced in each dish and the dishes were incubated at 37°C in a
humidified atmosphere for 10 minutes to allow for dye transfer. Cultures were then
examined under an Olympus inverted microscope equipped with a reflected light
fluorescence attachment with HBO-100 W/2 mercury lamp (Olympus, Tokyo,
Japan). Gap-junction communication was measured by counting the number of
cells from the scrape-loaded line that were stained with the fluorescence dye. Cells
were counted on 20 different locations on each plate. Samples were analyzed in
triplicate.
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7.

Statistical analysis
Statistical analysis was performed using the SAS software (SAS, 1988).

One way analysis of variance (ANOVA) was used to determine differences in toxin
recovery. Scheffe's test with an alpha value of 0.05 was used to compare
differences among the treatments.
C.

Results and discussion

1.

Growth curve
A growth curve (Figure 6 .1) was constructed to optimize growth times and

standardize the experimental conditions for this assay. From the growth curve, it
was determined that plating a cell suspension containing ca. 1.3x104 cells/ml
yielded the adequate growth to confluency in the time required to perform this
experiment. This was crucial since it has been observed that FBi does not elicit any
effect to cells in culture until after an initial lag period o f 24-48 hours (Yoo et al.,
1992). It was important to test cells at confluency, but that would stay in a log or
stationary phase throughout the assay. Once the growth parameters were
determined, they were used for the rest o f the bioassays.
2.

Neutral red (NR) cytotoxicity assay
The NR assay is based on theincorporation of a weakly cationic dye (NR)

into the lysosomes of viable cells after their incubation with toxic chemicals. NR
penetrates cell membranes by nonionic diffusion and binds intracellularly to sites of
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Figure 6.1 Growth curves for Clone-9 rat liver cells. Values are mean+SEM of thirty counts.

the lysosomal matrix (Lullmann-Rauch, 1979). Xenobiotics that injure the plasma
or lysosomal membrane decrease NR uptake and subsequent retention. After the
cells are rinsed, only undamaged cells retain the dye. NR is then extracted from the
lysosomes and quantified spectrophotometrically. Methanol was used as a positive
control to optimize the neutral red cytotoxicity assay. Figure 6.2 shows the doseresponse relationship caused by the toxicity of methanol. It can be observed that as
methanol increased, the absorbance decreased indicating that less cells were able to
retain NR.
When cells exposed to FBi and/or AFBi were analyzed, an interesting
pattern was observed (Figure 6.3). All treatments had significantly higher (p<0.05)
absorbance than the control. This suggested that not only were the treatments not
acutely toxic, but they induced more intracellular NR retention. One plausible
explanation o f this effect is the possibility that the toxins are indeed acting as
peroxisome proliferators as previously reported (Martinez-Larranaga, 1996). Since
the morphology of peroxisomes resembles that of lysosomes (Darnell et al., 1990),
it could be possible that exposure to the toxins caused an increase of these
organelles as an early toxic response. The peroxisomes may have retained the NR
causing the increase in absorbance. Although this hypothesis needs more research,
it provides further evidence that peroxisomes and oxidative metabolism may play
an important role in FBi toxicity and in the interaction between AFBi and FB|.
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Figure 6.3 Toxic potential of fumonisin B| and/or aflatoxin B| to Clone-9 rat liver cells. Values are mean±SEM
of three replicates.

3.

Effect of fumonsin B| on gap-junction intercellular communication
The results of this study suggest that FBi inhibits gap-junction intercellular

communication of Clone-9 rat liver cells. Table 6.2 summarizes the results of this
assay and shows the significant differences between the different concentrations
tested.

Table 6.2 Effect of fumonisin Bi on gap-junction intercellular communication of
Clone-9 rat liver cells
*
Sample
Mean±SEM (n=60)
Negative control
A
6 .2 ± 0 . 1
F
Positive control (H 2 O2 ) 400pM
1.3±0.2
A,B
1 ng FB [/plate
4.9±0.2
lxlO1 ng FBi/plate
B,C
3.8±0.2
lxlO2 ng FBi/plate
C
3.5±0.1
lxlO3 ng FBi/plate
C
3.2±0.2
F
lxlO4 ng FB,/plate
1.5±0.2
C,D,E,F
lxlO3 ng FBi/plate
1.7±0.2
lxlO5 ng FB i/plate + 1 ng AFB [/plate
E,F
1 .2 ± 0 . 1
1X105 ng FB [/plate + l xlO 1 ng AFB [/plate
C.D.E
2.6±0.3
C,D
1X105 ng FBi/plate + lxlO2 ng AFBi/plate
2 .8 ± 0 . 2
lXlO3 ng FB [/plate + lxlO3 ng AFB [/plate
C.D
2.9±0.3
lxlO3 ng AFB [/plate
A
5.2±0.2
GJIC is expressed as the mean number of fluorescent cells counted from the scrapeloaded line.
Values with the same letter are not significantly different.
It was noted that FB| inhibits GJIC in a dose-response fashion (Figure 6.4).
Communication decreased as FBi concentration increased. These results show that
inhibition o f GJIC may play a role in FBi carcinogenesis. This is supported by
other reports on FBi role on membrane structure and function. Yoo et al. (1992)
reported that after 24-48 hours of FB| exposure LLCP-PK1 cells lost cell-cell
contact.
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Figure 6.4 Effect of fumonisin B| on gap junction intercellular communication (GJIC) of Clone-9 rat liver
cells. Positive control H2 O2 (400 pM)=0.21 ±0.029. Values are meaniSEM of sixty replicates.

Furthermore, Niedel et al. reported that TPA (12-O-tetradecanoylphorboI13-acetate), a known tumor promoter, inhibits GJIC. It has been speculated that
TPA mediates its tumor promoter effects through the activation o f protein kinase C
(PK-C) and the subsequent phosphorylation of critical cellular proteins (Ashendel
et al., 1985; Blumberg et al., 1984; Niedel et al., 1983). There are also several
reports that suggest a role for TP A-induced production of active oxygen species in
the promotion of initiated cells (Kensler and Trush, 1984). Repine et a/. (1974) have
reported that TPA elicits a rapid burst of free radical scavenging enzymes. Several
authors have demonstrated that PK-C activation is involved in TPA-induced
inhibition of GJIC (Oh et al., 1988; Gainer and Murray, 1985; Enomoto and
Yamasaki, 1985; Davidson et al., 1985). Furthermore, PK-C has been shown to
phosphorylate the rat liver gap junction protein in a cell-free system (Takeda et al.,
1987). These reports could be related to some of the potential modes of action
suggested for FBi.
FBi has been shown to be a natural inhibitor of sphingolipid metabolism,
and sphingolipids are the natural inhibitors of the Ca2+ activated, phospholipid
dependent phosphorylating enzyme protein kinase C (PKC). Thus, it has been
speculated that FBi may also affect PKC-regulated functions (Kharmalov et al.,
1993; Hannun et al., 1986). Yeung et al. (1996) have reported that FBi induces
PKC translocation via direct interaction with the diacylglycerol binding site. PKC
is activated by diacylglycerol (DAG) generated via receptor-mediated hydrolysis of
inositol phospholipids to relay information derived from a variety of extracellular
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signals to regulate many Ca2+-dependent processes. In addition, PKC also serves as
an intracellular receptor for tumor-promoting phorbol esters, which are stable DAG
analogues. The reports that FBi induces PKC translocation via a direct action on
the DAG site that also binds phorbol esters (Yeung et al., 1996) coupled with the
reports that PKC activity plays an important role in phorbol esters tumor promotion
activity (Ashendel et a l, 1985), suggest that FBi may inhibit GJIC through a
mechanism similar to that of the phorbol esters.
Na et al. (1995) reported that a dose of up to lxlO4 ng AFBi/ml did not
significantly inhibit GJIC. These results were confirmed in this study where lxlO3
ng/plate did not significantly (p<0.05) decrease GJIC (Table 6.2). Figure 6.5 shows
that when a range of 1 to lxlO3 ng AFB i/plate is combined with lxlO5 ng FBi/plate
there is relatively no change in GJIC inhibition. Therefore, these results imply that
there is no interaction between the two toxins in this system. FBi GJIC inhibitory
mode of action could be considered independent of AFBi. However, the metabolic
capability o f Clone-9 rat liver cells is unknown. Hence, the lack of interaction
could be due to lack of enzyme systems capable of activating AFB). The possible
interaction between FBi/AFBt that could affect GJIC should be studied in
metabolically competent systems to determine if in reality AFBi does not affect
FBi inhibition of GJIC.
The results presented in this study suggest that the inhibition of GJIC could be a
non-genotoxic mechanism of FBi involvement in carcinogenesis. Furthermore, the
positive response observed with a short term in vitro assay such as the scrape-
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Figure 6.5 Effect of aflatoxin Bi on the inhibition of gap junction intercellular communication (GJIC) of Clone9 rat liver cells caused by 1x10s ng FBj/plate. Positive control H2 O2 (400 |iM)=0.21 ±0.029; lxlO3 ng
AFB |/plate=0.83+0.033. Values are mean+SEM of sixty replicates.

loading technique provides a useful tool to study FB[. It was observed that
inhibition of GJIC in Clone-9 rat liver cells could be a useful end-point for future
FBi studies.

194

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

VII.

Effect of hydrogen peroxide and sodium bicarbonate on the toxin
content and the toxic/mutagenic potential of aflatoxin- fumonisin
naturally co-contaminated corn

A.

Introduction
Perhaps too much attention has been given to the carcinogenic potential of

mycotoxins, such as, aflatoxin. However, the possibility that low levels of
mycotoxins or combinations of several mycotoxins could cause secondary
mycotoxin-related syndromes in humans, in a way similar to those now being a
threat to animal populations cannot be overlooked. If this were true, then the real
implications o f mycotoxin presence in human foods would be more threatening.
Until there is a better understanding on the mode of action and the interaction
between mycotoxins and the multiple components in diet, every effort should be
made to reduce or eliminate mycotoxins from the human dietary chain.
The previous chapters have shown some evidence that simultaneous
exposure to AFBi and FBi can elicit a wide variety of toxic responses. The exact
mechanisms by which this occurs are still poorly understood. Thus, it is impossible
to assess the real risk posed by co-exposure to these toxins. Furthermore, the
potential interactions presented in this study bring out the fact that exposure to
xenobiotics is a more complex issue. In reality, humans and animals get exposed to
a multitude o f

compounds that may have either toxic or protective effects.

Therefore, the ultimate toxic outcome relies on

each individual’s capacity to

maintain a balance. Taking these concepts into consideration, it is clear that
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limiting the exposure to agents with known toxic potential will help maintain the
equilibrium on the side of health.
Com is a dietary staple in many areas o f the world. In some areas in Mexico
and Latin America, com can provide up to 70% of the daily caloric intake.
Therefore, potential exposure to AFBi and FBi is high. However, shifting
consumer preferences in areas of the world that are less poverty stricken has also
elevated the risk of exposure in populations that were traditionally not considered
at risk. A recent study has reported that in the United States o f America, tortilla
sales between 1994 and 1995 showed that tortillas are the fastest growing segment
of the U.S. baking industry. This segment is expected to continue growing
approximately 54% in the next five years. According to the tortilla industry
association, tortillas are more popular today than all other ethnic breads, such as,
bagels, English muffins and pita bread. It has been estimated that industrial growth
in 1998 will continue to remain at about 10% to 14% for most tortilla producers.
Furthermore, the growth outlook for European markets is estimated to be 50%
(Cornell, 1998). Even if these trends include wheat-flour tortilla sales, they suggest
that dietary practices are rapidly changing; therefore, consumers are more liable to
get higher and more frequent exposure to mycotoxins, such as, AFBi and FBi in
com and com products. This, added to the lack of information regarding
fumonisins’ ultimate role in health and disease, and the evidence that relates
aflatoxins to mutagenic events and hepatic cancer, emphasize the need to develop
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control mechanisms such as detoxification procedures which address multiple
mycotoxins.
In previous studies (Lopez-Garcia, 1995; Park et al., 1996), the use o f
hydrogen peroxide and sodium bicarbonate was proposed as a specific alternative
for fumonisin detoxification during nixtamalization, a traditional process used in
tortilla manufacture which involves boiling and soaking of com in lime water. The
results of this study indicated the use of H2 O 2 and NAHCO 3 without
nixtamalization was effective in reducing fumonisins below detectable levels and
the reduction was accompanied by a decrease in toxicity to brine shrimp (Artemia,
sp.). These studies also reported that no mutagenic by-products emerged as a result
of the reaction(s). Other studies (Valdivia, 1995) have reported that H2 O2 and
NaHCOs were effective in reducing aflatoxin levels in com. Furthermore, evidence
for the involvement o f oxidative mechanisms in toxin degradation

has been

presented

used

in

previous

chapters.

These

reactions

could

be

to

detoxify/decontaminate com, before consumption.
H2 O2 and NaHCOj are readily available food grade ingredients and their
use could be adapted to any com processing operation. Thus, the objective of this
study

was to determine if H2 O 2 and/or

NaHCC>3 were

effective

in

decontaminating/detoxifying aflatoxin- fumonisin-naturally co-contaminated com.
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B.

Materials and methods

1.

Corn and bacterial cultures
Naturally contaminated com containing 375 pg/g total fumonisins and 20 ng/g

total aflatoxins was kindly provided by Dr. Jeff Ellis (Texas State Department of
Agricultural Chemistry).
Salmonella typhimurium tester strains TA-100 and TA-98 were kindly
provided by Dr. Bruce N. Ames (University o f California Berkley, Berkley, CA).
Artemia sp. larvae were purchased from a local pet store (Baton Rouge, LA).
2.

Chemicals
Acetic

acid,

ammonium

sulfate,

ampicillin, D-biotin,

disodium

hydrogen phosphate, glucose-6 -phosphate, L-histidine, magnesium sulfate, 2mercaptoethanol,

ortho-phtaldehide,

sodium

ammonium

sulfate,

disodium

tetraborate, sodium chloride, sodium dihydrogen phosphate, 13-nicotinamide
adenine-dinucleotide phosphate (NADP) and trifluoroacetic acid were purchased
from Sigma Chemical Co. (St. Louis, MO). Chloroform (HPLC grade), citric acid
monohydrate, dimethyl sulfoxide, ethyl ether anhydrous, hexane (HPLC grade),
methanol (HPLC grade), potassium chloride, potassium phosphate dibasic
anhydrous and water (HPLC grade) were acquired from Mallinckrodt Baker, Inc.
(Paris, KT). Bacto agar and crystal violet were ordered from Difco Laboratories
(Detroit, MI); glucose from Fisher Scientific (Fair Lawn, NJ). Acetomitrile (HPLC
grade) was from Baxter Co. (Muskegon, MI). Ethanol was obtained from Aaper
Alcohol and Chemical Co. (Shelbyville, KT). Oxoid nutrient broth No. 2 was from
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Unipath LTD (Basingstoke, Hampshire, England). Post-mitochondrial supernatant
(S9 mix) was purchased from Molecular Toxicology, Inc. (Boone, NC).
Pure fumonisins B| and B2 were kindly provided by Dr. Robert M. Eppley
(Center for Food Safety and Applied Nutrition - CFSAN, U. S. Food and Drug
Administration-FDA, Washington, D.C.). Pure aflatoxin

Bi was generously

provided by Dr. Mary Trucksess (CFSAN-FDA, Washington, D. C.). Aflatoxin Bi,
B2 , Gi, and G2 HPLC standard 50 jig/g mixture was purchased from Romer
Laboratories, Inc. (Union, MO).
3.

Corn treatments
Naturally contaminated com containing 375 pg/g total fumonisins and 20

ng/g total aflatoxins was weighed and separated into 100 g portions. The different
treatments (Control-distilled water, 3% H2 O2 , 2% NaHC0 3 , and 3% H2 0 2 + 2 %
NaHCOs) were randomly assigned to three samples. The com was exposed to the
treatments for one hour at room temperature with mixing every

2 0

min and then

frozen at 20°C to stop the reactions. After freezing, the samples were freeze-dried
for 72 hours. The dry samples were kept under refrigeration (4°C) until analysis.
4.

Aflatoxin analysis
Extraction,

clean

up,

and

quantitative

determination

by

liquid

chromatography (HPLC) were performed according to the method reported by
(Thean et al., 1980). This method was described in detail in Chapter III. The results
were compared to the control treatment (distilled water) and a percentage of
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aflatoxin reduction was calculated. Aflatoxins Bi (AFBi) and B2 (AFB 2 ) were
quantified individually. Aflatoxins Gi and G2 were not detected in the original com.
5.

Fumonisin analysis
Fumonisin extraction, clean up and quantitative determination by HPLC

was performed according to the AOAC official method 995.15 for fumonisins Bi,
B2 , and B3 (AOAC, 1995). The results were compared to the control treatment
(distilled water) and a percentage of fumonisin reduction was calculated.
Fumonisins Bi and B2 were evaluated individually; fumonisin B3 was not
determined due to lack of a pure toxin standard.
6.

Toxicity/mutagenicity testing
A composite sample from each treatment was prepared by mixing the crude

extracts from the fumonisin and aflatoxin extractions. The fined solution contained
124 pg/ml total fumonisins and 6.7 ng/ml total aflatoxins.
7.

Salmonella!microsomal Mutagenicity assay
Salmonella tester strain TA-100 was used to evaluate the mutagenic

potential

of

aflatoxin

and

the

decontamination

reaction

products.

The

Salmonella!microsomal mutagenicity assay was conducted essentially as described
by Maron and Ames (1983). This method was described in detail in Chapter III.
Aflatoxin Bi ( 8 8 , 8 .8 , 0.88, and 0.088 ng/ml) and fumonisin B 1/B 2 (125, 12.5, 1.25,
and 0.125 pg/ml) concentrations were run. Mutagenicity was evaluated with and
without metabolic activation (S-9). Composites from the com extracts were
prepared to obtain a representative sample for each treatment. Dilutions were made
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from each sample to obtain ca.

12.4,

1.24, 0.124, and 0.0124 pg of

fumonisin/reaction products per plate and 0.67, 0.067, 0.0067, and 0.00067 ng of
aflatoxin/reaction products per plate.
8.

Brine shrimp assay
The brine shrimp assay (Artemia sp.) was performed according to the

method reported by Park et al. (1986). Tubes containing 10 and 100 pi of the
composite sample extracts were evaporated to dryness under a N 2 stream in a water
bath at 60°C. Negative (methanol) and positive (fumonisin B[, 0.5 pg/tube)
controls and an extract of aflatoxin/fumonisin free com were included.
9.

Statistical analysis
Statistical analysis was performed using the SAS software (SAS, 1988).

One-way analysis of variance (ANOVA) was used to determine differences in toxin
production and toxicity to S. typhimurium. Scheffe’s test with an alpha value of
0.05 was used to compare differences among the different treatments.
C.

Results and discussion
The treatment involving the combination of H2 O2 and NaHC 0 3 was the

most effective in significantly (p<0.05) reducing AFBi, FBi, and FB 2 (Figure 7.1).
However, less reduction was observed for AFB2 . These results suggest that the
main oxidation reaction occurs on the double bond present in aflatoxin Bi (Figure
2.1). This effect becomes even more evident when observing the individual effect
of H2 O2 and NaHCC>3 on AFB2 (Figure 7.1). H2 O2 showed no significant (p<0.05)
reduction of this toxin. However, treatment with NaHCC>3 resulted in higher
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Figure 7.1 Chemical reduction of aflatoxin B) and B2 , and fumonisin Bi and B2 naturally contaminated corn
exposed to H2 O2 and NaHC0 3 separate or in combination decontamination treatments.Values are mean±SEM
of three replicates.

reduction. In the case of FBi and FB2 , an additive effect can be observed. The
treatment involving both, H2 O2 and NaHC 0 3 reduced FB| and FB2 twice as much
as the reduction observed with the individual chemicals. These results show that the
use o f a combination o f H2 O2 and NaHC 0 3 is significantly effective in reducing
both, aflatoxins and fumonisins.
Hydrogen peroxide and sodium bicarbonate could be incorporated as an
additional processing step in any com processing set up. However, a potential
problem has been observed. The reaction with these chemicals is exothermic and
there is abundant foaming. This could pose a problem in an industrial operation.
Thus, new research on these treatments should include the addition of an antifoaming agent to reduce the foaming problem. Further evaluation of safety, and
effect on sensory characteristics and technological properties as well as pilot plant
escalation is recommended for these treatments.
With respect to brine shrimp toxic potential, positive toxic responses were
obtained by the untreated sample. However, the chemical treatments involving
H202/NaHCC>3 significantly (p<0.05) reduced the toxicity (Figure 7.2). When
comparing the chemical modification o f fumonisins and aflatoxins based on HPLC
analysis and the toxic potential, a clear relationship was observed (Figure 7.3). The
higher percentage o f reduction, the lower the brine shrimp mortality. The brine
shrimp assay is only a preliminary testing system. Therefore, further acute toxicity
testing of these treatments with more elaborate assays should be performed to
further evaluate their safety.

203

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission

100

□ 12 hours
□ 24 hours
■ 36 hours

80

■ 48 hours
60

40

to
o
•£-

20

(-) control

(+) control

Untreated

NaHC03

H202

H202
NaHC03

Sample
Figure 7.2 Toxic potentials to brine shrimp of aflatoxin B| and B2 , and fumonisin B) and B2 naturally
contaminated com exposed to H2 O 2 and NaHC( > 3 separate or in combination decontamination treatments.
(+): positive control=0.5pg FB|/tube; (-): negative control=methanol. Values are mean±SEM of three replicates.
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Figure 7.3 Total toxin reduction (total aflatoxin=AFB|+AFB2 ; total fumonisin=FB|+FB2 ) as determined by
HPLC compared to the toxic potential of the raw com extracts as determined by brine shrimp after 48 hour
exposure. Extracts from decontamination treatments using H2 O2 and NaHCC>3 separate or in combination
Values are mean±SEM of three replicates.

For the Salmonella!microsomal mutagenicity assay, sample revertant
colonies greater than or equal to two times the spontaneous reversion rate are
considered a positive mutagenic response. In samples analyzed without metabolic
activation (Figure 7.4). the untreated sample showed a positive mutagenic response.
Since AFBi is not mutagenic without metabolic activation, this suggests the
presence of mutagenic compounds other than AFBi. However, the treated samples
did not show a positive response. Therefore, these results imply that the treatments
might be effective in detoxifying other unidentified compounds.
Mutagenic responses were not apparent for any of the treatments with
metabolic activation (Figure 7.5). It is important to note that the untreated com
extracts did not contain a high enough AFBi concentration to elicit a mutagenic
response. However, the lack of mutagenicity presented by the treated samples
implies that no mutagenic by-products were generated in the oxidation reactions. It
is also important to consider that raw com extracts were used to determine the
samples’ toxic/mutagenic potential;

therefore,

the complex matrix may have

provided complex protective or antimutagenic reactions.
These treatments need more evaluation to be deemed safe. However, the
information presented in this study suggests that treatment with HiCh/NaHCOs
could be a good option for the com processing industry. Since these chemicals are
already in use as food grade additives with several applications in the food
industry, their addition during com processing operations could present a good
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Figure 7.5 Mutagenic potential of corn extracts from aflatoxin/fumonisin co-contaminated corn exposed to
decontamination treatments (H2O2 and NaHCC>3 separate or in combination) using tester strain Salmonella TA100 with metabolic activation. Values are mean±SEM of three replicates.

cost-effective option to reduce the risks associated with aflatoxin and fumonisin co
contaminated com. Since mycotoxin contamination is heterogeneous in nature, it is
difficult to estimate the real toxin content in the whole lot; even with the use of
good

sampling

programs.

Therefore,

the

development

of cost-effective

decontamination treatments will help establish manufacturing procedures that
include decontamination steps regardless of the results of mycotoxin analyses.
These processes would help reduce the overall potential threat posed by aflatoxin
and fumonisin co-contamination in com.
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VIII.

A.

Reduction o f risks associated with mycotoxin contamination*

Introduction
The unavoidable and unpredictable character of naturally occurring

toxicants, such as, mycotoxins poses a unique challenge to food safety. Surveys of
several agricultural commodities including products for human consumption, have
consistently revealed the presence o f mycotoxins. It would be unthinkable to
destroy all contaminated products without seriously compromising the global
availability

of food.

Hence,

risk

management

through

processing

and

decontamination/detoxification to avoid potential risks associated with mycotoxins,
and maintain the world's food supply has become a major issue in food safety. The
previous chapters have shown that there are many different issues involved in
mycotoxin contamination. Therefore, only a true interdisciplinary approach will
help in ultimately reducing the risks associated with dietary exposure to
mycotoxins.
B.

Integrated mycotoxin management programs
A food safety program in a given country will have to consider factors such

as the public health significance of the contaminant, the effects on the availability
of the countries' food supply, economy, legal infrastructure, analytical resources,
producer/consumer education, the effectiveness of communication systems as well
as the availability o f pre-harvest, harvest, and post- harvest technologies.

* Portions of this section has been reprinted with permission from Ref. 98-160), p.
(407) by courtesy of Marcel Dekker Inc. (See Appendix C).
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Prevention through pre-harvest management is the best method for
controlling mycotoxin contamination; however, should the contamination occur,
the hazards associated with the toxin must be managed through post-harvest
procedures if the product is to be used for food or feed purposes. Ideally, there
should be an integrated management system where mycotoxin hazards would be
minimized in every phase of production.
Once a food commodity has been harvested, there should be routine steps to
ensure the safety of the product. Figure 8.1 shows a decision making process to
develop a food safety program that will ultimately prevent potential hazards
associated with exposure to mycotoxin contaminated food and feed. This process
involves several steps that include the identification of the toxicant, hazard
evaluation, exposure determination, risk determination, and risk management. A
hazard evaluation provides a description of the expected lesion and of the
dose/response relationship. The determination is made based on available data on
comparative toxicological properties of the compound of interest, usually using
laboratory animal and in vitro toxicological tests. Following the development of
suitable analytical and sampling procedures, a determination must be made of the
geographic and temporal distribution of the toxic agent in each major commodity
susceptible to contamination. Combined with the commodity consumption data,
this information can lead to a determination o f exposure to the toxic agent by
various human and animal populations. A risk determination is made using
available information on hazard evaluation and exposure assessment (Park and
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Stoloff, 1989). Finally, after the risk has been determined, risk management
decisions can be made. A good risk management program involves the
establishment of regulatory limits, a monitoring program, a sampling plan, and
development of alternative processing/ decontamination procedures, or diversion to
less risk uses. This program should also include the development of strategies to
destroy highly contaminated products.
Processing can play an important role in diminishing the potential risks of
mycotoxin-contaminated food commodities. Thus, it is important to evaluate the
effects of processing on individual toxins to determine the actual risk posed to
humans/animals. A large amount o f data has been generated through surveys on
incidence and levels o f mycotoxin contamination in agricultural products, such as
nuts, oilseeds and grains (Stoloff, 1982; 1976). However, published information on
mycotoxins in foods processed for human consumption is limited. More research is
needed to provide food manufacturers and regulatory authorities with information
on mycotoxin persistence and transformation during processing. This information
would be helpful in the development of effective food safety programs.
In the past, the establishment o f a regulatory limit for the mycotoxin
considered to pose the highest risk, i.e., aflatoxin, was thought to be enough to
ensure a safe food supply. Any product that was found to be contaminated over the
regulatory limit had to be diverted to less risk uses or destroyed. At present, not
only is more information available, but also the quantity of food supply is more
limited throughout the world (FAO, 1996). Furthermore, there have been several
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reports on the co-contamination of various toxins, i.e., aflatoxin Bj/fumonisin
B i (Park et al., 1996), ochratoxin A/aflatoxin Bj (Harvey et al., 1989; Brownie and
Brownie, 1988), ochratoxin A/citrinin (Brown et al., 1986; Glahn et al., 1988),
ochratoxin A/deoxynivalenol (Kubena et al., 1984), ochratoxin A/penicillic acid
(Kubena et al.,

1984), ochratoxin A/T-2 toxin (Kubena et al.,

1989),

aflatoxin/cyclopiazonic acid (Smith et al., 1992), aflatoxin/kojic acid (Giroir et al..
1991), aflatoxin Bj/deoxynivalenol (Huff et al., 1986), and aflatoxin Bj/T-2 toxin
(Harvey et al., 1990). More

documentation on the levels and types of co-

contaminating mycotoxins occurring in different commodities is needed to more
clearly define the mycotoxin combinations and concentrations to which humans
and animals are likely to be exposed. A multi-toxin model should be considered
when evaluating a particular decontamination/detoxification process. This complex
environment poses new regulatory concerns. When the effect of processing and
modified processing to destroy/inactivate one or several toxins is considered, many
decision making paradoxes may rise. Should innovative processing designed to
detoxify a product be allowed, or should traditionally processed products
contaminated with low/medium doses of several mycotoxins stay in the market.
More research is needed in the area of alternative processing that will
decontaminate/detoxify mycotoxin-contaminated commodities, and render products
that will be approved by regulatory agencies and stay commercially competitive.
Ultimately, the best decontamination/detoxification process would be the one that

214

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

is approved by regulatory agencies, cost-effective, and that reduces the risks of
exposure to multiple-toxin contaminated commodities to acceptable levels.
When evaluating the effectiveness of a specific processing procedure on a
given mycotoxin or multi-toxin system, many factors need to be examined. These
factors include:
1. Chemical stability of the mycotoxin(s);
2. Nature o f the process;
3. Type and interaction with the food matrix; and
4. Interaction between different mycotoxins present.
Some processes involve the separation o f the commodity into different
fractions, i.e., milling or oil pressing. In these cases, it is important to determine
which fraction remains contaminated. If most o f the toxin(s) remain with process
by-products and these are not used for human consumption, then the process may
be deemed effective in detoxifying the main product. However, caution should be
used when determining the end fate of the by-products, i.e., animal feed. When
traditional processing methods

are not sufficient to decontaminate/detoxify the

commodity, then decontamination procedures and/or modified processing must be
considered (Figure 8.2). In these cases, careful evaluation of the procedure must be
performed before considering it as an alternative. It is well known that most
mycotoxins would not remain chemically stable in extreme conditions, i.e., extreme
pH, heat, etc. However, these procedures would not result in a usable food/feed
product.

Thus, special considerations

must

be

made

when developing
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decontamination/detoxification procedures. Park and co-workers (1993) have
proposed specific criteria for evaluating the acceptance of a given mycotoxin
reduction or decontamination procedure. In order to be effective, the process must:
1. Inactivate, destroy, or remove the toxin;
2. Not produce or leave toxic residues in the food/feed;
3. Retain nutritive value and food/feed acceptability of the product;
4. Not alter significantly the technological properties of the product;
5. If possible, destroy fungal spores.
Managing the risks associated with mycotoxin contamination should involve
an integrated system. Processed foods cannot be safe if prevention, control, good
manufacturing practices, and quality control are not used at all stages of
production. Figure 8.3 shows selected aspects of an integrated aflatoxin control
program. This can be used as a model system when developing food safety
programs for other mycotoxins or naturally occurring toxicants. Each phase would
have to be adapted according to the toxin and the commodity in question. A Hazard
Analysis Critical Control Point (HACCP) type of approach to processing
mycotoxin-contaminated commodities should be considered. Control parameters
would include timeliness of harvesting, temperature, and moisture during storage
and transportation, selection of agricultural products prior to processing;
processing/decontamination conditions, i.e., temperature, addition of chemicals and
final product storage and transportation. This approach should be developed not
only

for

specific single toxins, but also for multi - toxin models, i.e.,
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aflatoxin Bj/fumonisin B j.

As mentioned

before, a food safety management

program for naturally occurring toxicants should involve different phases such as
the ones outlined below:
I. Setting of regulatory limits
II. Establishment of a monitoring program
A. Establishment of a sampling plan
1. Sample collection
2. Sample preparation
3. Analysis
B. Permitted uses of mycotoxin-contaminated products
C. Designation o f use for violative products
III. Control through processing
A. Good manufacturing practices
B. Quality control
IV. Decontamination through specific treatments
A. Evaluation o f the final product
B. Designation of use of treated product
The establishment of regulatory limits may vary in each country depending
on level of exposure, sociological, political and economic factors. Due to the
increased international trade, it has been suggested that an international standard be
set. However, at present, different regulations are in place. Table 8.1 shows current
regulatory status for aflatoxins in the United States. Currently, mycotoxin
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regulatory data are available for ninety countries. Seventy seven countries are
known to have some regulations on mycotoxins. and thirteen countries are known
to have no regulations. No data are available for about forty countries with more
than five million inhabitants, most of them in Africa (FAO, 1998). Most of the
existing mycotoxin regulations are for aflatoxins (Table 8.2).

Table 8.1 Current aflatoxin action levels (total) established by the Food and Drug
Administration (Park, 1993)
Food or feed
Action level
(pg/kg, ppb)
Human foods (except milk)
20
Milk
0.5
Animal feeds (except as listed below)
20
Cottonseed meal (used for mature beef, swine and poultry
rations)
300
Com and peanut meal for breeding beef cattle, breeding
swine, or mature poultry
too
Com and peanut meal for finishing swine
200
Com and peanut meal for feedlot cattle
300
Table 8.2 Medians and ranges in 1995 of maximum tolerated levels (pg/kg) for
aflatoxins and numbers o f countries that have regulations for these (FAO, 1996).
Range
Median
Number of
Countries
Bi in foodstuffs
0-30
4
33
B|, Ba, Gi, G2 in foodstuffs
0-50
8
48
Bi in foodstuffs for children
0-5
0.3
5
Mi in milk
0.05
0 -1
17
Bi in feedstuffs
5-1000
19
20
Bi, B2 , Gi, G2 in feedstuffs
0 -1 0 0 0
21
50

Once a regulatory limit has been set, sampling plays an important role in
determining the fate of a particular product. Adequate, random sampling techniques
should be used at each point of analysis. It is important to consider the existence of
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"hot spots" or highly contaminated portions of the product. If these highly
contaminated portions are not detected, the toxin(s) would then be distributed
throughout the lot rendering a highly contaminated product. Once the levels of
contamination have been determined through a monitoring program, the final use
of the commodity can be determined. The product may be deemed either safe for
human consumption, safe for feed use through treatment, or totally unsuitable for
use at any point in the food chain.
A good example of management through a monitoring program is the
aflatoxin control program used by the State of Arizona (United States) (Park,
1993). During the year 1978, almost 910,000 pounds of milk were dumped with
contamination levels as high as 10 ppb aflatoxin Mj. As a result of this huge
commercial loss and the need to establish an effective aflatoxin control program,
the State instituted a program to monitor aflatoxin levels in whole cottonseed and
cottonseed products, the major source of aflatoxin contamination in feed. All
cottonseed produced in the state is tested for aflatoxin content. The maximum size
of the lots tested is

100

tons, and the testing is conducted in state-certified

laboratories. The end use of the product is dictated by aflatoxin levels found.
Cottonseed lots testing over 20 pg aflatoxin/kg are usually treated with ammonia to
reduce aflatoxin levels. Cottonseed products containing less than 20 ppb aflatoxin,
with or without ammonia decontamination treatment, can be used for dairy rations.
The key aspect of the aflatoxin decontamination program is that the product is
tested for aflatoxin levels before and after the ammonia treatment, as appropriate.
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The use of this program has resulted in a significant benefit in keeping Arizona's
milk supply safe from aflatoxin contamination (Table 8.3).

Table 8.3 Aflatoxin residues in milk produced in Arizona (Park, 1993)__________
No. of samples with an
AFMi concentration of
% of samples containing
Year
No. of samples
0.2-0.5 pg/1
>0.5 p.g/1
detectable levels of
AFMi
535
0
26
140
972
1980
169
0
17
940
1981
109
0
11
802
1982
227
0
28
900
1989
121
0
13
a: In 1978 909,442 lb o f milk with aflatoxin levels as high as 10 p.g/1 were
destroyed.
1 9 7 9 *

a

T_

i n

In an integrated mycotoxin management program, each phase would help
prevent the risk of exposure to the toxins. After pre-harvest control, harvesting and
monitoring, most of the contaminated product would have been separated and
destined to different uses or decontamination treatments. However, industrial
processing is still an important phase of control. The final goal of processing would
not only be the decontamination of the commodity, but also the prevention of new
mold colonization with its subsequent mycotoxin production. Thus, when the
product

reaches

the

consumer,

the

hazards

associated

with

contamination of food would have been minimized.
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mycotoxin

IX.

Summary and conclusions
This study explored different aspects of aflatoxin B| and fumonisin Bi co

contamination in com. Special emphasis was placed on potential interactions
between toxin production and toxic/mutagenic potential.
Although no definite pattern to relate the ability of Aspergillus jlavus and
Fusarium moniliforme to produce different toxins and change the toxic/mutagenic
potential of contaminated com could be established, evidence that indicated that
many factors are simultaneously involved in these processes was presented. It was
shown that A. Jlavus and F. moniliforme can co-exist in the same environment and
produce different levels of aflatoxins and fumonisins, respectively. It was also
observed that old mycelia of a toxigenic strain o f A. Jlavus can reduce aflatoxin
levels over time, and that F. moniliforme may either inhibit aflatoxin production or
enhance its degradation. Additionally, it was shown that F. moniliforme is capable
o f producing unidentified compounds with mutagenic potential. There was
evidence that both mold strains are capable o f producing a wide variety of
toxic/mutagenic compounds and that fungal interaction(s) can shift toxin
concentrations over storage time.
More information is needed on the ecological relationships between A.
Jlavus and F. moniliforme and their potential interactive effects on mycotoxin
production and stability. It would be interesting to explore these relationships over
shorter storage periods (<15 days). Further understanding would also be gained by
performing a similar study at different moisture and temperature levels. These
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levels should include storage conditions normally used for com. Results from such
studies would help assess the potential toxin production and degradation in real
conditions to better understand the risks associated with aflatoxin and fumonisin
co-contamination.
The potential involvement of fungal cytochrome P450 enzymes as well as
oxidation enzyme systems as key factors in toxin production and degradation was
exposed. Further research in this area would help understand toxin production and
degradation pathways to develop better mechanisms for biological control.
It was determined that different AFBi/FBi ratios can elicit divergent
responses in the Salmonella/microsomal mutagenicity assay using tester strains
TA-100 and TA-98. Evidence was provided to show that these reactions were
dependent on metabolic activation achieved by addition of

S9 mix (rat liver

postmitochondrial supernatant). The results from this study suggested that FBj
affects AFBi mutagenic potential in a dose-dependent fashion. The mutagenic
potential of lxlO 3 ng AFBi/plate was reduced by addition o f 1 to 102 ng FBj/plate.
However, higher FBi concentrations (lxlO 3 to lx l0 5 ng/plate) exerted an opposite
effect; and mutagenicity was returned to its original level in a dose-response type of
relationship. These complex interaction mechanisms may be attributed to several
factors that may include the direct chemical reaction between both toxins or toxin
byproducts, and/or a mechanistic interaction where FBi could be affecting one or
more of the enzyme systems involved in xenobiotic activation/detoxification
pathways.
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When the effect of FBi on the mutagenic potential of 10 pg 2aminofluorene/plate was evaluated, the same response was observed. This provided
further

evidence

that

FBi

may

affect

some

of

the

xenobiotic

activation/detoxification enzymes present in the S9 mix.
The study of the effect of FBi on individual microsomal enzymes, such as
P4501A2, and cytosolic enzymes prostaglandin synthetase, glutathione peroxidase
and glutathione-S-transferase among others, may help clarify the mechanisms
involved in interaction and understand the potential health hazards associated with
simultaneous exposure.
Addition of 1 to lxlO 5 ng FBi to lxlO 3 ng AFBi affected AFBi recovery in
the same fashion as it affected its mutagenic potential. Recovery of AFBi/AFBr
metabolites was decreased by addition of 1 to 102 ng FBj. In the lxlO 3 to lxlO 5 ng
FBi range, AFBi/AFBi-metabolites recovery was increased in a dose-dependent
way. These results indicated that the recovered metabolites may have been
responsible for the mutagenic response observed previously. Analysis by thin layer
chromatography showed that the recovered AFBi could have been a metabolite that
co-eluted with AFB 2 aFurther research in this area may help understand the mechanisms involved
in AFB i/FB i interactions. It would be interesting to characterize the metabolites
produced by these reactions. Additionally, a study of the kinetic parameters
involved in these reactions would also help determine the specific mechanisms
involved in these interactions.
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This study also determined that FBi inhibits gap junctional intercellular
communication of Clone-9 rat liver cells in a dose-dependent fashion. These results
provide further information on the possible mechanisms involved in FBi’s
carcinogenicity. Furthermore, it was established that the use of the scrape-loading
dye transfer assay using Clone-9 rat liver cells could be used as a short-term assay
to study FB[. More research is needed to determine if this technique would be
useful for com extract analysis. This technique could be added to the battery of
short-term assays used to monitor the safety of com decontamination treatments.
When AFBi (1 to lxlO3 ng/plate) was added to FBi (1x103), no change in the
inhibition o f gap junctional intercellular communication was observed. The
metabolic competency o f Clone-9 rat liver cells is unknown. Therefore, although
there is some evidence, it cannot be concluded that that AFBi does not affect this
FBi toxic response.
It was also observed that exposure of clone-9 rat liver cells to FBi and/or
AFBi increased the retention of neutral red. Since this dye is mainly uptaken by
lysosome membranes, these results provided further evidence that peroxisome
proliferation and oxidative metabolism may be involved in the interaction between
these two toxins.
The use of hydrogen peroxide (3%) and

sodium bicarbonate (2%) was

proposed as a decontamination treatment for both, aflatoxins and fumonisins. This
study showed that these treatments were effective not only in reducing the toxin
content o f naturally contaminated com, but also in reducing toxicity to Artemia sp.
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No mutagenic by-products were created by these treatments as tested by the
Salmonella!microsomal mutagenicity assay using tester strain TA-100 with and
without metabolic activation. Although further evaluation is needed, these
treatments could be a good cost-effective strategy to reduce the hazards associated
with aflatoxin and fumonisin co-contaminated com.
This study showed that simultaneous production o f AFBi and FBi is a
dynamic process and exposure to both, AFBi and FBi can change toxic/mutagenic
responses. Furthermore, it was shown that testing two or more compounds changes
the perspective of their activity. Therefore, when risk assessment considerations are
made, potential interactions between co-contaminating agents should be taken into
account. Since aflatoxins and fumonisins are ubiquitous, unavoidable and
unpredictable contaminants of com, a multi-toxin interdisciplinary approach should
be taken not only by research groups, but also by regulatory agencies to better
understand and regulate the potential impact of co-contamination in food safety.
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Appendix A: List of Abbreviations
2-AF

2-aminofluorene

AA

Arachidonic acid

AFB|

Aflatoxin Bi

AFBi

Aflatoxin B2

AFBaa

Aflatoxin B2 a

AFGi

Aflatoxin Gi

AFG 2

Aflatoxin G2

AFMi

Aflatoxin Mi

AFPi

Aflatoxin Pi

AFQi

Aflatoxin Qi

AP

Aminopentol

ATCC

American type culture collection

CFSAN

Center for Food Safety and Applied Nutrition

DAG

Diacylglycerol

DMSO

Dimethyl sulfoxide

EC

Human esophageal cancer

ELEM

Equine leukoencephalomalacia

ER

Endoplasmic reticulum

FAO

Food and Agriculture Organization of the United Nations

FBi

Fumonisin Bi

FB2

Fumonisin B2
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fb 3

Fumonisin B3

FDA

United States Food and Drug Administration

FMO

Flavin containing monooxygenase

G-6 -P

Glucose-6 -phosphate

GJ

Gap junction

GJIC

Gap junction intercellular communication

GPI

Glycosylphosphatidylinositol anchor

GST

Glutathione-S-transferase

HPLC

High pressure liquid chromatography

Ksa

3-ketosphinganine

LC

Liquid chromatography

LO

Lipoxygenase

LY

Lucifer yellow

MFR

Membrane folate receptor

MSD

Mystery swine disease

MW

Molecular weight

NADP

P-nicotinamide-adenine-dinucleotide-phosphate

N-Acyl-So

Ceramides

NTD

Neural tube defects

NR

Neutral red

OPA

orto-phtaldehyde

P450

Cytochrome P450
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Pal-CoA

Palmitoyl-CoA

PBS

Phosphate buffer solution

PBS-Ca, Mg

Phosphate buffer solution without calcium or magnesium

PBS+Ca, Mg

Phosphate buffer solution with calcium or magnesium

PCR

Polymerase chain reaction

PDA

Potato dextrose agar

PKC

Protein kinase C

PHF

Partially hydrolyzed fumonisin

PHS

Prostaglandin H synthetase

PPE

Porcine pulmonary edema

PUFA

Polyunsaturated fatty acids

S9

Sprague-Dawley rat liver post-mitochondrial supernatant

Sa

Sphinganine

Sa-P

Sphinganine-phosphate

SEM

Standard error mean

So

Sphingosine

So-P

Sphingosine-phosphate

TCA

Tricarballilic acid

TFA

Trifluoroacetic acid

TLC

Thin layer chromatography
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Appendix B: Raw data for interaction study

Experiment 1
AFB 1/FB 1 Combinations
Salmonella tester strain TA-100 with S9
Sample information is presented on Table 4.1
NA: Not available
Sample
N at Rev.

plate a
152

plate b
154

plate c
154

M ean
153

SEM
1

Fumonisin
A 1 ng
B lO n g
C 100 ng
DIOOOng
E l 0000 ng
F 100,000 ng

138
155
276
168
179
169

150
260
200
176
183
98

148
328
182
NA
168
196

145
248
219
172
177
154

4
50
29
57
4
29

Aflatoxin + Fumonisin
l(lngAFBl)
1A
IB
1C
ID
IE
IF

116
224
187
184
179
135
180

136
180
132
198
169
155
126

141
93
145
182
187
144
168

131
166
155
188
178
145
158

8
38
17
5
5
6
16

2 (10 ng AFB1)
2A
2B
2C
2D
2E
2F

214
174
214
428
224
236
216

207
181
195
266
360
218
184

190
208
204
348
296
206
198

204
188
204
347
293
220
199

7
10
5
47
39
9
9

3 (100 ng AFB1)
3A
3B
3C
3D
3E
3F

536
620
508
556
1704
1356
536

528
468
548
432
1512
1308
470

516
417
468
504
1500
992
512

527
502
508
497
1572
1219
506

6
61
23
36
66
114
19

4 (lOOOng AFB1)
4A
4B
4C
4D
4E
4F

2988
1824
1128
1220
1488
1380
2268

2216
1776
1332
924
1752
1392
1788

2616
1764
1332
952
1632
1500
NA

2607
1788
1264
1032
1624
1424
2028

223
18
68
94
76
38
240
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AFBi/FBi Combinations
Salmonella tester strain TA-98 with S9
Sample information is presented on Table 4.1
NA: Not available

Sample

plate a

plate b

plate c

Mean

SEM

Nat. Rev.

28

24

26

26

1

1
1A
IB
1C
ID
IE
IF

30
36
35
31
NA
45
41

32
30
39
31
NA
42
46

31
27
42
NA
43
52
36

31
31
39
31
43
46
41

1
3
2
0
14
3
3

2
2A
2B
2C
2D
2E
2F

39
53
21
35
29
43
38

44
12
NA
52
52
47
44

37
27
NA
45
32
43
44

40
31
21
44
38
44
42

12
0
5
7
1
2

3
3A
3B
3C
3D
3E
3F

248
132
120
78
152
200
200

158
236
NA
82
228
118
146

376
208
NA
96
168
216
244

261
192
120
85
183
178
197

63
31
0
5
23
30
28

4
4A
4B
4C
4D
4E
4F

972
864
960
468
NA
744
1080

1092
1212
720
672
NA
900
1296

1020
1394
936
408
588
924
972

1028
1157
872
516
588
856
1116

35
155
76
80
196
56
95

A
B
C
D
E
F

31
22
39
35
27
31

27
10
35
56
47
50

36
24
41
40
40
39

31
19
38
44
38
40

3
4
2
6
6
6

2
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Experiment 2
AFB 1/FB 1 Combinations
Salmonella tester strain TA-100 with S9
Sample information is presented on Table 4.1
NA: Not available

Sam ple

plate a

plate b

plate c

M ean

SEM

Nat. Rev.

352

388

348

363

13

336
460
415
496
480
428
432

356
392
512
400
456
556
488

382
420
392
404
448
480
464

358
424
440
433
461
488
461

13

2A
2B
2C
2D
2E
2F

440
388
472
432
432
512
616

508
392
664
284
364
520
584

476
468
NC
428
360
392
548

475
416
568
381
385
475
583

26
197
49
23
41

3
3A
3C
3D
3E
3F

664
416
472
572
684
1420

720
500
612
636
720
736

788
720
504
856
716
972

724
545
529

36
91
42

6 8 8

8 6

707
1043

A
B
C
D
E
F

456
2976
528
436
628
512

440
3648
408
508
520
556

428
3504
484
476
480
560

441
3376
473
473
543
543

1

1A
IB
1C
ID
IE
IF
2
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2 0

37
31
10

37
16
2 0

2 0

11
201

8

204
35
21

44
15

AFB 1/FB 1 Combinations
Salmonella tester strain TA-100 without S9
Sample information is presented on Table 4.1
NA: Not available

Sample

plate a

plate b

plate c

Mean

Nat. Rev.

154

144

172

154

146
139
146
189
97
126
126

148
135
135
143
126
117
142

177
137
166
169
143
165
107

157
137
149
167
136
125

2A
2B
2C
2D
2E
2F

118
106
157
151
163
151
181

134
105
154
158
156
161

149
143
141
173
153
171
163

134
118
140
159
158
159
168

3
3A
3B
3C
3D
3E
3F

61
125
176
214
147
125
127

120

128

130
147
158
199
119
152

169
142
181
127
162

103
119
164
171
176
124
147

A
B
C
D
E
F

127
143
95
143
170
153

125
173
105
126
157
116

1

1A
IB
1C
ID
IE
IF
2

121

101

1 2 2

157

124
158

102

101

174
169
158

148
165
142

121
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SEM
8

10
1

9
13
13
15
10

9
13
10

7
3
6
6

21

9
9
22

15
2
10

2

9
3
14
4
13

Experiment 3
AFB 1/FB 1 Combinations
Salmonella tester strain TA-100 with S9
Sample information is presented on Table 4.1
NA: Not available

plate a

plate b

plate c

Mean

SEM

Nat.Rev.

189

199

173

187

8

1
IA
IB
1C
ID
IE
IF

126
127
121
178
160
36
119

117
146
145
131
163
32
132

292
133
104
168
176
34
117

178
135
123
159
166
34
123

57
6
12
14
5
1
5

2
2A
2B
2C
2D
2E
2F

133
142
141
153
172
632
126

163
133
161
152
168
199
130

159
116
165
163
143
215
155

152
130
156
156
161
349
137

9
8
7
4
9
142
9

3
3A
3B
3C
3D
3E
3F

236
129
178
152
324
158
213

226
132
181
137
198
171
285

228
129
144
151
228
182
167

230
130
168
147
250
170
222

3
1
12
5
7
34

4
4A
4B
4C
4D
4E
4F

311
392
271
396
544
720
816

461
336
468
456
536
672
928

552
202
324
396
528
968
580

441
310
354
416
536
787
775

70
56
59
20
5
92
103

A
B
C
D
E
F

106
148
145
45
148
166

123
116
125
131
135
184

204
145
130
123
157
169

144
136
133
100
147
173

30
10
6
27
6
6

00

Sam ple
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AFBj/FBi Combinations
Salmonella tester strain TA-98 with S9
Sample information is presented on Table 4.1
NA: Not available

Sample

plate a

plate b

plate c

Mean

SEM

Nat .Rev.

27

36

34

32

3

1
1A
IB
1C
ID
IE

28
33
14
23
26
35

21
30
23
20
36
30

31
24
21
27
24
32

27
29
19
23
29
32

3
3
3
2
4
1

2
2A
2B
2C
2D
2E

29
28
162
29
28
26

27
25
185
18
35
23

28
19
169
33
23
29

28
24
172
27
29
26

1
3
7
4
3
2

3
3A
3B
3C
3D
3E

22
29
35
25
31
37

40
23
31
21
31
28

31
36
22
33
37
30

31
29
29
26
33
32

5
4
4
4
2
3

4
4A
4B
4C
4D
4E

71
77
67
67
127
203

66
59
53
54
113
118

54
80
48
65
158
119

64
72
56
62
133
147

5
7
6
4
13
28

A
B
C
D
E

32
31
17
20
22

22
25
24
30
30

21
27
29
21
24

25
28
23
24
25

4
2
3
3
2
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Appendix C: Letter of permission from Marcel Dekker, Inc.
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D e p a rtm e n t o f fo o d Science

May 1,1998

Ms. Julia Mulligan
Marcel Dekker
270 Madison Ave.
New York, N Y 10016

Dear Ms. Mulliean
I am writing to you regarding our contribution o f the chapter “Effectiveness o f
Post-Harvest Procedures in Management o f Mycotoxin Hazards" that will be printed in
the book Mycotoxins in Agriculture and Food Safety (Sinha/Bhatnagar, Eds.). I would
like to request your permission to include this chapter as part o f my doctoral dissertation
at Louisiana State University. In order to print this chapter in my dissertation, I need a
written letter o f permission from your company. This letter would be included as an
appendix in the final document The dissertation will be submitted to Louisiana State
University Graduate School in June and will be copyrighted.
Please let me know if you need more information regarding this matter. I
appreciate your help, and look forward to hearing from you soon. C£ € ^ ^

Sincerely yours.

Rebeca Lopez-Garcia
Ph.D. Candidate

TV'-Cl A . j

1W»£ vi, rtf*

PERMISSION GRANTED with Vm imoonuuemd th«t
CKoo*' credit M (non to tiercel M w
Inc.
«*—..> 0 Lot mould mdude:
•
> nunc 1*1. TITLE O f BOO* OR iCHRNAL
« ______ Number _ . I t o m l O m c me. * T
T ear 0< PubhCitnn
Gcct -tun to be leprinted ihmAd

R c p n n ta d Irom R d I

L P

ti* ime*
*>»

V M ate d O i U a r h e . _______________ _____
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Vita

The author was bom on January 1, 1971, being second child to Dr. Raul B.
Lopez-Garcia and Mrs. Rebeca Gomez-Deses de Lopez-Garcia and sister to Mr.
Raul B. Lopez-Garcia. In 1995. she graduated with high honors from La
Universidad La Salle in Mexico City, Mexico, with a major in Chemistry and a
concentration in Food Science. Immediately after, she enrolled in Louisiana State
University to pursue a doctoral degree in Food Science with the Interdepartamental
Concentration in Toxicology. Her research interests focused on the study of
possible interactions in multi-toxin systems, in particular, aflatoxin Bi and
fumonisin Bi in com; and the development of

industrial decontamination

procedures. During her doctoral program, the author became highly involved with
the Institute of Food Technologists where she held several local and national
leadership positions. In 1996, she was conferred membership to the Omicron Delta
Kappa National Leadership Honor Society. Throughout her program, she received
fellowship awards from The Institute of Food Technologists and The American
Association of Cereal Chemists. Her studies were supported by the Mexican
government through El Consejo Nccional de Ciencia y Tecnologia (CoNaCyT) and
by Louisiana State University through a graduate tuition award. Additionally she
held research and teaching assistant positions in the Department of Food Science,
Louisiana State University. Currently, she is a candidate for the degree of Doctor of
Philosophy, which will be conferred in August, 1998.
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